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Abstract
Allergies and asthma result from immune responses to common environmental antigens. Despite the
fact that both diseases have been described as having a strong genetic background, influences by envi-
ronmental factors are not negligible. In fact, direct exposure to environmental pollutants (e.g tobacco
smoke or chemicals) has already been associated with the development of such diseases and pieces of
evidence pile up that early life exposure to these substances is critical. The group of chemicals called
“phthalates” are classified among the incriminated substances. Long non-coding RNAs (lncRNAs) are
part of the cellular elements that can be influenced by such exposure. They have been extensively
studied over the last decade, highlighting potential roles in both normal and pathological cell functions,
and have been associated with various diseases including some immune-related ones such as allergic
reactions. Nevertheless, the role they play in environmental health still requires to be clarified.
Maternal exposure to benzyl butyl phthalate (BzBP), a chemical from the phthalate family present
in daily-life products (e.g. vinyl flooring, adhesives), has been associated with allergies and asthma de-
velopment in cohort studies. The underlying cellular mechanisms remain nonetheless mostly unknown.
Because the immune cells T helper (TH) and B cells are key actors in such pathologies, we hypothesized
that maternal exposure to BzBP may have an impact on asthma and allergy development by affecting
these cells. The present study therefore focused on the effect of maternal exposure to BzBP on TH and
B cells, with a particular interest in BzBP-induced changes in lncRNAs expression, motivated by their
cellular functions and their putative responsiveness to chemicals.
Using a murine model and RNA-sequencing, we observed that perinatal (during pregnancy and
breastfeeding) and prenatal (pregnancy only) exposure to BzBP led to differential expression in TH
cells, including for lncRNAs. With the aim of identifying putative roles of BzBP-regulated lncRNAs,
weighted correlation network analysis was performed. The results suggest that some of the non-coding
transcripts regulated by prenatal exposure to BzBP may be involved in TH cell-related functions such
as cell activation, TH2-cytokines expression and regulation of the inflammatory response.
Differential expression of lncRNAs due to prenatal exposure to BzBP was also observed in mouse
B cells. Recently published RNA-sequencing data for B cell development and activation (Brazao et al.,
2016) were integrated with our own data for correlation network analysis. The results revealed that
some of the BzBP-regulated lncRNAs were correlated with genes involved in B cell-related functions.
In particular, we hypothesized that two of these lncRNAs may play a role in germinal center B cell
functions.
Several non-coding transcripts that are regulated by prenatal exposure to BzBP and that may be
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involved in TH cell-related processes and in germinal center B cell functions were therefore identified.
Due to the association of the concerned processes and of this B cell sub-population with the devel-
opment of allergies and asthma, we suspect these genes to also be actors in such phenomenons after
prenatal exposure to BzBP. We propose models of how these genes are involved in immune-related
functions and how their regulation by BzBP may be critical. Taken together, these data thus provide a
whole new layer of information of the toxicological effect of prenatal exposure to BzBP and of how this
exposure might be associated with allergies and asthma development by providing an insight of under-
lying cellular mechanisms. Moreover, our study also contributes to filling the gaps in the knowledge
concerning the roles of lncRNAs in environmental health by showing that BzBP influences non-coding
transcripts that may be involved in pathologies.
2
1
Introduction
The mammalian body is continuously exposed to exogenous elements such as micro-organisms,
pathogens or toxins. Some of these have the power of disturbing the body functions and can also
cause damages or be life-threatening. However, one does not turn to be ill that often. Indeed, in
addition to the physical and physiological barriers, a powerful internal defense system resists against
those harmful elements: the immune system. This latter is based on various types of molecules and
cells that need to be finely tuned. In fact, if not kept under proper control, the immune system can
become detrimental rather than beneficial and lead to the development of diseases. For instance, the
exposure to environmental pollutants is one of the potential sources of disturbances in this system and
it has already been associated with immune-related diseases. From a mechanistic point of view, this
influence of our environment is carried by different mechanisms including epigenetics regulations and
long non-coding RNAs.
1.1 The immune system
The immune system∗ of an individual has the ability to eliminate foreign elements. Indeed, molecules
from pathogens can be recognized and induce an “immune response”. Such molecules are called “anti-
gens”. The first step of this immune response consists thus in the immunological recognition, which
is both fast and specific: the immune system is able to make the distinction between elements of the
body and foreign ones (self vs. nonself). Therefore, the immune response should be triggered only
if a pathogen is recognized in order to neutralize or eliminate this intruder. The immune system is
nonetheless also able to actively regulate its own response in order to avoid self-damage to the body
(see Section 1.4). Moreover, in the hypothetical case that an individual is exposed a second time to the
same element, the immune system has the ability to keep track of it. We talk about immunological
memory.
To reach these different goals, the immune system is made of a complex ensemble of molecules and
∗The general information concerning the immune system and its cells summarized in the following sections derived
from the books “Immunobiology” (by Murphy and Weaver [? ]), “Kuby immunology” (by Goldsby et al. [? ]) and
“Immunology, a short course” (by Coico and Sunshine [? ]).
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cells that work closely together. The cells of the immune system, called “leukocytes” or “white blood
cells”, are present at 7.3× 103 cells/mm3 of blood from an adult. They all derive from a single type of
cell from the bone marrow: the hematopoietic stem cell. This latter differentiates in either a common
myeloid or lymphoid progenitor, and each of those can differentiate in a broad variety of cells such as
presented in the Figure 1.1.
The common myeloid progenitors are at the root of red blood cells such as erythrocytes and platelets,
and of various cells from the immune system such as eosinophils, neutrophils, basophils, mast cells,
monocytes and dendritic cells. All these immune cells play a role in the “innate immune response” (left
part of the Figure 1.1). In parallel, the common lymphoid progenitors differentiate in natural-killer
cells and dendritic cells that join the innate immune response as well, and in T lymphocytes and B
lymphocytes that are the cellular components of the “adaptive immune response” (right part of the
Figure 1.1).
Hematopoeitic 
stem cell 
Common myeloid 
progenitor 
Dendritic cell 
Monocyte 
Natural 
killer cell 
 
Mast cell 
Macrophage 
Platelets 
Erythrocyte 
Common lymphoid 
progenitor 
Eosinophil 
Basophil 
Neutrophil 
Granulocytes 
B cell 
Cytotoxic 
(CD8+) T cell 
T helper 
(CD4+) cell 
Figure 1.1. The immune cells. The cells part of the innate immune cells (blue) and of the adaptive immune
system (orange) are represented.
The innate immune system is made of physical and chemicals barriers (e.g. skin, acid pH of the
stomach), a complex ensemble of molecules that leads to the destruction of the pathogen called the
“complement system”, and of a broad variety of cells as mentioned above. The innate immune system
can respond quickly, within the first hours after the contact with the foreign element, and represents
therefore the first protection barrier (Supplementary Figure S1 in Appendix A). Moreover, it is able to
distinguish the self from the non-self, avoiding in principle the destruction of healthy self-cells. Indeed,
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the cells of the innate immune system express “pattern recognition receptors” (PPR), such as the
extensively studied membrane Toll-like receptors (TLR) or cytosolic NOD-like receptors (NLR), which
can recognize some conserved non-self molecules also called “pathogen-associated molecular patterns”
(PAMP) (e.g. the Lipo-polysaccharide (LPS) from the bacterial membrane or nucleic acids associated
with viral molecules). Nevertheless, it misses the ability to recognize pathogens specifically (no antigen-
specific receptors at the surface of the cells). This lack of antigen-specificity of the innate immune system
leads to its last characteristic: it is unable to keep track of previously encountered pathogens. The
innate immune response is therefore quick, self vs. non-self differentiating but remains nonetheless
unspecific and without memory.
On the contrary to the innate immune system that is present in any animal, the adaptive immune
system appeared later in the evolution, and can be found only in the jawed vertebraes (from gnathos-
toma to mammals) [? ]. The adaptive immune system is exclusively represented by cells: the T and B
lymphocytes, also commonly named T and B cells. These cells can provide an immunological response
only a few days after getting in contact with the pathogens (Supplementary Figure S1 in Appendix A).
However, they have antigen-specific receptors at their surface and can keep track of the encountered
pathogens. This last point confers the T and B cells the ability to give a quicker response in case of a
second contact with already-known pathogens. The response provided by the adaptive immune system
is therefore slower but specific and with memory.
To summarize, the innate and adaptive immune systems show different characteristics (antigen
receptors, immunological memory, response speed) and are orchestrated by different actors. However,
the two systems should not be considered totally independent of each other. Indeed, the two groups of
cells secrete proteins that can regulate and chemically attract one another (cytokines and chemokines).
Additionally, some cells from the innate immune system, such as macrophages or dendritic cells, are
directly involved in the triggering of the immune response by activating T cells (see Section 1.2).
Finally, cell types were recently described as having an intermediate role between the innate and
adaptive immune systems (e.g. natural killer cells [? ? ], innate lymphoid cells [? ], γ:δ T cells [?
], MAIT - Mucosal associated invariant T - cells [? ? ]), highlighting even more that the separation
between the two parts is not as clear as first assumed.
Considering that we focused on the cells from the adaptive immune system in this study, the
following parts will be dealing with T and B cells only.
1.2 T cells
Some common lymphoid progenitors migrate from the bone marrow to the thymus for their mat-
uration process, hence the name of the resulting cells: the “thymus-dependent lymphocytes” or “T
cells”.
The thymus is a primary lymphoid organ located in the upper anterior thorax where T cells inten-
sively proliferate. Nevertheless, the size of the thymus does not increase since most of the said T cells
actually die by apoptosis. Far from being a waste of resources and energy, this is proof of a highly
selective process taking place there. The thymus is active during the childhood and adolescence, but
its activity diminishes over life-time and this organ has the tendency to shrink. However, the number
5
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of T cells remains stable during life, leading to think that the existing T cells can survive and keep
dividing and proliferating.
T cells express a characteristic antigen-receptor at their surface, the “T Cell Receptor” (TCR),
which is a dimer made of 2 chains encoded on different chromosomes. The chains that compose the
TCR define the names of T cell sub-populations: the cells with TCR made of α and β chains are
therefore called α:β T cells, in opposition to the γ:δ T cells (TCR made of γ and δ chains). The
differentiation of the common lymphoid progenitors leads to an abundant α:β T cell population but a
minor γ:δ T cell population. Considering that this project was focusing only on the most well described
α:β T cells, we keep referring to those simply as “T cells” in the following.
Additionally, T cells are themselves divided into two sub-populations: the “cytotoxic T cells” (TC)
and the “T helper cells” (TH). While the TC cells can recognize infected cells and trigger their death,
the TH cells are involved in the regulation of other immune cells and of the immune response in general.
TC and TH cells are also called “CD8
+ T cells” and “CD4+ T cells”, respectively, due to their specific
surface markers. However, these proteins are not expressed by the common lymphoid progenitors when
they enter the thymus. Before being able to do so, the cells go through different developmental stages.
Among those, the T cells rearrange the genes at the loci coding for the TCR chains in order to get
an antigen-receptor that is efficient but not self-reactive. This rearrangement process results in the
generation of different TCR and gives thus the ability to the T cell populations to recognize a broad
variety of antigens. We talk about a “repertoire”.
1.2.1 T cell receptor loci rearrangement leads to the recognition of a broad
variety of antigens
TCR are made of two chains that contain two domains each. The sequences of the N-terminal
domains of both α and β chains are variable (domains V), while the sequences of their second domains
are constant (domains C). The genes that encode for those chains are expressed only in T cells and all
four loci (encoding for the α, β but also γ and δ chains) are present in the germline (Figure 1.2). The
α-chain locus contains V (“variable”) and J genes (“junction”), while the β-chain locus presents an
additional type of genes, the D genes (“diversity”). The rearrangement of the loci implies the “removal”
of some genes in order to get new associations between genes from the different families listed above.
Several enzymes intervene in this process in order to recognize sequences on each side of the gene
segments (V,J,D), to generate hairpins between two segments to be newly associated, “break” them
and ligate the new “neighbor” genes.
The β-chain locus is the first one to be rearranged during T cell development. The successful rear-
rangement of one chromosome blocks further β-chain rearrangement and leads to the allelic exclusion
of the other β-chain locus [? ]. The rearrangement of the α-locus stops when the TCR is functional
(positive selection) or when the cell dies. Moreover, this second rearrangement excludes the possibility
of having α:β TCR and γ:δ TCR at the same time, due to the localization of the δ locus in between
α-chain genes.
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Germline DNA 
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Figure 1.2. T Cell Receptor loci rearrangement (human). The figure was adapted from “Kuby Immunol-
ogy” [? ]. The germline includes the genes coding for the four TCR chains. These loci include four types
of genes: the V (“variable”), D (“diversity”), J (“junction”) and C (“constant”) genes. The V, J and D
genes of each locus are “rearranged” what leads to new gene associations. This process is at the origin of the
TCR-repertoire.
1.2.2 Development of the T cells
The development process of T cells is illustrated in the Figure 1.3. As mentioned previously, when
the precursors start to differentiate into T cells, they have no lineage markers (CD4 and CD8) at their
surface. For this reason, the cells at this developmental stage are called “double-negative T cells”. This
stage is divided into 4 sub-phases named DN1 to DN4, respectively. The rearrangement of the TCR
starts at the DN2 step, with the rearrangement of the β-chain locus. While the cells that failed to
properly recombine the β-chain locus die by apoptosis, the successfully rearranged β-chains associate
with invariant pre-α-chains (pTα) that have a similar structure to α-chains, forming the “pre-T-cell
receptor” (pre-TCR) (stage DN3). As for the “final” TCR, the pre-TCR associates with the CD3
co-receptor before being transferred to the membrane. The export of pre-TCR at the surface of a cell
indicates that there was a productive rearrangement of the β-chain (“β-selection”) and is the signal
to go to the next stage (DN4) in which cells start to proliferate. During cell proliferation, there is no
further β-chain rearrangement and the two markers CD4 and CD8 are expressed: the cells are called
“double-positive” (DP) T cells. The α-chain locus starts to rearrange and most of the cells are then
capable of expressing the complete TCR at their surface at this stage. Finally, the cells stop to express
one of the two co-receptors at their surface, becoming either CD4 or CD8 single positive T cells.
Additionally, in order to ensure that their TCR are functional, the cells go through selection pro-
cesses. T cells cannot recognize antigens in the extracellular space but require the antigens to be
displayed at the surface of other cells called Antigen-Presenting Cells (APC), such as macrophages or
7
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CD8+ T cell 
CD4+ cell 
γ:δ 
Double negative Double positive Single positive 
DN1 DN2 DN3 DN4 
α:β 
Rearrangement  β-chain 
β-selection 
Rearrangement α-chain 
Positive selection 
Negative selection 
pre-TCR TCR CD8 CD4 γ:δ TCR to periphery 
Figure 1.3. T cells development in the thymus. Common lymphoid progenitors enter the thymus without
expressing the T cell characteristic co-receptors CD4 and CD8 at their surface: the cells are called “double-
negative” (DN). The rearrangement of the β-chain occurs first and is checked by the “β-selection” during which
β-chain associates with an invariant chain to form the pre-TCR. If this association occurs, the cells start to
express the CD4 and CD8 co-receptors at their surface (“double-positive” - DP - cells) and to rearrange the
α-chain locus. When a final TCR is expressed at the surface of the cells, these latter stop expressing one of the
two co-receptors and become either CD4 or CD8 single positive cells. In addition, the cells undergo negative and
positive selection processes during their development, which consists in eliminating cells that cannot recognize
any type of antigens and cells that recognize self-antigens, respectively.
dendritic cells. The antigens are usually peptides derived from intracellular or previously internalized
pathogens. These peptides are presented at the surface of the APC by a glyco-protein, the major
histocompatibility complex (MHC) (see Section 1.2.3 for details). However, the T cells must be able
to interact with self-MHC in order to recognize the peptide carried by this one. Therefore, the first
selection step “positive selection” consists in selecting cells that are able to interact with MHC at
the surface of epithelial cells, while the other cells die by apoptosis. In a second phase, when only cells
capable of interacting with self-MHC are remaining, the cells that recognize self-peptide:MHC com-
plexes need to be eliminated in order to avoid auto-reaction and eventual harmful immune responses.
We talk about “negative selection”. In order to have a large panel of self-peptides tested and not
just the thymus-specific ones, a gene called Aire (“autoimmune regulator”) leads to the transcription
of tissue-specific genes that would normally not be expressed in the thymus. Doing so, the APC can
present a broad variety of self-peptides to the immature T cells. However, despite this ingenious system
involving the gene Aire, the probability that every self-proteins is expressed in the thymus stays low,
meaning that some self-reactive T cells may remain.
After going through these selection processes, the remaining single-positive CD4+ (TH) and CD8
+
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(TC) cells are finally exported to the periphery. It is important to notice that until that point, the cells
were kept in an antigen-independent environment and that the encounter with a foreign antigen only
occurs after leaving the thymus.
1.2.3 Antigen recognition
As previously mentioned, T cells can usually not recognize antigens directly in the extracellular
space but need them to be presented at the surface of APC, with the help of MHC. Two types of MHC
exist that are called MHC class I and MHC class II, respectively. Both are different by their structures,
the type of peptides they can present, their expression at the surface of different cells and their roles.
The MHC class I is made of a polymorphic α chain encoded by the MHC genes cluster and of
the β2-microglobulin that is non-polymorphic and encoded by a different locus. On the other hand,
the MHC class II molecules are made of two chains α and β that are both polymorphic. Despite the
structural differences, the most external part of these complexes is in both cases the most variable part,
giving the opportunity to the cells to present a broad variety of antigens to the outside.
The peptides presented by the APC can derive from pathogens that replicate within the cells such
as viruses or intracellular bacteria (endogenous pathway), or from pathogens in the extracellular space
(exogenous pathway) (Figure 1.4). In most cases, the MHC class I molecules can present peptides
coming from proteins synthesized in the cytosol of infected cells, such as viral proteins. These proteins
are degraded by the proteasome and the peptides are transferred to the endoplasmic reticulum (ER)
where they are loaded on MHC class I molecules. Once the ensemble peptide:MHC class I is formed, it
is transported up to the membrane for antigen presentation. On the other hand, MHC class II molecules
are stored in vesicles. Those can merge with vesicles resulting from the endocytosis of extracellular
pathogens products. The peptides are then loaded and the peptide:MHC class II ensemble is transported
to the surface. However, one should notice that these two processes are not totally hermetic and that
some peptides from intracellular proteins might be presented by MHC class II molecules while some
peptides from extracellular space or pathogens might be presented by MHC class I molecules. We talk
about “cross-presentation”.
Because of their different ways of dealing with antigen presentation, the two classes of MHC
molecules are not expressed on the same types of cells and have therefore different functions. In
parallel to the interaction with the TCR, MHC class I interact with CD8 co-receptor and therefore
present peptides to TC cells. This interaction is important for keeping infection under control and
MHC class I is thus expressed on almost all cell types. On the contrary, the MHC class II interact
with CD4 co-receptor and present antigenic peptides to TH cells whose main function is to regulate the
immune response. Therefore, the MHC class II molecules are usually present only on the “professional”
APC, which belong themselves to the immune system, such as dendritic cells, B cells and macrophages.
Additionally, some immune cells such as dendritic cells or monocytes can express a MHC class I-like
protein called CD1 that load antigenic glycolipids instead of peptides. However, T cells that can rec-
ognize such glycolipids:CD1 complexes are limited, with a limited repertoire of TCR, and usually do
not express either CD4 or CD8 co-receptors.
In either way, if the antigen is identified as a threat, its recognition by the TCR triggers signaling
cascades within the T cells that lead to the activation of these latter.
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Figure 1.4. Antigen presentation to the T cells. The figure was adapted from “Kuby Immunology” [? ].
Endogenous pathway: Intracellular proteins are degraded by the proteasome and the resulting peptides are
transferred within the ER by TAP (“Transporter associated with antigen processing”). There, the peptides are
loaded on MHC I complexes that were previously associated with calnexin first and then with calreticulin and
tapasin. The peptide:MHC I complexes are transported up to the membrane and can be recognized by CD8+ T
cells. Exogenous pathway: Pathogens from the extracellular space are internalized and degraded. The vesicles
containing the resulting peptides merge with some containing MHC II, which were associated with invariant
chains until then. The peptide:MHC II complexes are transported up to the membrane and can be recognized by
CD4+ T cells. Additionally, the cells can present lipids from the internalized pathogens at their surface with
CD1 complexes. The two systems are not hermetic to each other and cross-presentation can occur.
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1.2.4 Activation and differentiation of TH cells
After achieving their maturation in the thymus, T cells migrate through the bloodstream to the
secondary lymphoid organs (e.g. lymph nodes, spleen). Because these cells did not get into contact with
an antigen yet, we talk about “na¨ıve cells”. However, before getting an actual function, these na¨ıve
cells require to get “activated”. To do so, one cell must get into contact with a peptide:MHC complex
on the surface of an APC and recognize the presented peptide as an antigen. If receiving appropriate
signals, the cell starts proliferating and undergoes clonal expansion. Moreover, the activation of the
na¨ıve TH cells is followed by their differentiation into different sub-populations of “effector cells”
(e.g. TH1, TH2, TH17) that have different properties and functions. While most of these effector cells
will die after a few days, some are conserved and turned into “memory cells”, in order to keep track
of a given antigen. Considering that we focused exclusively on TH cells in this study, the description
of the activation and differentiation processes is limited to this type of cells.
ε ε δγζζ
Signal 1 Signal 2Signal 3
T cell
APC
Activation of NFκB, NFAT, AP-1
Specific gene transcription
Cell proliferation and differentiation
TCR CD4
CD3
peptide:MHC II
complex
CD28
CD45R CD22
B7
cytokine and
specific receptor
ITAM
Figure 1.5. TH cell activation. Three signals are required for the proper activation of na¨ıve TH cells: (1)
the interaction of the TCR:CD3 complex with a peptide:MHC complex at the surface of an APC, what leads to
phosphorylation cascades initiated by the ITAM (“Immunoreceptor tyrosine-based activation motif”) contained
in the CD3 chains , (2) the interaction of co-receptors (e.g. B7 with CD28 or CD22 with CD45R) and (3) the
detection of cytokines in the extracellular space. When those signals are all present, the expression of specific
transcription factors is triggered what results in the activation of specific genes and in cell proliferation and
differentiation.
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In order to be activated and therefore participate in the adaptive immune response, the na¨ıve TH
cells require several signals (Figure 1.5). The first one consists in, as mentioned before, the interaction
between the TCR and the peptide:MHC complex. While the TCR is mainly located in the extracellular
space, it is associated with CD3 co-receptor invariable chains (CD3γ, CD3δ, CD3 and ζ chains) that
have prominent intracellular parts. They are the ones that trigger phosphorylation cascades within TH
cells, leading to the expression of transcription factors known to be critical for T cell activation (e.g.
NFAT, NFκB, AP-1). However, this signal is not sufficient for the cells to survive and proliferate. In
addition, co-receptors at the surface of TH cells (e.g. CD45, CD44 or CD28) and of the APC must
interact as well, giving a survival signal to the cells (secondary signal). For instance, this leads to
the expression of Interleukin (Il)-2 by TH cells, a cytokine involved in cell proliferation. Finally, these
interactions between the co-receptors create a tight space between the two types of cells (known as
“immune synapse”) where cytokines are secreted by the APC and are recognized by receptors at the
surface of TH cells. According to their nature, these cytokines can trigger different signaling cascades
within TH cells and differentially influence gene expression (tertiary signal).
After receiving these different signals, the newly activated TH cells can thus differentiate into
various subsets of effector cells, according to the cytokine microenvironment perceived during their
activation (summarized in Figure 1.6). The most well described subsets are the TH1, TH2, TH17
and regulatory T cells (Treg). However, other subsets have been identified even if they are currently
less well described, such as TH9 or TH22. In addition, a subset of TH cells is described to provide
assistance to B cells for their own activation in the lymphoid follicles, the T follicular helper cells (TFH).
Each subset has different functions and is characterized by different features (e.g. transcription factors,
secreted cytokines). Shortly, TH1 cells are characterized by the secretion of Interferon γ (IFNγ)
and have been described as involved in the control of intravesicular infections. On the other hand,
TH2 specifically secrete IL-4, IL-5 and IL-13 and have been associated in the control of infections by
parasites. TH17 cells that are by the cytokines IL-17 and IL-21. IL-17 is involved in recruiting innate
immune cells, helping therefore in the fight against extracellular pathogens. Treg, on the contrary to
the other subsets previously mentioned, tend to rather inhibit the activation of other immune cells.
They therefore regulate the immune response and are involved in preventing immune-related diseases
(see Section 1.4). Finally, the TFH are identified by their specific localization (into lymphoid follicles).
They are critical for the maturation of B cells and especially for the isotope switch process that gives
the B cells the ability to produce various types of antigen-receptor (see Section 1.3).
To sum up, TH cells are an important group of cells for the adaptive immune response. They develop
and mature in the thymus where they get the ability to recognize a large spectrum of antigens thanks to
the recombination of the gene loci encoding their antigen-receptor, the TCR. The na¨ıve T cells migrate
from the thymus to the lymphoid organs where they may get activated by contact with an antigen
presented at the surface of an APC. If the required signals are received, na¨ıve TH cells get activated
and differentiate into various sub-populations that have characteristic properties and functions.
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Figure 1.6. Na¨ıve TH cell differentiation. After their activation, na¨ıve TH cells differentiate into different
subsets of effector cells according to the surrounding cytokines and to the activated transcription factors. Several
subsets of effector cells have been described, with characteristic secreted cytokines and transcription factors.
1.3 B cells
B cells are the second important actor of the adaptive immune response. Similarly to T cells, B cells
can specifically recognize antigens thanks to their antigen-specific receptors, the immunoglobulins.
A specific immunoglobulin can be membrane-bound at the surface of the cells and thus be called B-cell
receptor (BCR), or secreted as antibody. The antibody secretion is the main function of B cells in
the humoral immune response, leading to the protection of the extracellular spaces. In opposition to
the T cells, the mature B cells with a specific BCR at their surface can be activated by direct contact
with an antigen. They can then differentiate into plasmocytes, cells that are capable of secreting
antibodies, or into memory B cells.
1.3.1 Immunoglobulins
Immunoglobulins are large glycoproteins made of 4 polypeptide chains, forming a Y-shape (Figure
1.7). Two types of chain exist: the heavy (H) and the light (L) chains. Each immunoglobulin is made
of two H chains and two L chains that are linked by disulfide bonds. The H and L chains of one
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immunoglobulin are specific for the same antigen, providing two identical antigen-binding sites. Each
chain is composed of immunoglobulin domains and only the first domain at the N-terminal side of each
chain is responsible for the variability of the antigen-binding sites (domains V).
heavy chain 
light chain 
CH3 
CH2 
CH1 
VH 
antigen-binding sites 
CL 
VL 
constant  
region 
variable  
region 
disulfide bonds 
Figure 1.7. Structure of an immunoglobulin. The B cell antigen-specific receptor is made of two chains
(light and heavy - or L and H) that contain one variable domain each (V). These variable domains are the ones
in contact with the antigen. Thanks to its symmetrical structure, an immunoglobulin can interact with several
copies of an antigen at the same time.
In addition to the two types of L chains (κ and λ), there are five major types of H chains (also called
isotypes) that lead to five different types of immunoglobulins (Ig): the IgG, IgM, IgD, IgA and IgE that
are characterized by different constant domains (domains C). These different constant domains (also
called Fc portions) are at the origin of different functions, such as the activation of the complement,
the binding to macrophages to enhance phagocytosis or the binding to granulocytes for inflammation
elements release. Nevertheless, thanks to their specific antigen-binding sites, all Ig provide a protection
against extracellular pathogens and their products.
1.3.2 B cell development
B cell development occurs in the bone marrow, where the common lymphoid progenitors differ-
entiate into B cell progenitors (pro-B cell) (Figure 1.8) that do not have any BCR at their surface
yet. However, they already express the chains Igα and Igβ that are involved in the signal transduction
(similarly to the co-receptor CD3 and ζ-chains for the T cells) and a specific B cell surface marker
(CD19). Pro-B cells proliferate and differentiate into B cell precursor (pre-B cells) if the appropri-
ate microenvironment is generated by the stromal cells of the bone marrow (direct contact and IL-7
secretion).
Similarly to the rearrangement of the TCR loci in T cells, the loci encoding the different chains of
the immunoglobulins are rearranged during the development of the B cells (Supplementary Figure S2 in
Appendix A). The H chain loci are the first ones to rearrange (in pro-B cells). Once this rearrangement
finished, the H chains associate with surrogate light chain components and are exported at the surface
(pre-BCR). Only if this step is achieved properly then the rearrangement of the light chains loci starts.
Because of the allelic exclusion principle, the locus of only one type of light chains is expressed (κ or
λ). A productive rearrangement of the L chains is necessary for the pre-B cells to become immature
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Figure 1.8. B cell development in the bone marrow. The H chain loci are rearranged in pro-B cells. If the
resulting H chains associate with surrogate L chains and are exported at the surface, the pre-B cells proceed with
the rearrangement of the L chain loci. The resulting immature B cells express at their surface a complete BCR
that is further tested during a negative selection process. Cells with self-reactive BCR either die by apoptosis or
attempt to “edit” their receptor after re-internalization. The remaining mature B cells express IgM and IgD at
their surface and are ready to migrate to the periphery.
B cells. This latter present a complete BCR (membrane-bound IgM) at their surface. A negative
selection process occurs at this step in order to eliminate self-reactive B cells. Cells that can recognize
a self-antigen either die by apoptosis or try to modify their BCR. We talk about “editing”. This process
consists in the internalization of the BCR and in a new rearrangement of the L chain loci in an attempt
to get a BCR that would not be auto-reactive. Only if this editing is productive, the cells can go to
the next developmental stage. This last step of the B cells development consists in the co-expression
of IgM and IgD at the surface, giving mature B cells.
1.3.3 Activation of the B cells and antibody production
Mature B cells migrate from the bone marrow to secondary lymphoid organs where they are subdi-
vided into two sub-populations, the marginal B cells and the follicular B cells, according to their
localization within the organ (the “marginal zone” and the “follicles”, respectively). In there, they
can get activated by contact with an antigen before differentiating in either plasmocytes or memory
B cells (Figure 1.9). Nevertheless, as for TH cells, the contact of the BCR with a specific antigen is
not sufficient for the activation of the B cells. For this reason, the BCR is associated with Igα and
Igβ chains, starting points of the activation signaling cascades, and with co-receptors such as CD19 or
CD21.
B cells can be activated by direct contact of their BCR with some antigens. However, it must be
noticed that to proliferate and to provide a long-term protection, an additional contact with TH cells
is often required. Thus, two types of antigens are described: the thymus-dependent antigens (TD)
that require additional contact with TH cells to complete the activation, and the thymus-independent
15
1. Introduction
Mature B cell 
Naive B cell 
Apotosis 
Activation 
Proliferation 
Activation 
Proliferation 
+ TD Ag  
 
+ TFH cell Somatic hypermutation 
Affinity maturation 
Isotope switching 
Memory B cell 
Plasmocyte 
Secreted 
antibodies 
B
O
N
E
 M
A
R
R
O
W
 
L
Y
M
P
H
O
ID
 O
R
G
A
N
 
Figure 1.9. From na¨ıve B cells to antibody secretion and memory B cells. Mature B cells migrate from
the bone marrow to the secondary lymphoid organs where they can get activated for the first time. B cells can
get activated by direct contact with an antigen, with or without the assistance of TH cells (thymus-independent -
TI - vs. thymus-dependent - TD - antigens). The cells that are activated by TD antigens interact with TH cells
and undergo additional processes such as somatic hypermutation, affinity maturation and isotope switching, in
order to provide a highly specific and lasting response. On the other hand, the cells that are activated by TI
antigens can provide a quicker but shorter and less specific response.
antigens (TI) that do not. The TI antigens are few and only antigens such as microbial molecules
(e.g. LPS, polymeric proteins) will trigger cell activation. They lead to a quick activation and a quick
response of the B cells towards the concerned antigen, but only a few antibodies will be secreted and
no memory cells will be induced.
On the other hand, when a BCR recognizes a TD antigen, the complex is internalized and the
antigen is degraded in order to present the resulting peptides associated with MHC II molecules at the
surface of the B cells. The peptide:MHC II complex can then be recognized by a TCR specific to the
same antigen at the surface of TH cells (see Section 1.2). However, how do those cells get into contact
considering the low probability of having a B cell and a TH cell specific for the same antigen? Within
the secondary lymphoid organs, TH cells and B cells are located in restricted areas called “T cell zone”
and “B cell zone”, respectively. When a B cell recognizes its specific antigen within the B cell zone,
it starts expressing chemokine receptors at its surface, what leads to its migration to the T cell zone
where the corresponding chemokines are abundantly secreted by TH cells.
The marginal B cells that are then activated provide a quick response by differentiating into short-
lived plasmocytes secreting low-affinity antibodies [? ]. Before heading back to the marginal zone, these
cells additionally regulate the activation of surrounding TH cells and of the follicular B cells. When
the latter are activated, they proliferate within the follicle. Some of those will directly differentiate
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into short-lived plasmocytes or into memory B cells. However, most of the activated follicular B cells
will migrate to the germinal center, a sub-part of the B cell follicle (germinal center B cells). This
is within this sub-structure that the cells will go under “somatic hypermutation” and “isotope class
switching”, the last steps of maturation of their antigen-receptor.
The somatic hypermutation consists in increasing even more the size of the repertoire of antigen-
receptors (the first step was the rearrangement of the loci) by inducing mutations that lead to changes
in the amino-acids sequence of immunoglobulins variable regions. A B cell population that is specific
for one given antigen has then BCR with different specificities and affinities for this same antigen.
However, most of these mutations result in the loss or decrease of their ability to recognize the antigen.
Therefore, the ability to bind the antigen is being watched and made sure that it always increases. We
talk about affinity maturation. Additionally, the activated B cells undergo class-switching. This
consists in a new rearrangement of the H chain locus that concerns the constant part only. While the B
cells were capable of expressing only IgM and IgD (membrane-bound) until then, they can also express
IgG, IgA and IgE (secreted) afterwards. The isotope switching depends on the cytokine environment
(e.g. IL-4 tends to induce switching to IgG and IgE, and IL-5 to IgA). These cytokines are produced
by the TH cells, showing one more critical point about their role in B cell functions. After this step,
the cells can differentiate either into long-lived plasma cells that are able to secrete antibodies or into
memory B cells. These memory B cells play an important role in the “secondary response” that take
place when an individual gets in contact with a pathogen for the second time. Indeed, the activation of
memory B cells makes them divide again and produce directly highly specific antibodies from various
isotope classes and at a higher concentration, reducing drastically the latency period of the immune
response.
In addition to the sub-populations of B cells described above, another B cell type has been recently
studied: the regulatory B cells, or Breg[? ]. The origins of this sub-population remain until now
unclear and it appears that they could derive from various cell types such as immature B cells, mature
B cells or even plasmocytes [? ]. They have been described as IL-10 secreting cells and they thereby
have an immunosuppressive function and regulate other lymphocytes (B and T cells) [? ? ? ] in a
similar fashion to Treg cells.
B cells are therefore the second group of cells part of the adaptive immune system. They develop
within the bone marrow where they acquire an antigen-specific receptor at their surface, the BCR. The
na¨ıve B cells migrate to secondary lymphoid organs where they can get into contact with an antigen
and therefore get activated. To do so, most of the B cells require assistance from TH cells. The cells
undergo then intense proliferation and fine-tuning of their antigen-specific receptor. When migrating
from the secondary lymphoid organs to the periphery, the activated B cells are able to secrete their
antigen-receptors called then “antibodies” that are involved in the elimination of pathogens in various
ways.
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1.4 Allergies and asthma are pathologies related to dysfunc-
tions of the immune system
We saw along the previous parts that the immune system provides a strong and highly efficient
protection to the organism. Using these natural attributes, the immune system can be “trained”
or controlled in order to fulfill therapeutic aims. For instance, vaccination gives the opportunity to
the immune system to generate memory cells towards virulent pathogens, and therefore to have the
organism ready to respond quickly to it in case of contact. However, it can also happen that the
immune system does not fulfill its function (failure of defense) or response in an inappropriate manner
(e.g. autoimmunity or allergies).
The immune system can fail to defend its host body in two different ways: either the pathogens
have developed a way to “escape” so it cannot be recognized and therefore destroyed, or the immune
system is not efficient enough like in immunodeficiency diseases.
In addition, the immune system can respond to the body’s own cells or tissues. In this case, the
immune system responds to self-antigens. This phenomenon is called autoimmunity and can lead to
“autoimmune diseases”, which result in the damaging of the tissues and in severe secondary effects.
This is due to the fact that self and non-self antigens have similar properties and therefore the selection
of the lymphocytes during their development might not have been 100% efficient.
Finally, immune responses can be triggered by elements that are not from pathogens, but by common
environmental elements such as pollen, dust, food or drugs. These harmful immunological responses
are called “hypersensitivity reactions” or “allergic reactions”, and the antigens causing them are
then named allergens. These reactions were classified by Coombs and Gell into four groups (from type I
to type IV) according to their characteristics and the elements involved. Shortly, type I hypersensitivity
reactions involve IgE secreted by B cells that trigger the release of chemical mediators leading to e.g.
food allergies, allergic rhinitis or allergic asthma. The type II and type III hypersensitivity reactions
involve IgG secreted by B cells and occurs in some drug allergies. Finally, type IV hypersensitivity
reactions involve TH cells, and especially TH1 (e.g. allergic contact dermatitis) or TH2 (e.g. chronic
asthma), and sometimes TC cells (e.g. transplant rejection). Nevertheless, in order to limit these
allergic reactions, the immune response is scaled down by e.g. the Treg[? ] and Breg[? ? ].
Concerning the type I hypersensitivity reactions, they involve IgE produced by B cells (differentiated
in plasmocytes), which normally represent only a small portion of the produced Ig in healthy individuals
(< 1% of the total Ig in a mean adult). Therefore, this type of allergic reactions involves an increase
of the IgE production. This increase is due to (1) more na¨ıve TH cells differentiating into TH2 cells
and (2) to the action of the cytokines produced by these TH2 cells (IL-4, IL-5, IL-9, IL-13) on B cells,
what influences the class-switch process toward IgE production. The resulting IgE can then bind at
the surface of cells from the innate immune system (e.g. mast cells, eosinophils, basophils) that have
a high-affinity receptor for their constant part (FcRI) at their surface. The binding of IgE with these
receptors leads to the release of inflammatory mediators contained within those cells, and consequently
to allergic reactions. Allergic asthma is one of the diseases related to these IgE-mediated allergic
reactions. It is caused by the entrance of an allergen through the respiratory tract and the resulting
TH2 cell-mediated immune response. This disease is characterized by airway inflammation,
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airway hyperreactivity (AHR) and increased serum IgE levels [? ].
Even though everybody is exposed to the same allergens, only some people become sensitized and
develop allergies against them. The predisposition of one person to develop allergies (also called atopy),
especially IgE-mediated ones, varies from one individual to another. Although these diseases have been
described as having a strong genetic background, influences by environmental factors are not negligible
[? ? ]. In fact, a study reported that the risks of developing asthma are less than 50% genetics
related, meaning that this disease is mainly due to environmental factors or to the interaction between
environmental and genetic factors [? ].
Allergies and resulting diseases such as asthma concern hundreds of millions of individual worldwide
according to the World Allergy Organization (WAO) [? ]. The prevalence of allergic diseases has been
increasing and is predicted to keep doing so. For instance, the WAO estimated that the global number
of patients with asthma is 300 million and expects it to reach 400 million by 2025. This fact raises
these diseases to the rank of global health issue.
Throughout this first part of this chapter, we saw that the immune system provides an important
protection to individuals. To do so, it involves many complementary actors, including the TH cells
and the B cells. While the first ones have been described as involved in the regulation of the immune
response by secreting cytokines, the second ones are the key drivers of the humoral response and secrete
antibodies. Nevertheless, both types of cells have also been described as involved in the development of
immune-related diseases, such as allergies and asthma. Those two pathologies are concerning about 5%
of the world population (according to the numbers from 2014) and this number is expected to increase
over the next decades. For this reason, in addition of the need of understanding their underlying cellular
mechanisms, it is nowadays important to identify their triggers in our environment in order to limit as
much as possible this “epidemic”.
1.5 Environmental motivations
Our environment contains many substances that we cannot see or that we are not even aware
of. However, the direct exposure to some of those environmental pollutants (e.g. tobacco smoke or
chemicals) can impact our health [? ? ? ], including our immune system and the risk of developing
related pathologies such as allergies and asthma [? ? ? ]. Additionally, it appears that prenatal
exposure to these substances is critical as well. Indeed, several studies could link prenatal exposure to
environmental pollutants and the development of allergies and asthma in the early life of the offspring
[? ? ? ]. The group of chemicals called “phthalates” is part of the incriminated substances.
1.5.1 Phthalates: unavoidable environmental pollutants
Phthalates, or di-esters of phthalic acid, are a group of chemicals mainly used as plasticizers: they
are used during plastic manufactures (especially for polyvinyl chloride plastics - PVC) in order to make
the material more transparent, more flexible or more durable. In addition, some phthalates are also
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used as solvents for the fabrication of other products. Taken together, phthalates end up to be present
in a broad variety of daily-life products such as automobile plastics, children’s toys, food containers,
cosmetics, vinyl flooring, etc. [? ]. However, they are not covalently bound to the material or substances
to which they belong and therefore spread in their surroundings [? ]. One can therefore be exposed
by eating or drinking contaminated food, by dermal contact, but also to a lesser extent by breathing
contaminated air (with phthalates vapors or with dust containing phthalates particles). Important
to be noticed, the children are a group at higher risk because of their hand-to-mouth behavior that
increases the risk of contamination by dust [? ].
Phthalates are quickly processed by the organism after entering the body [? ]. They are converted
into monoesters (metabolites) that are usually considered as the biologically active molecules. These
metabolites are quickly eliminated in the urine and feces [? ? ]. Phthalate concentrations can be
measured in different biological matrices such as blood, urine, breast milk, using chromatography
coupled with mass spectrometry techniques [? ? ? ]. The biological measurements are usually
accompanied by questionnaires to estimate the contamination sources in the environment of a person.
Although no one can completely suppress them from his environment, the level of exposure to phthalates
varies from one individual to another according to the lifestyle (depends e.g. on the location and on
the amount of phthalates-containing products used) [? ].
1.5.2 Phthalates and health
The effects of phthalates on health have been studied over the last years with both cohort and
experimental studies. The cohort studies provide sometimes contradictory results, which might be
due to small study groups or lack of control. Nevertheless, various effects have been clearly identified
according to the nature of the chemical. For instance, the di-2-ethylhexyl phthalate (DEHP) is the
most studied phthalate and is present in products made of PVC such as shower curtains, automobile
plastics or plastic toys. Studies have shown that it has different harmful effects when directly exposed
to it as reviewed by ? ], including a higher risk of developing allergy and asthma for children [? ? ] or
a higher risk for women to develop endometriosis [? ]. On the other hand, the diethyl phthalate (DEP)
is contained in cosmetics and in some pharmaceuticals. It was described as having an effect on the
body-mass index of girls [? ? ] and is associated with an increase of airway inflammation in children
[? ]. As a last example, the benzyl-butyl-phthalate (BzBP) is part of products such as vinyl flooring,
furniture outer layer, artificial leather, etc. It has been described as linked with various diseases and
pathologies as well, including an increase of airway inflammation in children [? ] and of the risk of
developing allergy and asthma [? ? ].
Despite these informative studies, rather few ones focused yet on the elucidation of the underlying
cellular mechanisms, as reviewed by ? ]. For instance, BzBP was shown to regulate the mRNA
translation by interacting with eIF4F, an important translation initiator [? ]. On the other hand, it
was also observed that the exposure to BzBP or DEHP leads to an increase of the expression of the
nuclear receptor PPARα (Peroxisome Proliferator-activated Receptor) genes in mouse liver tumor [?
]. Additionally, in silico studies showed that phthalates, including BzBP, can in theory interact with
various receptors such as PPAR [? ], androgen and progesterone receptors [? ]. ? ] therefore proposed
a model consisting in the transport of phthalates by fatty acids through the cellular membrane and
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to the nucleus, where they could then be transferred to nuclear receptors such as PPAR that act as a
transcription factor after dimerization. Even though these first results suggest that phthalates act like
endocrine disrupting compounds (EDC), their precise ways of action of remain to be clarified.
In addition to these effects due to direct exposure to phthalates, studies showed that maternal
exposure to these substances can impact the health of the children in various ways as well [? ]. For
instance, prenatal (during pregnancy) and perinatal (during pregnancy and breastfeeding) exposures
to BzBP lead to a higher risk of developing asthma in the first years of life. Indeed, the cohort
study Lifestyle and Environmental Factors and Their Influence On Newborns Allergy (LINA) showed a
correlation between the maternal urinary concentration of mono-n-butyl phthalate (MnBP), the major
metabolite of BzBP [? ? ], during pregnancy and an increased risk of asthma development by the
children [? ? ]. Using a mouse asthma model, ? ] confirmed that maternal exposure to the parent
molecule BzBP is linked to an enhanced asthma phenotype in the offspring. Although the observed
effects may have been associated with the diffusion of BzBP through the placental barrier or in breast
milk, they showed that the exposed mothers (F0) did not present asthma symptoms while the F1
generation and their next generation (F2) did, what suggested that the effect of BzBP can also be
“transmitted” in a trans-generational manner.
1.5.3 Environment and epigenetic regulations
Some heritable traits are not attributable to changes in the DNA sequence itself but to other types
of regulation. We talk about “epigenetics”. Epigenetic regulations include DNA methylation and
histone modifications that can lead to changes in genes expression (active vs. silenced genes) and that
can be transmitted to daughter cells. Epigenetic modifications are a ubiquitous phenomenon and result
for example in different cell phenotypes in a single organism (e.g. skin, brain, immune cells, etc.).
DNA methylations are by definition methyl groups bound to DNA molecules. In mammals, they
are mainly located on cytosine residues followed by a guanine residue (CpG dinucleotides). They lead
to changes in the DNA conformation and therefore alter the interaction with DNA-binding proteins.
For instance, methylation of CpG in a gene promoter usually leads to its silencing [? ].
The second type of epigenetic regulations consists in the modification of residues not directly from
the DNA molecule but from histones. The latter are proteins involved in the DNA packaging in
nucleosomes. Histone modifications are mainly acetylation or methylation (mono-, di- or tri-) and are
mostly located on lysine (K) residues. These modifications regulate DNA processes such as chromatin
conformation changes, repair, replication and transcription [? ? ]. According to their localization and
their nature, their effects vary. For instance, the tri-methylation of the 4th lysine residue on histone H3
(H3K4me3) occurs usually at the promoter of active genes, while H3K27me3 is associated with gene
silencing [? ].
Although epigenetic modifications are a normal process happening in every single cell of an indi-
vidual, they can also be involved in the development of several pathologies. For instance, epigenetic
changes have been associated with diseases such as cancer [? ? ], neurodegenerative [? ? ] and autoim-
mune diseases [? ]. Additionally, recent studies suggest that epigenetic regulations are also involved in
the development of allergic diseases [? ? ].
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Epigenetics modifications are influenced by environmental factors (endogenous and exogenous) [? ].
We talk about “environmental epigenetics”. Moreover, epigenetics have been described as involved
in environmental health (link between exposure to environmental factors and disease development)
[? ? ? ]. For example, ? ] showed that the phthalates DEHP and BzBP lead to modifications of
histones methylations in dendritic cells, in the promoter of the gene Irf7 that codes for a transcription
factor of the same name. The consequences of such modifications were the down-regulation of this
gene and of its depending genes Ifna10 and Ifnb. IFNα and β are the cytokines encoded by those two
genes, respectively, and that stimulate the production of IFNγ by TH cells when secreted. This study
showed that the phthalates-induced down-regulation of these genes in dendritic cells suppressed the
IFNγ production but enhanced the one of IL-13 by TH cells. This suggests that these phthalates cause
epigenetic modifications that may lead to a switch from TH1 to TH2 immune response and therefore
increase allergic phenotypes (see Section 1.4).
Additionally to effects due to direct exposure such as the one mentioned above, indirect exposure to
environmental factors can also lead to changes in epigenetics regulations. Hence, prenatal and perinatal
exposures have been described as critical for epigenetic dysregulations [? ] and the resulting diseases
were previously reviewed [? ? ]. Keeping with the example of BzBP, ? ] observed in their trans-
generational mouse model that prenatal and perinatal exposures were linked to severer asthma in the
offspring. On the cellular level, they showed that perinatal exposure to BzBP led to variations of DNA
methylations. This resulted in the down-regulation of protein-coding genes, including the gene Zfpm1
that has been described as a repressor of the Gata3 -mediated TH2 cell development [? ? ] and
therefore as a regulator of the TH2 response. The down-regulation of Zfpm1 was also observed in their
LINA cohort, for children prenatally exposed to high concentrations of a BzBP metabolite (MnBP).
Taken together, these results suggested that maternal exposure to BzBP has an asthma-promoting
effect mediated by epigenetic changes and by subsequent dysregulations of the expression of genes
involved in the immune response.
The consequences to the exposure to environmental factors can therefore appear quickly but also
“last long” due to the influence on epigenetic regulations. One of the possible outcomes of the triggered
modifications is the development of pathologies, including immune-related diseases. The previously
mentioned examples showed that the phthalate BzBP is part of the substances that can results in
such disturbances by influencing DNA methylations and histone modifications after direct or perinatal
exposure.
However, how are those epigenetic modifications set up and maintained? Several elements are
involved in these processes, including a category of molecules called “non-coding RNAs” [? ? ].
For a long time, it was considered that the DNA information was transcribed in RNA that was itself
processed and translated into proteins, the supposedly only biologically active molecules of the cells [?
]. However, over the last decades, studies turned the tables. The ENCODE project showed that only a
small portion of the human genome (about 3%) encodes for proteins while more than 60% of the genome
is expressed in each cell [? ? ]. Similar observations were made more recently for the mouse genome [?
]. The products of this genome-wide transcription are the non-coding RNAs, which by definition do not
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code for proteins. The non-coding RNAs are divided into different categories according to e.g. their
size (small vs. long non-coding RNAs), their structure or yet their function. Nevertheless, despite the
fact that these categories may have different characteristics and modes of action, small as well as long
non-coding RNAs have been shown to play an important role in gene expression regulation, including
by being involved in the regulation of epigenetic modifications [? ? ]. One of the most well described
example is the “X-chromosome inactivation” that occurs in female individuals to “correct” the double
dosage of X-chromosome associated genes, and that involves several long non-coding RNAs (e.g. Xist,
Tsix, Jpx [? ? ]).
1.6 Long non-coding RNAs
More than 90% of the genome can be transcribed but the protein-coding genes represent only a
small portion of the genome. This implies that most of the genome is transcribed into non-coding
RNAs, including long non-coding RNAs (lncRNAs) [? ]. Considered for a long time as the products of
“junk DNA”, these non-coding RNAs are now considered as a new layer of information and regulation
with evidences for it piling up constantly.
1.6.1 What are they?
LncRNAs are non-protein coding transcripts usually defined as RNAs longer than 200 nucleotides
(nt) and correspond to the larger class of non-coding RNAs (more than 80% of the total non-coding
RNAs[? ? ]). Although their number is difficult to determine, catalogs estimate that there are between
15000 and 20000 human lncRNAs [? ? ]. They can be detected in the cytoplasm or in the nucleus [?
] and they are generated by the RNA polymerase II and III [? ? ]. Additionally, lncRNAs appear to
be more cell-type specific than protein-coding genes [? ? ].
Similarly to mRNAs (protein-coding), lncRNAs can be poly-adenylated or spliced [? ]. However,
they are usually expressed at a lower level than mRNAs and can therefore be more difficult to detect
[? ? ], and they generally lack a conserved open reading frame (ORF) [? ]. Nevertheless, the barrier
between mRNAs and lncRNAs is thin: some RNAs can be bifunctional (one mRNA can fulfill the same
functions a lncRNA) [? ] and alternative splicing can alter the coding potential of a transcript (one
mRNA can have a lncRNA as isoform, and vice versa) [? ]. Additionally, lncRNAs can associate with
ribosomes and are the source of new peptides that may have functional roles themselves [? ? ].
Due to their large number, lncRNAs are far from being completely annotated and therefore still
request strategies to do so. Both bioinformatical and experimental approaches have been developed
over the last years [? ? ]. Additionally, for the ones that have been already annotated, a few functional
characterization studies were performed. Considering that the role of most of the lncRNAs is therefore
unknown yet, they have not been classified according to these criteria but according to their relative
position to protein-coding genes (summarized in Figure 1.10).
The primary sequence of lncRNAs is generally poorly conserved due to the fact that there are fast
evolving elements [? ? ]. The translation of results obtained with one organism to another is therefore
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Figure 1.10. The genome encodes for various types of lncRNAs. Genes coding for lncRNAs are shown
in yellow, while protein-coding genes are shown in blue. Exons and introns are depicted by blocks and thin lines,
respectively. The arrows indicate the direction of the transcription.
critical. However, their functions appear to be supported by the secondary structure of some parts
rather than by their primary sequences [? ? ]. Different types of domains have been identified in their
structure: RNA-, DNA- and protein-binding domains [? ]. One lncRNA can contain several types of
those and thus serve several purposes as shortly described below (Figure 1.11).
Nuclear lncRNAs can be cis- or trans-acting. In both cases, they can serve as guides for chromatin-
modifying complexes and therefore regulate the chromatin structure at these locations [? ? ].
They can act as a signal and regulate the transcription by guiding a transcription factor to its
site of action [? ? ], but also as a decoy by interacting with a transcription factor and therefore
preventing its interaction with the DNA sequence [? ? ]. They can additionally block the interaction
of a transcription factor by interaction with the DNA at the binding site (RNA-DNA interaction) and
regulate the splicing of pre-mRNA by interaction with the latter (RNA-RNA interaction). Finally,
they can serve as scaffold for protein complexes and therefore be involved in the formation of
subnuclear structures such as the lncRNA NEAT1 and the paraspeckles [? ]. On the other hand,
cytoplasmic lncRNA have different function as well [? ]. They can modulate mRNA stability [? ? ]
and translation control. While some have been identified as precursors for small non-coding RNAs
[? ], some lncRNAs appear to function as “miRNAs sponges” to repress their activity [? ? ].
Through these different functions, lncRNAs have been associated with multiple cellular systems
and were shown to be important regulators of physiological responses [? ? ], including in the immune
system [? ].
1.6.2 Actors in the immune system
Several studies including lncRNAs profiling revealed differences between the different immune cells
and in between the sub-populations of one said immune cell type (e.g. developmental stages, sub-
populations resulting from their activation). For instance, a study highlighted differences between the
lncRNAs expression profiles of B and T cell progenitors, suggesting that lncRNAs are involved from
the early stage of lymphocyte development [? ]. These differences between B and T cells lineages
were confirmed for mature and memory cells [? ]. The transcription of non-coding transcripts was
also reported at the antigen receptors loci [? ? ]. Additionally, several studies revealed that lncRNA
expression profiles change throughout the T cell development and TH cell differentiation [? ? ]. Similar
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Figure 1.11. LncRNAs fulfill diverse functions. Adapted from ? ] and ? ].
observations were made for B cells [? ? ]. Taken together, these results imply that lncRNAs play a
role in immune cell development, maintenance and activation.
A few functional studies highlight the role of some of these lncRNAs in the regulation of the immune
system. Moreover, in addition to immune-cell specific lncRNAs, some transcripts that were primarily
described in other cells appear to sometimes have a specific role in immune cells as well. Published
transcripts in B and TH cells are summarized in Table 1.1.
Considering the variation of their expression profiles throughout the development and the activation
of immune cells, lncRNAs appear to play a role in those physiological processes. However, such dynamic
changes have also been attributed to pathologies, including immune-related ones. For instance, it
appears that lncRNAs are regulated in the early stages of chronic lymphocytic leukemia [? ], and more
than 1000 lncRNAs are differentially expressed in CD4+ cells from patients with Coeliac Disease [?
]. Similar observations were made in the context of severe asthma [? ], allergic rhinitis [? ] and more
recently in airway allergic inflammation [? ].
In addition to global changes in lncRNAs expression profiles, some lncRNAs have been described
individually as important regulators for the development of pathologies, including some of the ones
described in TH and B cells (summarized in Table 1.1). For instance, Linc-MAF-4 seems to play a role
in multiple sclerosis [? ] and it has been proposed that Gata3-As1 and Th2LCRR may play a role in
asthma and allergies by regulating the TH2 response [? ? ]. Additionally, some of these transcripts are
described with dual functions: one said transcript can prevent the development of one type of disease
but also be a key driver in the development of another. Thus, while increased levels of Ifnγ-As1 were
reported to maybe be involved in the pathogenesis of Hashimoto’s thyroiditis [? ], this lncRNA has
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Table 1.1. Overview of the published lncRNAs in TH cells and B cells.
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been described along NRON as involved in viral infection control [? ? ? ].
To summarize, due to the low percentage of protein-coding regions of the genome and to the small
proportion of regions coding for small non-coding RNAs, lncRNAs represent the broadest category of
transcripts. Various mechanisms have been attributed to them and they play major roles in physiological
processes. However, it appears that the dysregulation of their expression can lead to the development of
pathologies. Environmental factors contribute to the development of the same pathologies (see Section
1.5.3) and one can therefore wonder if they do so by influencing the expression of lncRNAs.
1.6.3 Roles in environmental health
Changes in the transcription of small non-coding RNAs due to environmental factors and subsequent
health issues have been reviewed on several occasions [? ? ]. On the other hand, such evidences
concerning lncRNAs are more sporadic and rely mainly on cell studies [? ? ]. Nevertheless, a few
studies performed on animal or on human tissues revealed differential expressions of lncRNAs when
exposed to a given substance. The carcinogen furan, cadmium and cigarette smoke were among the
studied substances. Shortly, furan is a substance that causes tumors in rodents [? ? ]. ? ] found
differentially expressed lncRNAs in the liver of female mice orally exposed to this substance, including
LincRNA-p21 that has been associated with cancer progression [? ]. Another study showed in a mouse
model that intraperitoneal exposure to cadmium changes the expression profile of lncRNAs [? ]. Since
they also observed that this exposure led as well to male infertility and that lncRNAs were already
described as critical for spermatogenesis, they hypothesized that their dysregulation was involved in the
process. Finally, ? ] showed that smoking may alter the expression of lncRNAs in the lungs. To do so,
they compared three groups of individuals that either smoked or not, and that either had the smoking-
related disease called “chronic obstructive pulmonary disease” (COPD) or not. The results highlighted
that hundreds of lncRNAs were differentially expressed between the non-smokers and smokers groups
and that those lncRNAs are involved in pathways related to COPD.
Environmental factors can therefore influence the expression of lncRNAs what can lead to the
development of pathologies. In theory, the regulated lncRNAs could therefore be used as biomarkers
of environmental exposures. Nevertheless, the role of lncRNAs in environmental health still requires to
be clarified and more investigated. To our knowledge, no study linked the exposure to environmental
factors, differential expression of lncRNAs and immune-related diseases yet. Additionally, we could not
find any information concerning studies that investigated the influence of prenatal exposure to a given
environmental factor on the expression of lncRNAs.
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1.7 Hypothesis and aim of this study
Allergies and asthma are becoming a global health issue considering the constantly increasing high
number of concerned persons. TH and B cells are the two cellular key actors of the adaptive immune
response and they have both been associated with the development of those pathologies through various
mechanisms, generally linked to their development and activation. Moreover, recent studies highlighted
that these diseases were influenced by genetic but also environmental factors. For instance, the phtha-
lates, including BzBP, are part of common environmental pollutants and have already been associated
with cellular disturbances and such diseases. The LINA cohort study thereby revealed that prenatal
exposure to high concentrations of a BzBP metabolite led to a higher risk of developing asthma in
childhood [? ]. ? ] confirmed with the aid of a mouse model that the parent molecule BzBP was the
one responsible for this effect. Indeed, they observed that young prenatally and perinatally exposed
mice to BzBP presented a severer asthma phenotype (e.g. AHR, IgE concentration) in comparison to
control individuals. Additionally, they showed that perinatal exposure to BzBP resulted in differential
expression of protein-coding genes and in variations of the DNA methylation patterns in TH cells.
LncRNAs have been described as involved in many cellular mechanisms, including in immune cells
such as TH and B cells. However, they also have been associated with the development of diseases
related to the immune system, and even recently with allergic reactions. Although little information is
available yet, studies showed that environmental exposure can lead to differential expression of lncRNAs
and to subsequent pathologies.
Considering the role of TH and B cells in allergic reactions and according to the results of previous
studies, we hypothesized that maternal exposure to BzBP results in a higher risk of developing allergies
and asthma by affecting the expression of lncRNAs in TH cells and B cells, including some that may
be key drivers in such phenomenons.
The aim of this study was therefore to identify lncRNAs that are (1) expressed in TH cells and B
cells, (2) influenced by maternal exposure to BzBP and (3) possibly involved in the development of
allergies and asthma.
The strategy to achieve these goals was divided into two phases. First of all, we re-analyzed TH
cell RNA-sequencing data from mice perinatally exposed to BzBP that we previously published [? ]
in order to confirm that lncRNAs were responsive to this exposure. The second phase consisted in
isolating TH and B cells from prenatally exposed mice, using the same mouse model as before [? ].
In order to picture the effect of prenatal exposure to BzBP on their activation, some isolated TH cells
were activated in vitro for 48 hours and 6 days this time. B cells were used as such. Paired-end RNA-
sequencing was performed for all the samples and differential expression analyses were carried out in
order to identify lncRNAs that were regulated by prenatal exposure to BzBP in the different types of
cells. Additionally, correlation network analyses were performed in the attempt to clarify the role of
these regulated lncRNAs. Published data were taken into account and integrated in order to obtain
the most global picture as possible.
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Methods
2.1 Sample preparation
2.1.1 Mice and spleens
BALB/cByJ mice were bred in the animal facility of the University of Leipzig (Germany) and
gracefully provided by Dr. Tobias Polte. Animal protocols used in this study were approved by the
Committee on Animal Welfare of Saxony/Leipzig (Permit Number: TVV10/10). The mice were bred
under conventional conditions such as 23◦C room temperature, 60% humidity, and 12 hours day/night
rhythm. These mice and their offspring were housed in polyphenylsulfone cages. All mice received
phytoestrogen-free diet (C1000 - Altromin) and water from glass bottles. Female mice were exposed to
BzBP (3 µg/mL) exclusively via drinking water, from one week before mating until delivery (prenatal
exposure). Control dams received normal drinking water. Just before delivery, pregnant mice were
separated into single cages. The following experiments were exclusively performed on the offspring of
the control and BzBP-exposed dams.
2.1.2 Spleen preparation and isolation of splenocytes
The whole isolation procedure was performed on ice and with chilled solutions. After being removed
from a freshly sacrificed mouse, a spleen was cut into pieces and placed on a 70µm mesh (BD Falcon)
itself placed onto a well of a 6-wells plate previously filled with 5mL of ice-cold 1x phosphate buffered
saline (PBS - Biochrom). The spleen was smashed with the plunger of a 1mL syringe and the mesh
was washed with 5mL ice-cold 1xPBS above the well. The 10mL of obtained cell suspension contained
the splenocytes and were transferred to a 15mL tube. The cells were centrifuged for 8 minutes, at
270xg, 4◦C. The cells were re-suspended by pipetting in 1mL of ice-cold 1xPBS and the 15mL tube was
filled up with 1xPBS and mixed by inversion before being centrifuged again for 8 minutes, at 270xg,
4 ◦C. The washing step was performed one more time using “Running Buffer” (1xPBS, bovine serum
albumin (BSA), EDTA, 0,09% azide - provided as ready-to-use by Milteny Biotec) instead of 1xPBS.
After the last washing step, the cells re-suspended by pipetting in 1mL of ice-cold Running Buffer. 9mL
of Running Buffer were added to get a final volume of 10mL and the cells were mixed by inversion. 5µL
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of cell suspension were diluted 1:20 with Trypan Blue (Fluka Analytical) and counted with a Neubauer
chamber. 2×105 splenocytes were stored at 4◦C for further Flow Cytometry measurements (see Section
2.1.7). The rest of the cells was directly used for the isolation of TH cells or B cells.
2.1.3 B cells isolation
Splenocytes were isolated from 7 mice (4 prenatally-exposed to BzBP and 3 non-exposed or “control”
mice) as described in Section 2.1.2. All the individuals were between 10 and 13 weeks old. The B cells
were separated from the splenocytes using the kit CD19 MicroBeads, mouse (Miltenyi Biotec) and
following the manufacturer instructions. Shortly, the freshly isolated splenocytes were centrifuged for
10 minutes, at 300xg, 4◦C. The cells were re-suspended in 90µL of Running Buffer (Miltenyi Biotec)
per 107 splenocytes. 10µL of CD19 Microbeads (included in the kit) were added per 107 splenocytes.
The cell suspension was mixed by pipetting and placed for 15 minutes at 4◦C. After the incubation,
the tube was filled up to 15mL with Running Buffer and centrifuged for 10 minutes, at 300xg, 4◦C.
A maximum of 1 × 108 total cells can be applied on a separation column used in this procedure.
If the number of splenocytes was higher, two columns were prepared as described in the following.
Additionally, since a minimum volume of 500µL can be applied on a single column (recommendations
of the manufacturer), the volume of the cell suspension was adjusted if necessary with Running Buffer.
A “LS” separation column (Miltenyi Biotec) was placed on an appropriate magnet (QuadroMACS
Separator - Miltenyi Biotec) with a 30µm pre-separation filter (Miltenyi Biotec) on the top of it. Both
were rinsed with 3mL of Running Buffer. After the whole volume went through the filter and the
column, the cell suspension was applied onto it, with a fresh 15mL tube place under to collect the
flow-through containing the unlabeled cells (positive selection). The column was washed 3 times with
3mL of Running Buffer. After the washing steps, the column was removed from the magnet and placed
onto a fresh 15mL tube. 5mL of ice-cold Running Buffer were added on the top of it and the elution
was enhanced by applying and pressing the plunger of the column (this tube contained the B cells).
5µL of the cell suspension were used for counting the number of isolated B cells, by diluting it 1:20
with Trypan Blue and using a Neubauer chamber. 2 × 105 cells from each sample were stored at 4◦C
for further Flow Cytometry measurements (see Section 2.1.7).
An aliquot of 1 × 106 cells was put in a 1.5mL Safe-lock tube and centrifuged for 10 minutes at
300xg. The cells were re-suspended in 700µL of TRIzol R© Reagent (Ambion R©) and stored at -80◦C for
further RNA experiments (see Section 2.2.1).
2.1.4 TH cells isolation
TH cells were isolated from the spleens of 4 prenatally-exposed and 4 non-exposed (control) mice
at the age of 10 to 13 weeks. The preparation of the spleens was performed as described above (see
Section 2.1.2). After counting, the splenocytes were divided into 2 pre-cooled 15mL tubes: 13 of the
cells in one tube for the isolation of the total population of TH cells (“total TH cells” - tube A) and
the remaining 23 in one tube for the isolation of na¨ıve TH cells only (“na¨ıve TH cells” - tube B). Both
tubes were centrifuged for 10 minutes, at 300xg, 4◦C. The supernatant was removed and the cells were
directly used for the further steps described below.
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2.1.4.1 Isolation of the complete population of TH cells
To perform the isolation of the total population of TH cells from the tube A, we used the components
of the “CD4+ T cell isolation Kit, mouse” (Miltenyi Biotec) and followed this procedure. The cell pellet
was re-suspended in 40µL Running Buffer per 107 splenocytes contained in tube A. 10µL of Biotin-
Antibodies cocktail (included in the kit) were added per 107 splenocytes. The cell suspension was mixed
by pipetting and incubated for 5 minutes at 4◦C. After incubation, 30µL of Running Buffer and 20µL
of Anti-Biotin Microbeads (included in the kit) were added per 107 splenocytes. The cell suspension
was mixed by pipetting and incubated for 10 minutes at 4◦C. If the cell suspension had a total volume
< 500µL, it was filled up to this value with Running Buffer (according to the usage recommendations
of the separation columns from Miltenyi Biotec).
A “LS” separation column (Miltenyi Biotec) was placed on an appropriate magnet (QuadroMACS
Separator - Miltenyi Biotec) with a 30µm pre-separation filter (Miltenyi Biotec) onto it. Both were
rinsed with 3mL of Running Buffer. After the complete volume of Running Buffer went through the
filter and the column, a fresh 15mL tube was placed under the latter to collect the flow-through
(containing the TH cells - negative selection). The cell suspension was applied onto the column. Once
the suspension got totally soaked in by the column, this one was washed with 3mL of Running Buffer.
The column was then removed from the magnetic stand and discarded. 5µL of the flow-through were
used for counting the number of isolated TH cells, by diluting it 1:5 with Trypan Blue and using a
Neubauer chamber. 2 × 105 cells were stored at 4◦C for further Flow Cytometry measurements (see
Section 2.1.7).
An aliquot of 1 × 106 cells was put in a 1.5mL Safe-lock tube and centrifuged for 10 minutes at
300xg. The cells were re-suspended in 700µL of TRIzol R© Reagent (Ambion R©) and stored at -80◦C for
further RNA experiments (see Section 2.2.1). The remaining cells were activated and kept in culture
for the next days as described in Section 2.1.5.
2.1.4.2 Isolation of the na¨ıve TH cells
To perform the isolation of the na¨ıve TH cells from the tube B, we used the components of the
“CD4+ CD62L+ T cell isolation Kit II, mouse” (Miltenyi Biotec) and followed this procedure. The
cell pellet was re-suspended in 40µL Running Buffer per 107 splenocytes contained in tube B. 10µL of
Biotin-Antibodies cocktail (included in the kit) were added per 107 leukocytes. The cell suspension was
mixed by pipetting and incubated for 10 minutes at 4◦C. After incubation, 30µL of ice-cold Running
Buffer and 20µL Anti-Biotin Microbeads (included in the kit) were added per 107 leukocytes. The cell
suspension was mixed by pipetting and incubated for 15 minutes at 4◦C. After incubation, 10mL of
ice-cold Running Buffer were added to the cells. The cells were centrifuged for 10 minutes, at 300xg,
4◦C.
A maximum of 1×108 total cells can be applied on a separation column. If the number of splenocytes
was higher, two columns were prepared as described in the following. Additionally, since a minimum
volume of 500µL can be applied on a single column (recommendations of the manufacturer), the volume
of the cell suspension was adjusted if necessary with Running Buffer.
For the negative selection of the TH cells, a “LS” separation column (Miltenyi Biotec) was placed
31
2. Methods
on an appropriate magnet (QuadroMACS Separator - Miltenyi Biotec) with a 30µm pre-separation
filter (Miltenyi Biotec) on the top of it. Both were rinsed with 3mL of Running Buffer. After the whole
volume went through the filter and the column, a fresh 15mL tube was placed under the column to
collect the flow-through containing the TH cells. The cell suspension was applied onto the column.
Once the suspension got totally soaked in by the column, this latter was washed 3 times with 3mL of
ice-cold running buffer. The column was then removed from the magnetic stand and discarded. The
cells were centrifuged for 10 minutes, at 300xg, 4◦C.
The cells were re-suspended in 80µL of ice-cold Running Buffer per 107 splenocytes used for the
na¨ıve CD4+ T cells isolation (starting number of cells in tube B). 20µL of CD62L Microbeads (included
in the kit) were added per 107 splenocytes. The cell suspension was mixed by pipetting and incubated
for 15 minutes at 4◦C. After incubation, 10mL of ice-cold Running Buffer were added to the cells. The
cells were centrifuged for 10 minutes, at 300xg, 4◦Cand the cell pellet was re-suspended in 500µL of
Running Buffer.
For the positive selection of the na¨ıve cells, a “MS” separation column (Miltenyi Biotec) was placed
on an appropriate magnet (OctoMACS Separator - Miltenyi Biotec) and rinsed with 0,5mL Running
Buffer. Once the Running Buffer went completely through the column, a fresh 15mL tube was place
under it to collect the flow-through containing the unlabeled “non-na¨ıve” TH cells (positive selection).
The cell suspension was applied onto the column. Once the suspension got totally soaked in, the column
was washed 3 times with 0,5mL of ice-cold Running Buffer. Because the na¨ıve TH cells were attached to
the column, this one was removed from the magnet and placed into a new 15mL tube. 1mL of ice-cold
Running Buffer was added onto the column and the elution was enhanced by directly applying and
pressing the plunger of the column. 5µL of the cell suspension were used for counting the number of
isolated na¨ıve TH cells, by diluting them 1:5 with Trypan Blue and using a Neubauer chamber. 2×105
cells were stored at 4◦C for further Flow Cytometry measurements (see Section 2.1.7).
An aliquot of 1 × 106 cells was put in a 1.5mL Safe-lock tube and centrifuged for 10 minutes at
300xg. The cells were re-suspended in 700µL of TRIzol R© Reagent (Ambion R©) and stored at -80◦C for
further RNA experiments (see Section 2.2.1). The remaining cells were activated and kept in culture
for the next days (see Section 2.1.5).
2.1.5 In vitro activation of TH cells
Total TH cells (from Section 2.1.4.1) and na¨ıve TH cells (from Section 2.1.4.2) were activated in
vitro for 48 hours and 6 days. For doing so, one 96-well plate per cell-type was coated the day before
the isolation with anti-mouse-CD3 antibodies (BioLegend). The antibodies were diluted in 1xPBS at
a final concentration of 4µg/mL. 125µL of this solution were pipetted per well and the plates were
placed at 4◦C over-night. On the experiment day, the plates were washed 3 times with 1xPBS and
each well was filled with 150µL of freshly prepared culture medium (RPMI medium 1640 (Gibco R©,
Life Technologies), 10% Fetal Bovine Serum (Biochrom AG), 1% L-Glutamine (Sigma), 1% Penicillin
/ Streptomycin (PAA), 55µM β-mercaptoethanol (Carl Roth)).
The “to-be-activated” cells were centrifuged for 10 minutes, at 300xg, 4◦C. The cells were re-
suspended at a density of 0.75 × 106 cells/mL, in freshly prepared culture medium. Mouse IL-2 (Life
Technologies) was added at a final concentration of 10ng/mL. Anti-mouse-CD28 antibodies were added
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at a final concentration of 4µg/mL (BioLegend). The culture medium was removed from the coated
wells and 150µL of the activation cell suspension were pipetted per well. The plates were placed in an
incubator at 37◦C, 5% CO2.
2.1.6 Harvesting of the activated TH cells
(The same procedure was applied in parallel for the two types of cells.)
After 48 hours, the cells were detached from half of the wells of the 96-wells plate (using mini cell-
scrapers). The cells were collected into a fresh tube and centrifuged for 10 minutes, at 300xg, room
temperature. The supernatant was transferred into fresh labeled tubes, and stored at -20◦C for further
experiments (see Section 2.5.1). The cells were re-suspended in 1mL of 1xPBS. 10µL of cell suspension
were used for counting the number of living cells by preparing a 1:2 dilution with Trypan Blue and
using a Neubauer chamber. 1 × 105 cells (based on the number of living cells) were stored at 4◦C for
further Flow Cytometry measurements (see Section 2.1.7). The remaining cells were centrifuged for
10 minutes, 300xg, at room temperature. The cells were re-suspended in 700µL of TRIzol R© Reagent
(Ambion R©) and stored at -80◦C for further RNA experiments (see Section 2.2.1).
After 72 hours of activation, the culture medium was changed. To do so, the cells were detached
from the remaining wells of the 96-wells plate. They were collected into a fresh tube and centrifuged for
10 minutes, at 300xg, at room temperature. The supernatant was transferred to fresh labeled tubes,
and stored at -20◦C for further experiments (see Section 2.5.1). The cells were re-suspended in 1mL
of 1xPBS. 10µL of cell suspension were used for counting the number of living cells by doing a 1:2
dilution with Trypan Blue and using a Neubauer chamber. The remaining cells were centrifuged for
10 minutes, 300xg, at room temperature. The cells were re-suspended in cell culture medium at a
density of 0.75 × 106 cells/mL (based on the number of living cells). Mouse IL-2 was added to get a
final concentration of 10ng/mL. In a fresh and uncoated 96-wells plate, 150µL of cell suspension were
pipetted per well. The plate was placed in an incubator at 37◦C, 5% CO2.
All cells were harvested after 6 days (3 days of activation + 3 additional days of cultivation) and
prepared in the same way as after 48 hours.
2.1.7 Flow Cytometry
The purity of the isolated cell populations and the percentage of activated TH cells were measured
by Flow Cytometry, with a Beckman Coulter FC500 instrument.
2.1.7.1 Purity of the isolated cells
Cells were kept aside at 4◦C at different steps during the TH cells isolation. Each aliquot was filled
up to 800µL with Running Buffer and equally divided into two 1.5mL Safe-lock tubes (tubes A and
B). The tube A was used for unstained control. 1µL of 1:10 dilution of anti-mouse-CD4 antibodies
(stock solution at 0.5mg/mL - BioLegend), 1µL of anti-mouse CD25 antibodies (BioLegend) and 1µL
of anti-mouse CD44 antibodies (BioLegend) were added within the tube B.
Similarly, the aliquot of B cells stored at 4◦C was filled up to 800µL with Running Buffer and
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equally divided into two 1.5mL Safe-lock tubes (tubes A and B). The tube A was used for unstained
control. 1µL of anti-mouse CD19 antibodies (BioLegend) and 1µL of anti-mouse CD45R/B220 anti-
bodies (BioLegend) were added within the tube B.
The samples were mixed by pipetting and transferred into labeled Flow Cytometry tubes and
directly measured.
2.1.7.2 TH cells activation
After 48 hours of in vitro activation, TH cells were harvested and some cells were stored at 4
◦C. The
cell suspension volume was adjusted with Running Buffer to reach a final volume of 800µL, before being
equally divided into two 1.5mL Safe-lock tubes (tubes A and B). The tube A was used for unstained
control and the tube B for checking the activation of the cells. 1µL of 1:10 dilution of anti-mouse CD4
antibodies (stock solution at 0.5mg/mL), 1µL of anti-mouse CD25 antibodies (BioLegend) and 1µL
of anti-mouse CD69 antibodies (BioLegend) were added within tube B. The samples were mixed by
pipetting and transferred into labeled Flow Cytometry tubes and directly measured.
2.1.7.3 TH cells viability
After 48 hours of in vitro activation, TH cells were prepared for measuring their activation by Flow
Cytometry, as described above (see Section 2.1.7.2). Once the unstained control was measured (tube
A), the same sample was used for cell viability measurement. For doing so, 100µL of 1:100 solution of
propidium iodide (PI stock solution at 1mg/mL - Life Technologies) were added to the sample in the
Flow Cytometry tube. The sample was mixed by pipetting and directly measured.
When TH cells were harvested after 6 days of in vitro activation and cultivation, an aliquot of cells
was stored at 4◦C. The volume of the cell suspension was adjusted to 400µL with Running Buffer. The
cell suspension was transferred into a labeled flow cytometry tube. The sample was measured a first
time as an “unstained” control. The same sample was used for cell viability determination, following
the same procedure as described above.
2.2 On the way to RNA-sequencing
2.2.1 RNA isolation
Total RNA was isolated from the samples collected during cell culture. For the B cells and the non-
activated TH cells, each sample contained 1× 106 cells. As many TH cells as possible were harvested
after 48 hours and 6 days of cultivation. The corresponding samples contained between 6.6× 105 and
3.1 × 106 cells per sample. For all the samples, the cells were lyzed with 700µL TRIzol R© Reagent
(Ambion R©) directly after harvesting and stored until then at -80◦C, as described in Section 2.1.
To isolate the total RNA, the samples were thawed and placed on the working bench, at room tem-
perature, for 5 minutes. MaXtract tubes (Qiagen) were centrifuged for 30 seconds at 14000xg. After
the incubation, the samples were transferred by pipetting to the labeled MaXtract tubes. 140µL of
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Chloroform (Chemsolute R©) were added to each. The samples were shaken vigorously for 15 seconds,
incubated for 3 minutes at room temperature and centrifuged for 15 minutes, at 12000xg, 4◦C. The
upper phase (aqueous phase) was transferred to a new 2mL Safe-lock tube for proceeding with the RNA
isolation, the other phases were discarded. The rest of the isolation procedure was performed using the
miRNeasy Mini kit (Qiagen) and the QIAcube instrument (Qiagen), following the instructions of the
manufacturer. The elution volume was set to 30µL.
2.2.2 DNAse digestion
The freshly isolated RNA samples were treated with a DNase treatment directly after the isola-
tion. For doing so, the Turbo DNA-freeTM kit (Ambion R©) was used, following the instruction of the
manufacturer for the rigorous digestion. The freshly isolated RNA samples were directly transferred to
0.5mL tubes and the following volumes were added:
Total RNA 30µL
10X buffer 3µL
Turbo DNAse 1.5µL
After mixing by pipetting, the samples were incubated for 30 minutes at 37◦C. 1.5µL of Turbo
DNase were then again added, the samples were mixed by pipetting and incubated for 30 minutes at
37◦C a second time. 5µL of DNase inactivation reagent were added. The samples were incubated
for 5 minutes at room temperature with some intermediate short vortexing steps in between, and
centrifuged at 10000xg for 1.5 minutes. The supernatant of each sample (containing the DNA-free
RNA) was transferred to a labeled 1.5mL tube before proceeding directly with ethanol precipitation.
2.2.3 Ethanol precipitation
The sample volume was adjusted to 180µL with RNase free water. 18µL 3M sodium acetate (Sigma-
Aldrich) and 4µL of glycogen (Ambion R©) were added before vortexing. 600µL of ice-cold 100% Ethanol
were added. The samples were again vortexed and placed at -20◦C overnight. The next day, the samples
were centrifuged for 30 minutes, at 10000xg, 4◦C. The pellet was washed twice with 900µL of ice-cold
70% Ethanol and centrifuged for 5 minutes, at 13000xg, 4◦C. The pellets were air-dried at room
temperature before being dissolved in 20µL of RNase free water. The samples were stored at -80◦C for
further experiments.
2.2.4 Quality control
The RNA concentration of each sample was measured with the Qubit R© RNA Assay Kit (Life
Technologies) using 2µL of RNA solution for each measurement. The RNA integrity was verified using
the RNA 6000 Pico kit for Agilent 2100 Bioanalyzer (Agilent Technologies). Samples with a RIN (RNA
integrity number) above 7 were used in the following.
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2.2.5 Ribosomal RNA removal
The removal of the ribosomal RNAs (rRNAs) was performed using the RiboZero magnetic core
kit and the RiboZero rRNA removal reagents, included in the ScriptSeqTM v2 Complete Gold Kit
(Human/Mouse/Rat) low input (Epicentre) and following the manufacturer instructions. The following
volumes were used:
Total RNA sample 150ng
RiboZero Reaction buffer 2µL
RiboZero rRNA removal solution 2µL
RNase-Free water up to 20µL
After the rRNAs removal on magnetic beads (included in the kit mentioned above), the samples
were transferred to labeled 1.5mL safelock tubes. The rRNAs-depleted RNAs were purified by ethanol
precipitation (see Section 2.2.3) and re-suspended the next day in 12µL of RNase-Free water before
proceeding to further experiments or storing at -80◦C. 1µL was used to verify the rRNA removal, using
again the RNA 6000 Pico kit for Agilent 2100 Bioanalyzer (Agilent Technologies).
2.2.6 RNA-sequencing libraries generation
The RNA-sequencing libraries were generated from the rRNAs-depleted RNA samples, using the
ScriptSeqTM v2 Complete Gold “low input” Kit (Human/Mouse/Rat) (Epicentre), following the man-
ufacturer instructions. The following volumes were used:
RiboZero treated RNA 9µL
RNA fragmentation solution 1µL
cDNA synthesis primer 2µL
After the cDNA synthesis and the 3’-terminal-tagging, the cDNA was purified using the Agencourt R©
AMPure R© XP beads (Beckman Coulter) following the instructions described in the ScriptSeqTM “low
input” kit protocol (Epicentre). 22.5µL of cleaned tagged-cDNA were transferred to a 0.2mL tube and
directly used for the amplification of the library (by Polymerase Chain Reaction - PCR). A different
index PCR primer (from “ScriptSeqTM Index PCR Primers” by Epicentre) was used per sample as
a reverse primer. For each reaction, the following volumes and thermocycler (Biometra) programmes
were used:
cDNA 22.5µL
FailSafe PCR PreMix E 25µL
Forward PCR primer 1µL
ScriptSeqTM index PCR primer 1µL
FailSafe PCR enzyme (1.25U) 0.5µL
95◦C 1 minute
95◦C 30 seconds
55◦C 30 seconds x 12 cycles
68◦C 3 minutes
68◦C 7 minutes
4◦C pause
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After the PCR, the libraries were cleaned using the Agencourt R© AMPure R© XP beads (Beckman
Coulter) following the instructions described in the ScriptSeqTM “low input” kit protocol (Epicentre).
18µL of the supernatant, which contains the RNA-sequencing library, were transferred to a fresh labeled
1.5mL safelock tube. 2µL were used for assessing the concentration with the Qubit R©dsDNA HS Assay
kit assay (Life Technologies). 1µL was used for the High-Sensitivity DNA kit with the Agilent 2100
Bioanalyzer (Agilent Technologies) to check the amplification of the library and get its size average and
its molarity.
2.2.7 Pooling of the librairies
Before sequencing, the RNA-sequencing libraries that had to be sequenced together (several runs
were required) needed to be pooled in such a way that the same amount of each library was sequenced.
To do so, 12nM of each library were used. The corresponding volumes were calculated using the
molarity given by the Bioanalyzer (see Section 2.2.6).
5 sequencing runs were performed in total, what means that 5 pools were prepared. For each pool,
50mL of 2% agarose (Roth) gel were prepared and stained with HDGreen Plus DNA Stain (Intas). Each
pool was diluted with 6x Gel loading dye (New England Biolabs) and run on the gel for 30 minutes,
at 150V. Afterwards, the region between 200bp and 600bp was cut (corresponding to the size of the
fragments to be sequenced) and transferred to a fresh 15mL tube.
The RNA-sequencing libraries pools were then eluted from the gel using the MinElute Gel extraction
kit (Qiagen), following the instructions of the manufacturer. The samples were eluted within 12µL of
EB buffer (10mM Tris-Cl, pH 8,5 - Qiagen). 2µL were used for concentration determination with the
Qubit R©dsDNA HS Assay kit assay (Life Technologies) and 1µL was used for quality control on a High
Sensitivity DNA chip on the Agilent 2100 Bioanalyzer (Agilent Technologies).
2.3 RNA-sequencing
Before sequencing, the samples had to be transferred to a v3 PE Flow-cell, the support on which
the sequencing takes place. For doing so, the instrument Illumina cBot and the TruSeq PE Cluster kit
v3 (Illumina) were used, following the manufacturer instructions. As an internal control, 0.5% PhiX
Control v3 (Illumina) were spiked in the sample preparation before clustering. The pooled libraries
resulting from Section 2.2.7 were diluted to a final concentration of 19pM before use.
The paired-end (2× 100 nucleotides) RNA-sequencing procedure was performed on the HiSeq2000
instrument (Illumina), using a TruSeq SBS v3 200 cycles kit (Illumina) and following the instructions
of the manufacturer.
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2.4 Data analysis
2.4.1 RNA-sequencing data analysis and identification of new transcripts
The sequencing reads were demultiplexed based on the indexes used for the RNA-sequencing libraries
preparation, using CASAVA (v1.8.4., Illumina). The following data analysis was performed using a
pipeline developed in our group, the uap - Universal Analysis Pipeline [? ]. We configured uap to
use the following programs: Cutadapt (v1.5, adapter type ’a’) [? ] for adapter removing, fastqc
(v0.11) and the fastx tool kit (0.0.13) for quality control, segemehl (v0.2.0) [? ] for read mapping
(parameters: -S for the split read mode, -H 1 -D 0). An average sequencing depth of 4.27 × 108
mapped reads properly paired per sample was obtained.
Additionally, Cufflinks (v2.2.1.1) [? ? ] was used to detect new transcripts (default parameters
and library-type: fr-secondstrand). New genes identified with Cufflinks are named “XLOC n”
with n a number that corresponds to the order in which the genes were assembled. From the output
of Cufflinks, the newly assembled genes were filtered to select the ones designated as “unknown” (u),
“antisense exonic” (x) or “antisense intronic” (s) by the program.
A merged assembly of Gencode M11, NCBI Mus musculus Annotation Release 106 and newly
assembled genes was generated. To do so, NCBI Mus musculus Annotation Release 106 was first
integrated to Gencode M11 (48709 genes) giving an extended annotation that comprised 57727 genes.
The newly assembled transcripts were filtered for the ones that were not overlapping with any genes
from this extended annotation. Additionally, newly assembled transcripts were filtered for multi-exonic
transcripts and single exonic transcripts longer than 953 nucleotides (corresponds to the 75th quartile
of the size repartition of annotated single exonic transcripts in Gencode M11). 28615 newly assembled
genes were then considered. This merged assembly (total of 86342 genes) was used for read counting
with htseq-count (v0.6.1, mode intersection-strict, strand-specific, type exon) [? ].
2.4.2 Coding potential of novel transcripts
Multiz alignments from 60 vertebrate genomes were scored with RNAcode [? ] as described pre-
viously [? ] to evaluate their protein-coding potential. An alignment and its corresponding genomic
region were considered as potentially protein-coding if the reported RNAcode p-value was below 0.05.
On the contrary, regions were considered as potentially non-coding if the p-value was > 0.05 and if
they did not overlap with an exon of any annotated CDS (sense) from Gencode M11 and NCBI Mus
musculus Annotation Release 106.
The newly assembled genes were therefore classified as “potentially protein-coding”, “bona fide
lncRNA” and “unknown” (no p-value reported by RNAcode for the concerned region) according to their
genomic localization.
2.4.3 Differential expression analysis
Differential expression analysis was performed using the R (v3.3.1) package DESeq2 (v1.14.1) [?
] from Bioconductor (https://www.bioconductor.org/). The data for the different types of cells
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(B cells, “total” TH cells and na¨ıve TH cells) were treated separately. When comparing the prena-
tally exposed and non-exposed groups, the treatment (prenatally exposure to BzBP) and gender were
considered for the design formula of the analysis (∼ gender + treatment). Genes with less than 10
normalized counts in less than 3 replicates were discarded. “Regularized log transformation” (rlog)
was used for normalization and Benjamini-Hochberg procedure was used for adjusting the p-values.
Annotation of the analyzed genes was made with Ensembl BiomaRt v86 (biomaRt v2.30.0) [? ]. Gene
Ontology enrichment was performed on the list of differentially expressed genes, using GOstats (v2.40.0)
[? ]. The same procedure was applied to perform differential expression analysis between the different
time-points of the TH cells activation time-line (∼ gender + time).
Additionally, the correlation coefficients between some selected genes and potentially related-genes
were calculated with the Spearman method. The Benjamini-Hochberg procedure was used for adjusting
the p-values again.
2.4.4 RNA-sequencing data for perinatally exposed mice
Additionally to the sample preparation and analysis described in the previous sections, RNA-
sequencing data from perinatally exposed mice published in ? ] were re-analyzed. These RNA-
sequencing data were analyzed with the uap as well, using the same configuration as for the results
of prenatal exposure to BzBP. The assembly of new genes by Cufflinks was excluded from this part
of the analysis. The read counts were therefore obtained with htseq-count for a merged assembly
of Gencode M11 and NCBI Mus musculus Annotation Release 106 only. The differential expression
analysis for this data-set was performed as described in Section 2.4.3 as well.
2.4.5 RNA-sequencing data for B cell development
We downloaded RNA-sequencing data from the study of B cells development by ? ]. We followed
the same procedure as for our own data for the analysis (same configuration of the uap) and the read
counts were obtained with htseq-count for the same assembly as used for our own data (see Section
2.4.1). Their sequencing depth was about 9 × 107 mapped reads properly paired, using a 2 × 100nt
paired-end sequencing protocol similar to ours.
2.4.6 Correlation Network Analysis
Weighted Gene Correlation Network analysis was performed using the R (v3.3.1) package WGNCA
(v1.51) [? ] for both TH cells and B cells analyzes. The construction of the network for the TH
cells was based on our own data (21 samples of “total TH cells” - see Section 3.5.1 for details), and
a soft-power (β) of 21 was used according to the recommendations of WGCNA developers at that point
(https://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/faq.html -
analysis performed in October 2017). On the contrary, for the B cells, the analysis was performed on
a published data set about B cell development [? ] (see Section 2.4.5). A soft-power (β) of 13 and a
threshold of 0.25 for the dissimilarity of module Eigengenes were used. Cytoscape (v3.5.1.) was used
for visualization of sub-networks.
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2.4.7 Pathway Analysis
Pathway analysis was performed using the Ingenuity Pathway Analysis (IPA) software (Qiagen)
on lists of genes obtained from the correlation network constructed on our TH cells data. The genes
identifiers (Ensembl gene IDs) were mapped to genetic networks available in the software database. The
enriched pathways were ranked according to how relevant they were for the genes provided as input.
Benjamini-Hochberg procedure was used for adjusting the p-values.
2.4.8 Conservation
In order to verify the conservation of some target genes, their respective sequences in the mouse
genome (mm10) were obtained using bedtools (version 2.26) [? ] and each were compared to a set of
genomes of Euarchontoglires using BLAT (v35) [? ]. The results were filtered for hits having a coverage
identity higher than 70%. The multiple alignments were performed and visualized with muscle (version
3.8.31) [? ] and clustalX [? ], respectively.
2.4.9 Data storage
Data that were too large to be stored in the appendices of this thesis (e.g. results of differential
expression analysis or GO term enrichment) were stored on the archiving system of the Helmholtz
Center for Environmental Research - UFZ. A list of the concerned tables and corresponding links is
available in the Appendix C.
2.5 Additional investigations
2.5.1 ELISA
A serie of ELISA (Enzyme-Linked Immunosorbent Assay) experiments was performed on TH cells
supernatants to measure the concentrations of the following cytokines: IFNγ, IL-13, IL-4 and IL-5. The
supernatant was collected during cell culture (see Section 2.1). For each cytokine, the corresponding
kit for mouse from eBiosciences was used, following the manufacturer instructions. Shortly, the plates
were coated overnight at 4◦C with 50µL per well of Coating Antibodies diluted in 1X Coating Buffer.
The next day, the plates were washed 3 times with 300µL per well of Wash Buffer (1x PBS (Biochrom),
0.05% Tween (Chemsolute R©) for 1 minute. The wells were blocked with 100µL of 1X ELISA/ELISPOT
Diluent (included in the kits mentioned above) for 1 hour at room temperature, and then washed once
more as described above. A standard solution was freshly prepared for each cytokine following the
manufacturer instructions. A serial dilution of this standard (total of 8 points) was prepared. To
remain in the detection range, the samples were diluted (1:2 ratio with 1X ELISA/ELISPOT Diluent)
before IFNγmeasurements. For the other measurements, the samples were used as such.
50µL of the different standard dilutions and of the samples were applied per well, with 2 technical
replicates for each. The plates were incubated for 2 hours at room temperature. The plates were
then washed four times. 50µL of Detection Antibody dilution were added per well and the plates were
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incubated for 1 hour at room temperature. The plates were again washed 4 times. 50µL of Avidin-
HRP* (included in the kits mentioned above) diluted in 1X ELISA/ELISPOT Diluent were added per
well and the plates were incubated for 30 more minutes. 6 washing steps with 2 minutes incubation
were performed. 50µL of 1X TMB solution (included in the kits mentioned above) were added to each
well and the plates were incubated for 15 minutes. Finally, 25µL of Stop Solution (1M H3PO4 - Fluka
Analytical) were added to stop the reaction and the plates were directly read with at 450nm with a
plate-reader.
2.5.2 Reverse Transcription
cDNA was generated from total RNA samples (see Section 2.2) by Reverse Transcription, using the
“High Capacity cDNA Reverse Transcription” kit (Applied Biosystems). The following volumes and
thermal profile were used for each reaction:
Total RNA 100ng
10X RT-buffer 2µL
100mM dNTP Mix 0.8µL
10X random primer 2µL
RNase inhibitor 1µL
Multiscribe RTase 1µL
H20 up to 20µL
25◦C 10 minutes
37◦C 120 minutes
85◦C 5 minutes
4◦C storage
The samples were then directly used for further experiments or stored at -20◦C.
2.5.3 Standard PCR
Standard PCR was performed on the cDNA generated as described in Section 2.5.2, using the
“Phusion R© High Fidelity DNA Polymerase” kit (New England Biolabs) and a dNTP mix (dNTP-Set
1 - CarlRoth). The primers are indicated in the following, with the annealing temperatures calculated
according to the recommendations from the polymerase manufacturer.
# Gene Forward primer Reverse primer ◦C
1 Gm15441 CTACTGTGTGGGTTCTGCT CGATATGCTCCTATTGCACT 58
2 Gm15441 CTACTGTGTGGGTTCTGCT CTAGCGGGGAAAATGGTTG 58
3 Gm15441 GACTTGCGAACTTGTGAGC TCTGCACTCTGAGGCTCTT 61
4 Gm15441 GACTTGCGAACTTGTGAGC CCCTCACTGATGGACTGTG 61
5 XLOC 070362 GAGCTGATTGGCAGAGTGA CCTAAGAAATCCCGTTCCTC 61
6 XLOC 089487 AAACACCTGGATGCTTCTTG CGCTTTGTAAATGGGCTATG 62
7 XLOC 089487 GGGCAATACCCATCCTCTA ACTGGAAGGGATGCATGTA 61
The localization of the primers is indicated in Figure 3.11 and the expected size of the products
in Supplementary Table S2A, Appendix B. The following volumes and thermal program were used for
each sample:
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Phusion HF Buffer 10µL
10mM dNTP mix 1µL
Forward primer 2.50µL
Reverse primer 2.50µL
cDNA (1:10 diluted) 10µL
H2O 22µL
DMSO 1.50µL
Taq DNA Polymerase 1µL
98◦C 30 seconds
98◦C 10 seconds
58-62◦C 30 seconds x 35 cycles
72◦C 1 minute
72◦C 10 minutes
4◦C pause
The PCR products were purified with the “MinElute PCR purification Kit” (Qiagen) and eluted
in 10µL EB Buffer (Qiagen). 1µL of the purified products was used for the High-Sensitivity DNA kit
with the Agilent 2100 Bionanalyzer (Aglient Technologies).
2.5.4 qPCR
qPCR was performed for a selection of genes on the cDNA generated as described in Section 2.5.2
with the following primers:
Gene Forward primer Reverse primer
Gm15441 CTACTGTGTGGGTTCTGCT CTCGAACTCGTTTCCTCTG
XLOC 070362 TCAGACTACAGCACCTATCA ACCACGGTGTCAGAGAACA
XLOC 089487 AAACACCTGGATGCTTCTTG TGTGTTCCACCGCTAGTCT
XLOC 449244 CCTAGGGTGGAAAGGTTTG AATCATATGTGCCCATCCAG
Gm38865 GCTCCCCTCTTACAGGGTT TGCATTCAACTGAAGCCATCC
Gm37033 GGTGAGCTCTTTGACCTTCA ACTCAGTCGCTTGGACAGAC
Gapdh GTTGTCTCCTGCGACTTCA GGTGGTCCAGGGTTTCTTA
The reactions were performed using the “Fast SYBR Green Master Mix” (Thermofisher) with the
following volumes:
cDNA (1:10 diluted) 5µL
2x Fast SYBR Green Master Mix 10µL
Forward primer 10M 1µl
Reverse primer 10M 1µl
Gapdh was used as reference gene. Efficiency was determined for each pair of primers, using a cDNA
serial dilution. The results were taken into consideration for the relative quantification of each gene,
with relative abundance = EffHKG
CtHKG/ Efftarget
Cttarget . In order to test the significance of the
observed results, a t-test was performed.
The qPCR products were run on a 2% agarose (Roth) gel stained with HDGreen Plus DNA Stain
(Intas), with the 100 bp DNA Ladder from New England Biolabs.
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TH cells and BzBP
The effect of exposure to BzBP on TH cells was evaluated in two phases. We first had a look at the
effect of perinatal (during pregnancy AND breastfeeding) exposure to BzBP on the transcriptome of
TH cells. We observed that 13.46% of the investigated genes were then differentially expressed genes,
including several hundreds of lncRNAs∗. Nevertheless, no functional annotations were available for the
latter. To investigate the roles of lncRNAs influenced by BzBP, similar experiments were performed
on prenatally (only during pregnancy) exposed mice. For this second step, older mice were used and
isolated TH cells were activated in vitro for several lengths of time. Furthermore, newly assembled
genes were considered in addition to the annotated ones.
3.1 Perinatal exposure to BzBP lead to differential expression
of lncRNAs in TH cells
Upstream to the investigation of the effect of prenatal exposure to BzBP on TH cells, RNA-
sequencing was performed on TH cells from mice that were perinatally exposed to BzBP as now
published in ? ]. For this aspect of the study, pups were weaned after three weeks and directly sac-
rificed. TH cells were then isolated from 7 spleens from 3 weeks old mice (3 from mice perinatally
exposed to BzBP vs. 4 mice that were not). After RNA-sequencing, counts were obtained for the anno-
tated genes from Gencode M11 and the non-overlapping genes from NCBI Mus musculus Annotation
Release 106 (total of 57727 genes). Lowly expressed genes (less than 10 normalized counts in less
than 3 replicates) were removed, lowering down the number of genes to 21517 genes for further analy-
sis, including 3520 lncRNAs.
Principal Component Analysis (PCA) was performed based on the normalized counts (by “regular-
ized log transformation” included in the DESeq2 package) and the results are presented in Figure 3.1.
∗according to the Ensembl biotypes, lncRNAs include intergenic lncRNAs (lincRNAs), antisense RNAs, TEC (“To
be Experimentally Confirmed”) RNAs, sense intronic RNA, sense overlapping RNA, bidirectional promoter lncRNA,
processed transcripts and misc (miscellaneous) RNAs
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Figure 3.1. Principal component analysis for TH cells after perinatal exposure to BzBP. PCA was
performed on normalized counts (“regularized log transformation” from the DESeq2 R package).
This highlighted an influence from the treatment (perinatal exposure to BzBP or not) but also from
the gender. Both criteria were therefore considered for the design of the differential expression analysis
(“∼ gender + treatment”).
We found that 2897 genes out of the 21517 investigated genes were differentially expressed (DE)
between the two treatments (FDR 0.05 - Online Supplementary Table SO-1, link in Appendix C),
including 1178 “up-regulated” genes (higher expression when perinatally exposed to BzBP) and 1719
“down-regulated” genes (Figure 3.2A). Biotype annotation highlighted that the DE genes included 1852
protein-coding genes and 801 lncRNAs (Figure 3.2B).
Gene Ontology (GO) Enrichment Analysis was performed on the list of DE genes. 231 GO terms
were significantly enriched (p < 0.001), including terms related to immunity and T cells such as “regula-
tion of immune system process” (GO:0002682, p = 2.46× 10−13), “cytokine production” (GO:0001816,
4.95× 10−11) or yet “T cell activation” (GO:0042110, p = 2.13× 10−10) (Online Supplementary Table
SO-2, link in Appendix C). These results imply that the genes regulated by perinatal exposure to BzBP
could have a role in TH cells regulation and activation. Moreover, as described in ? ], some of the DE
protein-coding genes have been previously described as related to allergic asthma phenotype (e.g. the
genes Fanca, Fads1, Zfpm1 ).
Taken together, these results revealed that perinatal exposure to BzBP led to the differential ex-
pression of genes that are involved in T cell regulation and activation. Some of the DE protein-coding
genes were directly described as associated with asthma, suggesting that they are key drivers in the
development of allergic asthma following perinatal exposure to BzBP. On the other hand, 801 DE lncR-
NAs were also found. While mainly were annotated as “predicted genes” and without any functional
description available, the few ones already described did not show relevant links with TH cell functions
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Figure 3.2. Perinatal exposure to BzBP led to differential expression in TH cells. Results are shown
for significantly differentially expressed genes (FDR 0.05). (A) Z-score of the expression level computed by row,
with each row corresponding to a BzBP-regulated gene (FDR 0.05). (B) The DE genes with biotype information
are divided in two subgroups “up-regulated” (more expressed in the perinatally exposed group than in the control
group) and “down-regulated”.
or with asthma and allergy development (e.g. NEAT1, Xist). A second phase of experiments was
planned in order to investigate the influence of prenatal exposure to BzBP on lncRNAs in TH cells
activation.
3.2 TH cell in vitro activation and viability are not influenced
by prenatal exposure to BzBP
TH cells were isolated from 8 spleens from 10 to 13 weeks old mice (between 3 and 4 times older
than individuals used for Section 3.1 in order to represent a more mature immune system). 4 samples
(including 2 females) corresponded to the prenatally exposed group or “treatment” group, and 4 samples
to the control group (including 2 females as well). From these samples, two distinct populations were
separated: the “na¨ıve TH cells” and the “total TH cells”. While the first ones corresponded to the TH
cells that were never in contact with an antigen and therefore never activated, the latter included any
TH cells. This implies that the “total TH cells” contained na¨ıve TH cells but also effector and memory
TH cells. In the following, for a matter of clarity, we keep referring to the two types of samples as
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“na¨ıve TH cells” and “total TH cells”, respectively, even after in vitro activation.
One “control” biological replicate had to be excluded because (1) the isolated cells contained a low
number of TH cells (56.4% for the corresponding “na¨ıve TH cells” sample - see below for details) and
(2) some of the related samples did not meet the criteria of high RNA quality (see Section 2.2). All the
samples associated to this replicate were therefore excluded from the RNA-sequencing pool and from
each analysis step, lowering the number of samples to 4 in the “treatment” group vs. 3 in the “control”
group (including 2 females). In the following, all the results presented correspond to the 7 remaining
samples.
The purity of the isolated cell populations was checked by Flow Cytometry (Figure 3.3). CD4 and
CD44 are markers for TH cells and for effector and memory TH cells, respectively. The “total TH
cells” samples contained in average 93.08% of TH cells (CD4
+ cells) and 73.94% of na¨ıve TH cells
(CD4+/CD44−). On the other hand, the “naive TH cells” samples contained in average 86.94% TH
cells and 85.73% of na¨ıve TH cells.
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Figure 3.3. Purity of the TH cells populations after isolation from mouse spleens. The percentage of
CD4+ cells and CD4+/CD44− cells are indicated for the two types of isolated samples (“na¨ıve TH cells” and
“total TH cells”). CD4
+ cells are TH cells and CD4
+/CD44− cells correspond to na¨ıve TH cells.
Cells from these samples were activated in vitro with anti-CD3 and anti-CD28 antibodies for 72
hours and then kept for 72 additional hours in fresh medium without antibodies or polarizing conditions,
summing up to a total of 6 days of cultivation. After 48 hours of in vitro activation, the percentage of
activated cells per sample was checked by Flow Cytometry (Figure 3.4A). The surface markers CD69
and CD25 are encoded by genes called Cd69 and Cd25 and are early and late markers of TH cells
activation, respectively. A given cell was considered as activated if at least one of these activation
markers was detected at its surface. CD69+/CD25−, CD69+/CD25+ and CD69−/CD25+ cells were
46
3.2. TH cell in vitro activation and viability are not influenced by prenatal exposure to BzBP
therefore all considered as activated cells. The “total TH cells” samples contained in average 64.36%
of activated cells and the “na¨ıve TH cells” samples 73.97%. For both types of samples, no significant
differences were observed between the “control” and “treatment” groups (p > 0.05).
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Figure 3.4. Prenatal exposure to BzBP did not affect the number of activated and PI-stained TH
cells. (A) Percentage of activated cells (CD69+/CD25−, CD69+/CD25+ and CD69−/CD25+ cells) detected
by Flow Cytometry after 48 hours of in vitro activation. (B) and (C) present the percentage of PI-stained cells
(dead cells) detected by Flow Cytometry after 48 hours and 6 days of cultivation, respectively.
Additionally, cells were stained with Propidium Iodide (PI) in order to estimate the percentage of
dead cells after 48 hours and 6 days of in vitro activation and cultivation (Figure 3.4B and C). “Total
TH cells” samples contained on average 39.41% and 49.61% after 48 hours and 6 days, respectively,
and “na¨ıve TH cells” samples 43.84% and 54.08%. No significant differences were observed between
the “control” and “treatment” groups (p > 0.05).
Finally, in order to evaluate the amount of cytokines secreted by the activated and cultivated “total
TH cells”, ELISA was performed on the cell culture supernatants collected after 48 hours, 72 hours
and 6 days. The measurements were made for cytokines previously described as involved in asthma
or allergies phenotypes (e.g. IL-4 [? ], IL-13 [? ], IL-5 [? ], IFNγ[? ]) . No significant differences
were observed between the “control” and “treatment” groups (p > 0.05). However, observing high
variations between the samples belonging to a given group, the analysis was re-run while considering
males and females separately. This highlighted differences in between both gender within the same
group and eventual tendencies of regulation by prenatal exposure to BzBP (Supplementary Figure S3
in Appendix A). Nevertheless, the number of replicates became critical after separating the samples in
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sub-groups according to the gender (between 1 and 2 replicates by sub-groups). Therefore, statistical
tests to support the previous observations could not be performed.
To summarize, even though tendencies could be observed, prenatal exposure to BzBP did not lead to
significant variations in the phenotype of TH cells, such as activation markers expression, cell viability
or cytokine secretion.
3.3 Na¨ıve TH cells are not affected by prenatal exposure to
BzBP
In the following, when mentioning the “0 hours” time-point we refer to the cells that were not
activated in vitro, the “48 hours” time-point to the cells activated in vitro for that time, and the
“6 days” time-point to the cells that were activated and then kept in culture for a total of 6 days.
Differential expression analysis was performed separately for the data corresponding to these three
time-points, and for the two types of samples (containing “total TH cells” and “na¨ıve TH cells” after
isolation, respectively). The results concerning the “na¨ıve TH cells” samples are shown in this section,
while the results concerning the “total TH cells” are presented in the following ones (from Section 3.4).
Lowly expressed genes (less than 10 normalized counts in less than 3 replicates) were discarded
before proceeding with differential expression analysis on “na¨ıve TH cells” samples. Out of the 86342
genes considered initially (see Section 2.4.1), 27768, 27333 and 28207 genes remained for the time-points
“0 hours”, “48 hours” and “6 days”, respectively.
PCA was performed on the normalized counts (obtained with “regularized log transformation”
from the DESeq2 package) of these selected genes. The results did not reveal a clear effect of the
treatment (prenatal exposure to BzBP) but highlighted a variation between samples related to the
gender (Supplementary Figure S3 in Appendix A). Both criteria were considered for the design of the
differential expression analysis (“∼ gender + treatment”).
The number of DE genes (FDR 0.05) found for each time-point is indicated in Table 3.1A (list of
DE genes available in Online Supplementary Table SO-3, link in Appendix C). Depending on the time-
point, between 0 and 37 genes were found differentially expressed between the two groups. Moreover,
except for the “48 hours” time-point, no lncRNA or newly assembled genes were found DE.
In order to control if the lack of differences might have been related with the quality of the sam-
ples, differential expression analysis was additionally performed to compare differential expression in
response to the activation since the latter should lead to strong differences (performed on the samples
from the control group only). We found between 9132 and 18430 DE genes (FDR 0.05) when comparing
the data of two different time-points. Similar results were obtained when considering the “total TH
cells” samples (Table 3.2).
To summarize, prenatal exposure to BzBP led to few differential expression in na¨ıve TH cells, but
no DE lncRNA could be found. Additionally, when activating and cultivating these cells in vitro for
48 hours and 6 days, few or no DE genes were found. This suggests that prenatal exposure to BzBP
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0 hours 48 hours 6 days
DE genes (total) 37 3 0
DE lncRNAs 0 1 0
DE newly assembled genes 0 0 0
A. “Na¨ıve TH cells”
0 hours 48 hours 6 days
DE genes (total) 325 2 842
DE lncRNAs 37 0 26
DE newly assembled genes 29 0 57
B. “Total TH cells”
Table 3.1. Prenatal exposure to BzBP led to differential expression in “total TH cells” samples but
not in the “na¨ıve TH cells” ones. The number of DE genes (FDR 0.05) between the two groups (prenatally
exposed to BzBP and control) was determined. Among the DE genes, the numbers of DE lncRNAs and newly
assembled genes were determined as well. The results are presented for the each time-points of the activation
time-line. (A) DE genes in “total TH cells”. (B) DE genes in “na¨ıve TH cells”.
Contrast ”Na¨ıve TH cells” ”Total TH cells”
0 hours vs. 48 hours 18430 16220
48 hours vs. 6 days 15014 13187
0 hours vs. 6 days 9132 7941
Table 3.2. TH cells in vitro activation is associated with differential expression. The number of DE
genes (FDR 0.05) between each time-point was determined (based only on the samples from the control group).
Results are presented for the two types of samples: “total TH cells’ and “na¨ıve TH cells”.
had a limited effect on na¨ıve TH cells and throughout their activation.
3.4 Prenatal exposure to BzBP leads to differential expression
in TH cells
The analysis for the “total TH cells” samples was performed in the same way as for the “na¨ıve TH
cells” samples (see Section 3.3). Lowly expressed genes (less than 10 normalized counts in less than 3
replicates) were discarded before proceeding with differential expression analysis on “total TH cells”
samples. Out of the 86342 genes considered initially (see Section 2.4.1), 27484, 26969, 27294 genes
remained for the time-points “0 hours”, “48 hours” and “6 days”, respectively.
PCA was performed based on the normalized counts and the results highlighted differences between
the time-points (Figure 3.5). For the “0 hours” and “6 days” time-points, samples were separated
according to the treatment and the gender. While most of the variance could be explained by the
gender at “0 hours”, the treatment appeared to have a stronger influence at “6 days”. On the contrary,
concerning the “48 hours” time-point, the gender appeared to have a strong influence but not the
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treatment. Both criteria were nevertheless considered for the design of the differential expression
analysis for each time-point (“∼ gender + treatment”).
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Figure 3.5. Principal component analysis for “total TH cells” after prenatal exposure to BzBP.
PCA was performed on normalized counts (“regularized log transformation” from DESeq2 R package) from the
“total TH cells” samples. The figures A, B and C correspond to the “0 hours”, “48 hours” and “6 days” of in
vitro activation time-points, respectively.
3.4.1 Prenatal exposure to BzBP affects TH cells differently than perinatal
exposure
Differential expression analysis was performed on the “total TH cells” samples from the “0 hours”
time-point (not in vitro activated). We found 325 DE genes, including 37 lncRNAs and 29 newly
assembled genes (Table 3.1B and Figure 3.6A - complete list of annotated DE genes available in Online
Supplementary Table SO-4, link in Appendix C). The RNAcode analysis revealed that 9 out of the 29
newly assembled genes coded for bonafide lncRNAs and 9 were potentially protein-coding.
GO Enrichment Analysis was performed on the list of DE genes. Significantly enriched terms
(p < 0.001) were all related to RNA metabolism and processing (Supplementary Table S3 in Appendix
B). This suggests that genes regulated by prenatal exposure to BzBP may be involved in such processes.
The experiments performed on perinatally exposed mice (see Section 3.1) were actually also made
on “total TH cells” samples that were not activated in vitro. We therefore compared the list of DE
genes obtained after the differential expression analysis on this first data set with the one obtained
from prenatally exposed mice. 33 genes were found in both cases. However, this overlap of the two
data sets was tested empirically and appeared to be random (p = 0.42, with 1000 permutations - list of
genes available in Supplementary Table S4 in Appendix B). This suggests that prenatal and perinatal
exposures affect TH cells differently at the transcriptome level.
Although we observed before that prenatal exposure to BzBP had little effects on na¨ıve TH cells,
these latest results show that it differs if a complete population of TH cells is considered (containing
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Figure 3.6. Prenatal exposure to BzBP led to differential expression in “total TH cells”. The DE
genes (FDR 0.05) are divided in two subgroups “up-regulated” (more expressed in the prenatally exposed group
than in the control group) and “down-regulated”. The number of DE genes is indicated for each found biotype.
(A) Results of the differential expression analysis for the “0 hours” time-point. (B) Results for the “6 days”
time-point.
na¨ıve, effector and memory TH cells) and they suggest that prenatal exposure to BzBP led to differential
expression in TH cells, including a number of lncRNAs.
3.4.2 The influence of prenatal exposure to BzBP on TH cells varies through-
out their activation time-line
Differential expression analyses was performed as well on samples from in vitro activated “total
TH cells” (Table 3.1B). Out of the 26969 genes considered for the “48 hours” time-point (see Section
3.4), only 2 protein-coding genes (Hdgfrp3 and Dhx36 - Supplementary Table S5 in Appendix B) were
differentially expressed between the two groups (FDR 0.05). None of them were described previously
as involved in TH cells activation or in allergies and asthma development. On the contrary, we found
842 DE genes (FDR 0.05) out of the 27294 genes investigated for the “6 days” time-point (see Section
3.4 - complete list of genes available in Online Supplementary Table SO-5, link in Appendix C). These
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included 620 protein-coding genes, 26 lncRNAs and 57 newly assembled genes (Figure 3.6B). The
RNAcode analysis revealed that 30 of the newly assembled genes coded for bonafide lncRNAs and 9
were potentially coding for proteins.
GO Enrichment Analysis was performed on the list of 842 DE genes at the “6 days” time-point.
302 GO terms were significantly enriched (p < 0.001) (Online Supplementary Table SO-6, link in
Appendix C). Out of these 302 GO terms, 46 included the words “cell cycle” in their description,
and 49 included “DNA”. Among those GO terms were thus included e.g. “mitotic cell cycle process”
(GO:1903047, p = 2.81× 10−62), “nuclear division” (GO:0000280, 1.94× 10−53), “DNA conformation
change” (GO:0071103, 1.41 × 10−33). These results suggest that the DE genes are involved in the
regulation of the cell cycle and in DNA-related mechanisms.
We checked for an overlap between the lists of DE genes (FDR 0.05) obtained for the different time-
points. 24 genes were found DE at both “0 hours” and “6 days” (Figure 3.7 - Supplementary Table
S6 in Appendix B), included 4 lncRNAs and 1 newly assembled gene (no coding-potential information
provided by RNAcode analysis). Although being small, this overlap was empirically tested and was
shown to be significant (p < 0.05, with 1000 permutations).
Summarizing, the results suggest that the effect of prenatal exposure to BzBP varies throughout the
TH cell activation time-line. Indeed, different numbers of DE genes were found for the 3 time-points
(with a FDR of 0.05) and the overlap between these lists remained small.
Considering the results presented in the sections 3.3 and 3.4, we kept the focus on the data generated
from samples containing “total TH cells” (na¨ıve, effector and memory) for further analysis. In the
following, we refer to the “total TH cells” simply as “TH cells”.
6 days
0 hour
48 hours
818 24 301
2
Figure 3.7. The effect of prenatal exposure to BzBP varies throughout the “total TH cell” activation
time-line. The Venn Diagramm shows the overlap between the lists of DE genes (FDR 0.05) found for the 3
time-points.
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3.5 BzBP-regulated lncRNAs are correlated with genes in-
volved in TH cell functions
The differential expression analyses performed for the different time-points showed that a total of
58 lncRNAs and 86 newly assembled genes were regulated by prenatal exposure to BzBP, after 0 hours
or 6 days of in vitro activation and culture. Although GO term enrichment analyses were performed on
the lists of DE genes, the individual functions of these genes in TH cells remain unknown. We therefore
performed a correlation network analysis in order to investigate the putative roles of the lncRNAs and
newly assembled genes found to be influenced by BzBP.
3.5.1 Immune-related groups of genes include genes regulated by BzBP
RNA-sequencing data were available for 21 samples (two treatment groups with three different
time-points of activation, with biological replicates). To avoid considering spurious correlations of
lowly expressed genes, out of the 86342 genes for which we obtained counts (see Section 2.4.1), only the
genes with counts > log2(100) (after “Variance Stabilizing Transformation” from the DESeq2 package)
in at least 10 samples (corresponded to the sample size for one type of treatment) were kept. This
lowered down the total number of genes to 15506.
The construction of weighted correlation networks with the WGCNA R package is based on “soft”
thresholding [? ]. This consists in assigning a numerical value called “adjacency” to each connection,
with adj(X,Y ) = ((corr(X,Y ) + 1)/2)β in the case of a signed network. The parameter β (soft-
power) needs to be carefully chosen in order to obtain a network satisfying the scale-free topology
(R2 > 0.80). However, the screening of β values for our filtered data-set did not highlight a value that
led to a scale-free topology fit index higher than 0.8 while maintaining a reasonable mean connectivity
(Supplementary Figure S5 in Appendix A). We assumed that this was due to a strong cluster in our
samples resulting from the activation status of the cells (Supplementary Figure S4 in Appendix A). We
therefore proceeded with the analysis by selecting a soft-power β of 21 according to the recommendations
of the developers of WGCNA available online (see Section 2.4.6).
The resulting network led to the identification of 20 modules of genes (Figure 3.8 and Supplementary
Figure S6 in Appendix A). The correlation between the Module Eigengenes of each module and each
trait (treatment, different time-points and interactions between each) were calculated. The results are
presented in a simplified form in Figure 3.8A, where an asterix symbol (*) corresponds to a significant
correlation (p < 0.05 - details of the values are available in Supplementary Figure S7 in Appendix A).
The number of genes included in each module is indicated in Figure 3.8B. Additionally, we checked for
the number of genes regulated by prenatal exposure to BzBP (results from the differential expression
analysis - see Section 3.4) included in each module. As for the number of lncRNAs and newly assembled
genes regulated by BzBP, it is indicated in brackets. In the following, we refer to the modules by the
colors automatically assigned by WGCNA.
GO term enrichment analysis was performed for each module. The two modules lightgreen and
lightyellow were both significantly correlated with the treatment but did not show significant enrich-
ment for any GO terms (p > 0.001). On the other hand, 63.5% of the genes included in the magenta
module were DE when prenatally exposed to BzBP. The GO terms enrichment analysis revealed that
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Figure 3.8. Genes regulated by prenatal exposure to BzBP in TH cells belonged to groups of genes
related to immune functions. (A) Modules of genes obtained by WGCNA are represented as a heatmap. A star
is indicated if there is a significant (p < 0.05) correlation between one module and a given trait. (B) The table
indicates the number of genes within each module and the number of genes that were found DE when prenatally
exposed to BzBP. The number of lncRNAs and newly assembled genes is additionally mentioned in brackets. GO
enrichment analysis was performed for each module: colored squares indicate that any term related to immune
function or allergies and asthma development were significantly enriched (p < 0.001).
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the genes contained in this module were related to cell cycle regulation (e.g. “mitotic cell cycle pro-
cess” - GO:1903047, p = 2.34× 10−44; “chromosome segregation” - GO:0007059, 2.17× 10−39; “DNA
conformation change” - GO:0071103, 3.42 × 10−32). All the genes regulated by BzBP in this module
were DE at the “6 days” time-point. These results support the previous observation concerning the
genes differentially expressed at this time-point as being probably involved in the cell cycle regulation
(see Section 3.4).
Nevertheless, we were interested in identifying key drivers in TH cells regulation and in the devel-
opment of asthma and allergies that are regulated by prenatal exposure to BzBP. We therefore focused
on modules that were significantly correlated to at least one trait and with a significant enrichment
for immune-related functions (p < 0.001 - highlighted in Figure 3.8B) . Following those criteria, 4
modules made the cut (purple, pink, salmon, blue). Additionally, the black module showed significant
enrichment (p < 0.001) for GO terms related to autophagy. It is a catabolic process that is found in
most of the eukaryotic cells, including TH cells. Autophagy has been described as required for various
functions in TH cells (including development, activation, differentiation and homeostasis) [? ? ] but
also as related to airway diseases such as asthma [? ? ]. We therefore added this module to the list of
selected ones. The latter are summed up in Table 3.3 with some of their corresponding enriched GO
terms (complete lists of enriched GO terms are presented in Online Supplementary Tables SO-7, link
in Appendix C).
Module Enriched GO terms
purple “positive regulation of cell communication” (GO:0010647)
“regulation of TH1 cell differentiation” (GO:0045625)
salmon “response to endogenous stimulus” (GO:0009719)
“T cell differentiation” (GO:0030217)
pink “positive regulation of immune system process” (GO:0002684)
“leukocyte migration” (GO:0050900)
black “autophagy” (GO:0006914)
“autophagosome assembly” (GO:0000045)
blue “antigen processing and presentation” (GO:0019882)
“immune system process” (GO:0002376)
Table 3.3. Modules identified by correlation network analysis on TH cells were related to immune
functions. These modules were significantly correlated to at least one trait (p < 0.05) and were significantly
enriched (p < 0.001) for GO terms related to immune functions or asthma and allergies development. Only two
enriched GO terms per module are mentioned here as examples, including the one with the lowest p-value. The
complete lists are available in Supplementary Tables ?? to ??.
3.5.2 LncRNAs and newly assembled genes regulated by BzBP may be key
drivers in immune functions
Scale-free networks such as this one contain highly connected nodes, also called “hubs” (or “whole-
network hub genes”). Nevertheless, ? ] suggested to rather focus on intra-modular hub genes, which
are genes with high Intra-modular Connectivity kIM values. We estimated the latter by calculating the
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Module Membership kME of each gene since both values were described as highly related in cases such
as ours (with a single network) and because Module Membership is considered as easier to compute [?
].
In our selected modules, we defined key drivers (“hub-like” genes) as genes with a Module Member-
ship kME > 0.8. Those comprised genes that we previously identified as DE when prenatally exposed
to BzBP, including 8 lncRNAs and 14 newly assembled genes (Supplementary Table S7 in Appendix
B). These lncRNAs and newly assembled genes were considered as “genes of interest” from now on,
and as having putative functions in TH cells or in asthma and allergies development. The results are
shown for the modules containing at least one of those genes in Figure 3.9.
The localization and the structures of concerned newly assembled genes were checked manually,
using the UCSC Genome Browser. A newly assembled gene was removed from the list of “genes of
interest” if (1) its localization might have corresponded to an additional exon of an annotated gene,
(2) it was resulting from an incoherent association of newly assembled transcripts by Cufflinks. This
step lowered down the number of “genes of interest” to 14 (8 lncRNAs and 6 newly assembled genes).
3.5.3 Genes from TH cell specific pathways are correlated with BzBP-
regulated genes
As mentioned before, a gene was considered “of interest” if it was included in one of the selected
modules, had a high Module Membership within this latter, and did not have an ambiguous localization
or structure. In order to identify the putative roles of these genes, we used network inference and
therefore had a look for their “close” neighbors within the constructed network. Two genes X and
Y were considered as “close” to each other if they (1) belonged to to the same module, (2) had an
adjacency adj(X,Y ) > 0.19, with adj(X,Y ) = ((corr(X,Y )+1)/2)β (β - the soft-power), corresponding
to a correlation coefficient corr > 0.85. Additionally, for each “gene of interest”, we filtered the 35
genes with the highest adjacency (or highest correlation) among its “close” genes (referred as top 35 in
the following - lists of these genes available in Supplementary Table S8 in Appendix B).
Pathway analysis was performed on these lists of “close” genes with IPA. Firstly, we insured that the
enriched pathways (p−adjusted < 0.05) were coherent with the enriched GO terms of the corresponding
module, on which we first based our selection. We thus filtered the “genes of interest” whose “close”
genes were involved in enriched pathways related to TH cells functions. Additionally, we filtered for
those for which more than one highly correlated gene (from the top 35 lists) were acting together in
the said pathways. This lowered down the number of “genes of interest” to 4, including 1 lncRNA and
3 newly assembled genes (Table 3.4).
These four genes were therefore further investigated. Nevertheless, since all of them were bioinfor-
matically predicted, standard PCR was first performed to confirm their expression and in an attempt
to confirm their structure (Figure 3.12). RT-qPCR was performed as well after efficiency determina-
tion of the concerned primers (Supplementary Table S1 in Appendix B). Additionally, we integrated
WGBS (Whole-genome bisulfite sequencing) results from our study with perinatal exposure to BzBP [?
] (see Section 3.1) in order to see if DMR (Differentially Methylated Regions) were located in the 10kb
upstream the TSS (Transcription starting sites) of these genes, which could explain their regulation.
Nevertheless, no DMR caused by perinatal exposure to BzBP could be found upstream of any of these
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Figure 3.9. LncRNAs and newly assembled genes were key drivers in selected modules from the
network based on TH cells. The Gene Significance for one correlated trait and the Module Membership were
calculated for each gene of the selected modules. Each dot corresponds to a gene. Blue dots and green dots
correspond to DE genes when prenatally exposed to BzBP, with the genes in green corresponding to the DE
lncRNAs or newly assembled genes. Additionally, beige dots stand genes related to other immune functions
(the list of immune-related genes was obtained using “ (immu*) AND “Mus musculus”[porgn: txid10090] ” as
keywords in the NCBI Gene database [? ]). The dashed vertical line corresponds to the module membership
threshold (0.8)used for selecting hub-like genes for further investigation.
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Gene Module Pathways (p− adjusted) Figure
Gm15441 blue “T Cell Receptor signaling” (4.17× 10−3) S8
“CD28 Signaling in TH cells” (8.91× 10−3) S9
XLOC 070362 black “Nur77 Signaling in T Lymphocytes” (1.35× 10−2) S10
XLOC 089487 salmon “TNFR2 Signaling” (1.51× 10−3) S11A
“TNFR1 Signaling” (2.75× 10−3) S11B
“TLR Signaling” (5.75× 10−3) S12
XLOC 449244 salmon “CD27 Signaling in Lymphocytes” (3.39× 10−2) S13
“TLR Signaling” (4.79× 10−2)
“NF-κB signaling Signaling” (4.79× 10−2) S14
Table 3.4. LncRNAs and newly assembled genes are highly correlated with genes involved in TH
cells specific pathways. The presented results were obtained during pathway analysis with IPA (“canonical
pathways”). The indicated pathways contained at least 2 of the genes from the “top 35” of a given gene of
interest (genes with high correlation coefficients). For each indicated pathway, the adjusted p-value (Benjamini-
Hochberg method) is given in between brackets. Genes called “XLOC” were newly assembled genes (automatic
names provided by Cufflinks). Figures to illustrate the mentioned pathways are available in Appendix A, and
the corresponding references are given in the last column of the table.
genes.
3.6 The antisense lncRNA Gm15441 is correlated with genes
involved in TH cells activation
Gm15441 is a predicted lncRNA (ensembl gene ID: ENSMUSG00000074398 in Ensembl 86) located
on the negative strand of the chromosome 3, as antisense to the protein-coding gene Txnip (Figure
3.11A). It has been annotated as a multi-exonic gene that can result in the transcription of two tran-
scripts with 3 and 4 exons respectively. PCR results showed that the exons 3 and 4 are expressed and
that the intron in between is spliced out (primer pair #1). Nevertheless, PCR products of unexpected
sizes were detected by Bioanalyzer (Figure 3.12A). The same observation was made for the primer pairs
#2, #3 and #4. These results suggest that the gene Gm15441 is expressed but the proper structure
is still to be determined.
Differential expression analysis between the different time-points of the activation time-line (per-
formed only on control samples) showed that this lncRNA was significantly down-regulated during TH
cells activation (log2 Fold Change = −3.08, p−adjusted = 9.49×10−12 when comparing the “48 hours”
time-point to the “0 hours” one) before being up-regulated at 6 days again (Figure 3.10B). Gm15441
was not found to be significantly differentially expressed between the time-points “0 hours” and “6
days”.
Considering the toxicological aspect of our study, Gm15441 appeared to be differentially expressed
when prenatally exposed to BzBP (log2 Fold Change = −0.77, p−adjusted = 3×10−3) at the “0 hours”
time-point only (Figure 3.10A). No correlation was found with Txnip when prenatally exposed to BzBP
or through the activation time-line (Txnip is part of the black module from the correlation network
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analysis). Additionally, RT-qPCR was performed on the same samples as used for RNA-sequencing in
order to verify the results from the differential expression analysis. Although the same tendency as for
the RNA-sequencing results was observed, the results were not significant (log2 Fold Change = −0.41,
p = 0.60 with Gapdh as reference gene) due to a high variation between the samples (Figure 3.13A) .
Gm15441 belonged to the blue module in the inferred network (kME = 0.90) . Its “closest” genes
(top 35 ) comprised Cd3g and Cd247 that are both elements from the CD3 co-receptor at the surface
of the TH cells (corr = 0.93 and 0.93, respectively). Additionally, Gm15441 was also correlated
(corr > 0.85) with genes such as Fyn, Ikbke, Ikbkg or Pik3cd (complete list of genes is represented in
yellow in the Figures S8 and S9, Appendix A). All these genes are involved in “TCR signaling”, “CD28
signaling” or “PKCθ signaling” and “Icos-IcoL signaling” pathways, that were associated with TH cells
activation. All these genes are key drivers of the blue module as well with kME > 0.87. Going back to
the comparison between the treatment and control groups, none of the genes correlated to Gm15441
in the network were found significantly regulated when prenatally exposed to BzBP.
Gm15441 was therefore found regulated both through the activation time-line and when prenatally
exposed to BzBP. Additionally, it was associated in the correlation network with genes involved in
several TH cells activation-related pathways.
3.7 A newly assembled gene was found to be correlated with
genes involved in autophagy
The newly assembled gene XLOC 070362 (chr11:5804953-5809907) was annotated on the plus strand
of the chromosome 11, between the genes Pgam2 and Polm (Figure 3.11B). It was predicted as a 4954
nt long multi-exonic gene, resulting from the assembly of two transcripts with 2 or 3 exons. The
RT-qPCR products were run on an agarose gel and the results suggest that the first intron is spliced
(Figure 3.12A). However, PCR using the primer pair #5 revealed that this transcript was not spliced
at this second location, indicating that XLOC 070362 is made of two exons only (Figure 3.12A). The
RNAcode analysis could not provide any information about the coding potential of this gene.
We found that this gene was DE during the activation time-line (Figure 3.10B). It is down-regulated
after 48 hours of in vitro activation in comparison to the “0 hours” time-point (log2 Fold Change
= −1.42, p− adjusted = 4.59× 10−06). The highest level of expression was observed for the “6 days”
time-point (log2 Fold Change = 0.82, p− adjusted = 1.88× 10−2 when comparing the “0 hours” and
“6 days” time-points). Additionally, XLOC 070362 was up-regulated at the “6 days” time-point when
prenatally exposed to BzBP (log2 Fold Change = 0.78, p − adjusted = 7.94 × 10−3) (Figure 3.10A).
This observation was verified by RT-qPCR (log2 Fold Change = 1.33, p = 0.05) (Figure 3.13B).
In the correlation network analysis results, XLOC 070362 belonged to the black module (kME =
0.93). This latter was associated with autophagy (see Section 3.5.2). Cabin1 and Camk4 are part
of the genes with the highest correlation coefficients (top 35 ) with XLOC 070362 (corr = 0.93 and
0.96, respectively). Additionally, this newly assembled gene is correlated (corr > 0.85) with genes such
as Mef2d, Map2k5 and Bcl2 that all belong to the “Nur77 signaling pathway”. All these genes are
themselves key drivers of the black module with kME > 0.88 and are all interconnected (corr > 0.78).
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Figure 3.10. Genes regulated by prenatal exposure to BzBP were also differentially expressed through-
out the activation time-line of TH cells. (A) Differential expression analysis was performed between the
control and treatment groups. The figure represents the relative transcript abundance (log2 Fold Change) in
the prenatally exposed to BzBP group in comparison to the control one. (B) Differential expression analysis
was performed for the different time-points of the activation time-line (on control samples only). The figure
represents the relative transcript abundance (log2 Fold Change) after 48 hours or 6 days of in vitro activation
and culture, in comparison to the “0 hours” time-point. The relative transcript abundance was also compared
between the “48 hours” and “6 days” time-points. Asterix symbols (*) indicates that p− adjusted < 0.05.
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Figure 3.11. Localization and structure of lncRNAs and newly assembled genes found to be regulated
by prenatal exposure to BzBP in TH cells and correlated with immune-related genes. The “genes of
interest” are indicated in red, and the neighboring or overlapping protein-coding genes in green. For each “gene
of interest”, the corresponding transcripts are shown in black. The primers used for standard PCR and qPCR
were designed in order to confirm the number of exons of these predicted genes. The primer pair n used to
obtained a product p was mentioned as #n (see Section 2.5). One color was used for each forward primer and
the corresponding reverse primers. (A) Gm15441. (B) XLOC 070362. (C) XLOC 089487. (D) XLOC 449244.
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Going back to the toxicological aspect of our study, it appeared that only one of these genes was
also regulated by BzBP. Indeed, Camk4 was found significantly DE when prenatally exposed to BzBP
(log2 Fold Change = 0.56, p − adjusted = 4.33 × 10−3 at the “6 days” time-point). Although no
correlation between XLOC 070362 and this gene was observed in the network, we noticed that the
protein-coding gene Nur77 that codes for the NUR77 protein, the core element of the “Nur77 signaling
pathway”, was also differentially expressed when prenatally exposed to BzBP (log2 Fold Change =
−1.66, p− adjusted = 8.25× 10−4 at the “6 days” time-point).
We therefore observed that XLOC 070362 was down-regulated in activated cells (“48 hours”) and
mainly expressed after 6 days of in vitro activation and cultivation. Additionally, its localization in the
correlation network implies that it might be involved in the regulation of the “Nur77 signaling pathway”,
itself associated with autophagy. Prenatal exposure to BzBP led to the differential expression of this
gene after 6 days of in vitro activation and cultivation.
3.8 Regulators of TH cells inflammatory response are corre-
lated with newly assembled genes
The newly assembled gene XLOC 089487 (chr11:99181664-99200362) was predicted as a multi-
exonic transcript located on the minus strand of the chromosome 11, in between the genes Ccr7 and
Smarce1 (Figure 3.11C). We could confirm by PCR that a second exon exists and that the first intron
is actually spliced out (lane 5 - pic observed at 390 bp with the Bioanalyzer). Nevertheless, we could
not confirm the length of the exon 2 with the primers #7 since no amplification products were obtained
(lane 6 - Figure 3.12A, Supplementary Table S2).
This gene was classified as a potentially novel protein-coding gene after the RNAcode analysis due
to the filter for > 1nt overlap with a predicted coding-sequence. In order to confirm this classification,
the percentage of overlap between the total length of the gene and the coding regions was checked. It
appeared that only 2% of XLOC 089287 actually overlap with coding-regions. We therefore re-classified
this gene as “potentially encoding for a lncRNA”.
This gene is DE across the activation time-line with an up-regulation after 48 hours and 6 days of in
vitro activation and cultivation in comparison to the “0 hours” time-point (log2 Fold Change = 0.91,
p−adjusted = 0.01 and log2 Fold Change = 1.44, p−adjusted = 8×10−5, respectively) (Figure 3.10B).
No significant differences was observed between the “48 hours” and “6 days” time-points. Additionally,
this gene was found DE at the “6 days” time-point when prenatally exposed to BzBP (log2 Fold Change
= 0.72, p−adjusted = 3×10−2) (Figure 3.10A). We attempted to verified it by RT-qPCR but, despite
a tendency for up-regulation as well, no significant differences bewteen the two groups were observed
(log2 Fold Change = 1.28, p = 0.13) (Figure 3.13C).
The correlation network analysis highlighted that the gene XLOC 089487 (salmon module, kME =
0.89) is highly correlated with genes involved in the Tumor Necrosis Factor Receptor (TNFR)1, TNFR2
and TLR signaling pathways, all involved in the regulation of the inflammatory response [? ? ]. They
include some common cellular elements to which XLOC 089487 was found to be highly correlated
in the network, such as Nfkbia, Tnfaip3 (top 35 ) and Jun (corr = 0.89, 0.93, 0.85, respectively).
However, within the results of our toxicological study and of the comparisons of the two treatments
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(prenatally exposed to BzBP or not), none of the genes mentioned above were found DE or correlated
with XLOC 089487.
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Figure 3.12. The expression and the structure of the selected genes were verified by PCR. The expected
size for the PCR and RT-qPCR products are summarized in Supplementary Table S2 in Appendix B. (A) The
standard PCR products were run on a Bioanalyzer chip in order to clearly identify the size of each product. For
each lane concerning a selected genes, the primers pair n used for the amplification in indicated as #n (list of
primer pairs available in Table 2.5.3). (B) The qPCR products were run on a 2% Agarose gel.
Similar observations were made for the gene XLOC 449244 (chr7:125190356-125192918). The latter
was newly assembled, located on the plus strand of the chromosome 7, between the two predicted genes
Gm45093 and 4933440M02Rik (Figure 3.11D). It was annotated as a 2562 nt long single exonic gene
and was classified as a bona fide lncRNA according to the results of the RNAcode analysis.
We found that the expression of XLOC 449244 increases throughout the activation of TH cells as
shown in Figure 3.10B (log2 Fold Change = 3.51, p − adjusted = 9.74 × 10−9 between the “0 hours”
and “48 hours” time-points; log2 Fold Change = 5.73, p − adjusted = 2.74 × 10−21 between the “0
hours” and “6 days” time-point; and log2 Fold Change = 2.22, p−adjusted = 7.84×10−6 between the
“48 hours” and “6 days” time-points). Additionally, it was down-regulated when prenatally exposed
to BzBP after 6 days of in vitro activation and cultivation (log2 Fold Change = −1.06, p− adjusted =
1.9 × 10−2) (Figure 3.10A). Nevertheless, although a tendency for down-regulation was observed as
well, this difference could not be verified by RT-qPCR (log2 Fold Change = −0.37, p = 0.69) due to a
high variation between the samples (Figure 3.13A).
XLOC 449244 also belonged to the salmon module in the results of the correlation network analysis
(kME = 0.91). The results showed that the genes Jun, Nfkbia, Bmpr1a and Map3k8 were comprised
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in the list of the “closest” genes to XLOC 449244 (top 35 - corr = 0.96, 0.89, 0.89, 0.90, respectively).
These genes are part of the CD27, NF-κB and TLR signaling pathways that have been associated with
different functions in TH cells, including the regulation of their inflammatory response [? ? ? ? ? ? ].
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Figure 3.13. Differential expression of the selected genes was checked by RT-qPCR. The RNA samples
used for RNA-sequencing were also used for performing RT-qPCR in order to check the differential expression
of the selected genes. Gapdh was used a reference gene for relative quantification of the targets. (n=3-4) (A)
Gm15441 at “0 hours”. (B) XLOC 070362 at “6 days”. (C) XLOC 089487 at “6 days”. (D) XLOC 449244
at “6 days”.
The two newly assembled genes lastly described (XLOC 089487 and XLOC 449244 ) both belonged
to the salmon module and were therefore correlated (corr = 0.75). The results showed that they were
both correlated with some common genes in the constructed network, that are all related to regulatory
pathways in TH cells and in the regulation of their inflammatory response.
To summarize, we first found that perinatal exposure to BzBP led to differential expression in TH
cells, including of lncRNAs. Moving on to a series of experiments on prenatally exposed to BzBP
mice, we could not observe any effect on the TH cells phenotype (e.g. activation, survival or cytokine
secretion). Nevertheless, RNA-sequencing revealed differential expression in TH cells after prenatal
exposure to BzBP as well when a complete population of cells was considered (in opposition to a
population containing na¨ıve TH cells only). Several tens of lncRNAs and newly assembled genes were
therefore found to be DE. Thanks to network correlation analysis, we observed that some of them were
associated with genes involved in TH cells functions.
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In addition of the effect on TH cells, we also investigated the effect of prenatal exposure to BzBP on
B cells since they are the second main actor of the adaptive immune system and a key actor in allergies
and asthma. To do so, we isolated total populations of B cells from adult mice that were prenatally
exposed or not to BzBP, and performed RNA-sequencing on the resulting samples.
4.1 Prenatal BzBP exposure leads to differential expression of
genes in B cells
In order to investigate putative differences in the transcriptome when prenatally exposed to BzBP,
B cells were isolated from 7 spleens from 10 to 13 weeks old mice (same age as for the isolation of
TH cells - see Section 3.2). While 4 of the mice (including 3 females) were prenatally exposed to
BzBP (treatment group), the remaining 3 (including 2 females) formed the control group. In order to
verify the purity of the isolated population, we checked for the number of CD19+ cells since CD19 is a
characteristic surface marker for B cells. Our samples contained on average 91.38% CD19+ cells.
After RNA-sequencing, lowly expressed genes (under 10 normalized counts in less than 3 samples)
were removed from the list of 86342 investigated genes (see Section 2.4.1) and the remaining 27132
expressed genes were considered for differential expression analysis. These included 13340 protein-
coding genes, 3101 lncRNAs and 7991 newly assembled transcripts.
Based on the normalized counts, we performed a PCA of our samples (Figure 4.1). A separation
between the treatment and control groups was partially observed (treatment effect), even though two
samples from the “treatment” group were found associated with “control” ones. Additionally, we could
observe an influence of the gender (gender effect). We therefore considered both for the design of the
analysis (”∼ gender + treatment”).
Out of the 27132 investigated genes, we found out that 353 genes were significantly DE between the
two treatments (FDR 0.05), including 92 “up-regulated” genes and 261 “down-regulated” genes (Figure
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Figure 4.1. Principal component analysis for B cells after prenatal exposure to BzBP. After filtering for
the lowly expressed genes, PCA was performed for the B cell samples, using the normalized counts (“regularized
log transformation” from the DESeq2 R package) of the remaining 27132 genes.
4.2A and Online Supplementary Table SO-8, link in Appendix C). Biotype annotations highlighted that
the DE genes included 112 lncRNAs and 72 newly assembled transcripts (Figure 4.2B). Moreover, the
RNAcode analysis revealed that 21 out of the 72 newly assembled transcripts were bona fide lncRNAs.
These results suggest that prenatal exposure to BzBP leads to differential expression of genes in B
cells, including for an important fraction of lncRNAs.
4.2 B cell developmental data were integrated to identify pu-
tative functions of lncRNAs
GO enrichment analysis performed with the list of DE genes showed significant enrichment (p <
0.001) for GO terms related to cell organization, metabolism and gene expression (e.g. “chromosome
organization” (GO:0051276), “DNA metabolic process” (GO:0006259), “positive regulation of gene ex-
pression” (GO:0010628) - complete list in Online Supplementary Table SO-9, link in Appendix C).
Nevertheless, the individual functions of the DE lncRNAs and newly assembled genes remained un-
known. We considered a weighted gene correlation network analysis to investigate the putative functions
of these transcripts. However, our low number of 7 samples was not sufficient for inferring correlation
networks. For this reason and to add an additional layer of information, we performed a “background”
correlation network analysis on B cell development RNA-sequencing data published by ? ] in 2016. This
study included RNA-sequencing data from B cells at 8 different developmental stages (pro, pre, imma-
ture, mature, follicular, marginal, germinal center and B1a - sub-population located in the peritoneal
cavity - B cells) with 5 replicates each. Our strategy consisted in using the network constructed on
these data in order to identify with which groups of genes the lncRNAs regulated by prenatal exposure
to BzBP were associated and to therefore attribute them putative functions (Figure 4.3A).
Applied protocols in the study published by ? ] were similar to ours and we analyzed these data
66
4.3. Groups of immune functions-related genes include genes regulated by prenatal exposure to BzBP
using the same configuration of the RNA-sequencing analysis pipeline (uap) as for our own (see Section
2.4). The counting was also performed with the same assembly that we used for our own samples as
our samples were sequenced about 5-fold deeper and thus enable a more precise assembly. Additionally,
for this correlation network analysis on the B cell development data, we filtered only the 27132 genes
that were considered for differential expression analysis on our own data and only kept those with
counts > log2(10) (after “Variance Stabilizing Transformation” from the DESeq2 R package) in at least
3 of their samples (Figure 4.3A). As mentioned before the sequencing depth of the ? ] data set was
about 5 times inferior to ours, what means that lowly expressed transcripts were not detectable in
their data. Therefore, this filtering step based on normalized counts removed 69,23% of the considered
genes, including some that were identified as regulated by prenatal exposure to BzBP in our data. This
lowered down the total number of genes to 8350.
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Figure 4.2. Prenatal exposure to BzBP led to differential expression of genes in B cells. (A) Z-score
of the expression level computed by row, with each row corresponding to a BzBP-regulated gene (FDR 0.05). (B)
indicates the biotypes of the differentially expressed genes (FDR 0.05) divided into the subgroups “up-regulated”
(more expressed in the BzBP prenatally exposed group than in the control group) and “down-regulated”. Genes
without biotype information were not plotted.
4.3 Groups of immune functions-related genes include genes
regulated by prenatal exposure to BzBP
As for the data analysis based on our results for TH cells, the WGCNA R package [? ] was used
for this weighted correlation network (see Section 3.5.1). In order to obtain a network based on the
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8350 selected genes satisfying the scale-free topology, a soft-power β of 13 was used (R2 = 0.81 -
Supplementary Figure S15 in Appendix A). In a first phase, this led to the identification of 38 modules
of genes. However, some module Eigengenes from distinct modules were highly correlated. Therefore, as
suggested by ? ], two modules N and M were merged if |cor(E(N), E(M))| > 0.75 (with E corresponding
to a module Eigengene). This filtering step lowered down the number of modules to 19 (Supplementary
Figure S16 in Appendix A).
The correlations between the Module Eigengenes of these modules and each trait (the 8 developmen-
tal stages and the 3 corresponding tissues) were calculated and the results are presented in a simplified
form in Figure 4.3B, where an asterisk symbol (*) corresponds to a significant (p < 0.05) correlation
(details of the values in Supplementary Figure S17 in Appendix A).
For each module, the number of included genes was checked, but also the number of genes that we
identified as being differentially expressed when prenatally exposed to BzBP (Figure 4.3C). Addition-
ally, GO enrichment analysis was performed for each module. Being interested in identifying putative
key drivers in the development of allergies and asthma, we filtered the modules for those that showed
a significant enrichment (p < 0.001) for B cell- or immune-related functions. Out of the 19 modules, 5
of them made the cut (Figure 4.3C and Table 4.1). In the following, we refer to each of these modules
by the color that is automatically assigned by WGCNA.
The Gene Significance for one of the main trait and Module Membership were calculated for all the
genes belonging to the selected modules. We defined the key drivers (“hub-like” genes) as genes with
Module Membership kME > 0.8 (estimate of the Intra-modular Connectivity kIM - see Section 3.5.2
for more details concerning this definition). The integration of the results of the differential expression
analysis of our toxicology data set (see Section 4.1) revealed that these key drivers included genes
regulated by BzBP (Supplementary Table S14 in Appendix B). Among those genes that were on one
hand differentially expressed if prenatally exposed to BzBP, and on the other hand found to be related
to immune functions in B cell development, six were either lncRNAs (with unknown function) or newly
assembled transcripts (listed in Table 4.2, data presented for the modules containing at least one of
those in Figure 4.4).
4.4 BzBP-regulated lncRNAs are correlated to germinal cen-
ter B cells specific genes
Two genes X and Y were considered as “close” to one another in the network if they (1) belonged to
the same module and (2) had an adjacency adj(X,Y ) > 0.36 (with adj(X,Y ) = ((corr(X,Y ) + 1)/2)β ,
where β represents the soft-power), corresponding to a correlation coefficient corr > 0.85. We looked
for functionally coherent groups of genes among the “close” genes of the six genes mentioned above
(Figure 4.5 for the two lncRNAs in cyan module and Supplementary Figure S18, Appendix A for the
remaining four genes).
Two out of the six built subnetworks comprised genes with related functions. Indeed, both predicted
lncRNAs Gm38865 and Gm37033 from the cyan module shared some of their “close” genes, and all
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Figure 4.3. Integration of published B cell developmental data with the results of differential expres-
sion analysis due to prenatal exposure to BzBP. (A) Schematic representation of the strategy. The two
available data sets are represented in the left squares. (B) Modules of genes obtained by WGCNA are presented
as a heatmap. A star indicates significant (p < 0.05) correlation between one module and a given trait. (C)
The first column of the table indicates the number of genes contained by each module, while the second column
indicates the number of genes in this module that were found differentially expressed when prenatally exposed to
BzBP. The number of differentially expressed genes of interest (lncRNAs and newly assembled) is additionally
mentioned in brackets. GO enrichment analysis was performed for each module: colored squares indicate that
any term related to immune function was significantly enriched (p-value < 0.001). (D) Schematic representation
of B cell development and of the relation between the different sub-groups according to ? ].
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Figure 4.4. LncRNAs regulated by prenatal exposure to BzBP in B cells were key drivers in modules
associated with immune-functions. Each dot corresponds to a gene belonging to the module. Blue dots and
green dots correspond to DE genes when prenatally exposed to BzBP with the genes in green corresponding to the
DE lncRNAs or newly assembled genes. Additionally, orange dots stand for genes described as related to B cells
functions and beige dots for genes related to other immune functions (these lists of genes was obtained using “
(B cells) AND ”Mus musculus”[porgn: txid10090] ” and “ (immu*) AND “Mus musculus”[porgn: txid10090]
” as keywords in the NCBI Gene database [? ], respectively). The dashed vertical line corresponds to the
module membership threshold (0.08) used for selecting hub-like genes for further investigation. The names of
the concerned DE lncRNAs or newly assembled genes were added to each plot.
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Module Trait Example enriched GO terms GO terms list
cyan Germinal center B
cells (0.96, 6× 10−23)
“immune response-activating signal trans-
duction” (GO:0002757), “antigen receptor-
mediated signaling pathway” (GO:0050851)
S9
lightgreen Follicular B cells
(0.59, 7× 10−05)
“regulation of humoral immune response
mediated by circulating immunoglobulin”
(GO:0002923)
S10
skyblue Cells in bone marrow
(0.9, 1× 10−14)
“leukocyte migration involved in inflamma-
tory response” (GO:0002523)
S11
brown Cells in bone marrow
(−0.59, 7× 10−05)
“interleukin-8 production” (GO:0032637)
and “positive regulation of interleukin-6 pro-
duction” (GO:0032755)
S12
black Pro B cells (−0.69, 1×
10−06)
“antigen processing and presentation of ex-
ogenous peptide antigen via MHC class II”
(GO:0019886)
S13
Table 4.1. Modules identified by correlation network analysis on B cell developmental data are
related to immune functions. These modules were significantly correlated to one of the traits (p < 0.05).
The correlation coefficient and the corresponding p-value are indicated for one relevant trait for each module
following the format (corr, p − value). Additionally, these modules were significantly enriched (p < 0.001) for
GO terms related to immune- or B cells-related functions. While some examples are given in this table, the
complete lists of enriched GO terms are available in the Appendix B, following the references indicated in the
last column.
Gene Identifier Module kME
Gm38865 105242725 cyan 0.92
Gm37033 ENSMUSG00000104388 cyan 0.83
4833403J16Rik ENSMUSG00000107481 lightgreen 0.82
XLOC 054211 - lightgreen 0.89
Gm15987 ENSMUSG00000085786 brown 0.82
XLOC 386966 - black 0.82
Table 4.2. Hub-likes genes from modules associated with immune functions comprised non-coding
transcripts influenced by BzBP in B cells. The modules associated with immune functions (Table 4.1) were
screened for non-coding transcripts (1) influenced by prenatal exposure to BzBP in B cells and (2) with Module
Membership kME > 0.80 (estimate of the Intramodular Connectivity kIM - see Section 3.5.2).
protein-coding genes from the latter were described as playing roles in germinal center- or general-
B cell functions or in asthma development (Table 4.3). All those “close” genes also represented key
drivers of the cyan module considering their high Module Membership (all with kME > 0.90) and were
all inter-connected with absolute correlation coefficients ≥ 0.90. The high correlation between these
lncRNAs and this group of genes related to B cell functions suggests that Gm38865 and Gm37033 may
be involved in similar functions.
The cyan module was found to be highly correlated with germinal center B cells (Figure 4.3B).
Differential expression analysis on B cell developmental data additionally showed that both Gm38865
and Gm37033 were up-regulated in germinal center B cells (log 2 Fold change = 5.13, p− adjusted =
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5.44× 10−21 and log 2 Fold change = 4.68, p− adjusted = 2.77× 10−20, respectively, when considering
germinal center B cells vs. the rest of the B cell sub-populations). Hence, considering those points and
the observations mentioned above concerning some of its key drivers, we further investigated the genes
from the cyan module and its BzBP-regulated key drivers, the two predicted lncRNAs Gm38865 and
Gm37033 (kME = 0.92 and 0.83, respectively).
A B
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Gm38865
XLOC_537580
XLOC_537581
Gm13448
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Figure 4.5. Subnetworks centered on Gm38865 and Gm37033. The different shapes of the nodes cor-
respond to their biotype: rectangles are protein-coding genes, ellipses are lncRNAs, octagones are miscRNAs,
round squares are antisense RNAs, and triangles are newly assembled genes.
Gene Described function Gm38865 Gm37033 References
Havcr1 Marker of germinal center B cells, regulation
of antibody production via the differentiation
of germinal center B cells into plasma cells,
asthma susceptibility
? ? [? ? ? ? ? ]
Nuggc Regulation of somatic hypermutation ? ? [? ]
Gcsam Marker of germinal center B cells ? ? [? ? ]
Fas Regulation of B and T cells homeostatis ? [? ? ]
Ffar3 Regulation of inflammatory processes in air-
ways
? [? ? ]
Rgs13 Regulation of the responsiveness to
chemokines, size control of germinal cen-
ters
? [? ? ]
Table 4.3. Gm38865 and Gm37033 were correlated to a group of genes associated with B cells
functions. These protein-coding genes are “close” to one or both (?) of the two predicted lncRNAs Gm38865
and Gm370033 that are differentially expressed when prenatally exposed to BzBP. They belonged to the cyan
module in the network built on B cell developmental data, which was itself associated with immune functions.
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4.4.1 Gm38865, sense intronic lncRNA to Foxp1
Gm38865 (entrez gene ID: 105242725) is a predicted lncRNA located on chromosome 6, sense-
intronic to the gene Foxp1 (Figure 4.6A). Foxp1 is an important transcriptional regulator during B cell
development in mouse [? ] and its expression is highly controlled in germinal center B cells [? ]. The
coding potential of Gm38865 was cross-checked with the results of our RNAcode analysis, in which it
was also categorized as a lncRNA.
From a structural point of view, Gm38865 was annotated as containing 2 exons and a single intron
of 34 nt, with a total length of 9192 nt. Considering that there were no obvious splice sites detectable
and none could be predicted using NNSPLICE (v0.9) [? ], we designed appropriate RT-qPCR primers
(overlapping the intron location) to confirm the presence of the intron (Figure 4.6A). Our analysis con-
firmed that the short intron is present and that the transcript is spliced (Figure 4.7B and Supplementary
Table S2B in Appendix B for the expected size products).
This gene appeared to be conserved (sequence similarity of at least 70%) in organisms from the
subfamily Murinae, including mouse (Mus musculus) and rat (Rattus norvegicus). Although, if follow-
ing the same criteria, Gm38865 was not found to be conserved in Human (Homo sapiens) a similar
structure has been annotated in the human genome, on the opposite strand of FoxP1 : the FoxP1-AS1
gene (entrez gene ID: 104502416), annotated as non-coding as well.
chr1
20kb mm10
180,340,000 180,350,000 180,360,000 180,370,000 180,380,000 180,390,000 180,400,000 180,410,000 180,420,000
chr6
AC155839.1
Gm19665
Foxp1
20kb mm10
Gm38865
99,090,000 99,100,000 99,110,000 99,120,000 99,130,000 99,140,000 99,150,000 99,160,00099,080,000
B
A
Itpkb
Gm37033 Gm37390
Gm36933
Gm39712
Figure 4.6. Genomic localization and surrounding of Gm38865 and Gm37033. The “genes of interest”
are indicated in red, the overlapping protein-coding genes in green and the other close genes in grey. The
localization of the qPCR primers is indicated in blue (unscaled). (A) Gm38865. A close up of the gene is added
in order to show the position of the primers used to determine the presence of the intron. (B) Gm37033.
In our RNA-sequencing data, Gm38865 was found to be significantly down-regulated in the treat-
ment group (log2 Fold change = −0.67, p− adjusted = 4.69× 10−04). Until now, we could not confirm
it by RT-qPCR due to high variation between the samples (Figure 4.7A). Additionally, a significant
correlation between the expression of Foxp1 and Gm38865 was not detected in our data or in the B
cell developmental data (FoxP1 belonged to the brown module).
The “close” genes to Gm38865 in the network based on B cell developmental data (see Section 4.4)
included the protein-coding genes Fas, Ffar3, Havcr1, Nuggc and Gcsam (Figure 4.5A), all related to
immune-, B cell- or germinal center B cell-related functions (Table 4.3). In our data, those genes were
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not found to be DE or correlated with Gm38865.
To sum up, Gm38865 is a multi-exonic lncRNA differentially expressed when prenatally exposed
to BzBP. In B cells developmental data, its expression profile is correlated with the ones of 6 protein-
coding genes that are all involved in general or germinal center-specific B cells functions.
4.4.2 Gm37033, sense intronic lncRNA to Itpkb
Gm37033 (ensembl gene ID: ENSMUSG00000104388 in Ensembl 86) is annotated as a TEC (“To
be experimentally confirmed”) RNA. It is encoded on chromosome 1 and is sense intronic to Itpkb, a
protein-coding gene involved in B cell survival and anergy [? ] (Figure 4.6B). Gm37033 is annotated
as a single exonic transcript with a length of 7350 nt that we were able to amplify by RT-PCR (Figure
4.7B - expected product sizes are listed in Supplementary Table S2B in Appendix B). The results from
our RNAcode analysis suggest that this gene has no coding potential and we therefore classified it as a
potential lncRNA encoding gene.
This gene appeared to be conserved through the superfamily of Muroidea (sequence similarity of at
least 70%), since it was found in mouse, rat and hamster (Cricetulus griseus). Additionally, although
Gm37033 was not found to be conserved in Human if following the same criteria, a gene is also annotated
in the human genome as ncRNA and sense intronic to Itpkb, the Itpkb-IT1 (entrez ID: 100506443).
Gm37033 was also found to be significantly down-regulated in the treatment group of our study (log2
Fold change = −0.88, p−adjusted = 4.4×10−07). Here again, although the transcript was detectable by
RT-qPCR, the differential expression could not be confirmed due to high variation between the samples
(Figure 4.7A). Additionally, a significant correlation between the expression of Itpkb and Gm37033 was
not detected in our data.
The “close” genes to Gm37033 in the network based on the B cell developmental data (see Section
4.4) included the protein-coding genes Rgs13, Nuggc, Havcr1 and Gcsam (Figure 4.5B), all related to
germinal center B cell functions (Table 4.3). One should notice that most of these protein-coding genes
were also found to be highly correlated with the lncRNA Gm38665 described above. Moreover, the
two lncRNAs Gm38665 and Gm37033 were correlated in the constructed network with corr = 0.77).
While we did not observe a significant differential expression of these four protein-coding genes in our
data (FDR 0.05), the expression profile of Havcr1 was found to be anti-correlated with the one of
Gm37033 (corr = −0.86, p = 0.02).
Gm37033 is thus a single exonic transcript, sense intronic to the protein-coding gene Itpkb, that
is differentially expressed when prenatally exposed to BzBP. Its expression in B cell developmental
data showed that it is expressed in germinal center B cells and that its expression profile correlates
with the ones of 4 protein-coding genes that all play a role in general or germinal center B cell functions.
To summarize, we found that prenatal exposure to BzBP led to differential expression of several
hundreds of genes in B cells. These regulated genes comprised lncRNAs and newly assembled genes.
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Figure 4.7. Differential expression of the selected genes in B cells was checked by RT-qPCR. The
RNA samples used for RNA-sequencing were also used for performing RT-qPCR in order to check the differential
expression of the selected genes. Gapdh was used a reference gene for relative quantification of the targets. (n=3-
4) (A) RT-qPCR results. (B) The RT-qPCR products were run on a 2% agarose gel. The expected sizes are
listed in the Supplementary Table S2B in Appendix B.
Integrating published data, we observed that two of these non-coding transcripts were associated with
genes involved in B cell- and more specifically germinal center B cell-related functions.
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Maternal exposure to BzBP has been associated with a higher risk for the children of developing
asthma symptoms and of allergic sensitization [? ? ]. For instance, an enhanced asthma phenotype
was reported in the offspring of BzBP-exposed mice after antigen challenge [? ]. For this study, we
hypothesized that this early life exposure to BzBP leads to the development of such pathologies by
affecting the transcription of lncRNAs whose functions are important for TH and B cells regulation.
To answer this question, our strategy consisted in performing RNA-sequencing on splenic immune
cells isolated from mice, which were subject to early life exposure to BzBP or not. The analysis of
the obtained data highlighted some lncRNAs or genes newly assembled during our study that were
regulated by BzBP-exposure and that may play a role in the subsequent asthma phenotype.
5.1 The gene expression in TH cells is influenced by maternal
exposure to BzBP
In order to investigate the effect of early life exposure to BzBP on TH cells, we conducted two
transcriptomics experiments that differed in the length of exposure (perinatal vs. prenatal exposure).
Differential expression analysis on our RNA-sequencing data first showed that perinatal exposure to
BzBP (during pregnancy and breastfeeding) led to dynamic changes in the TH cell transcriptome of the
offspring. We indeed observed that perinatal exposure to BzBP resulted in the regulation of more than
2800 genes. These genes were associated with immune-related functions according to GO Enrichment
Analysis (see Section 3.1).
While isolated total populations of TH cells were used as such for the investigation of the effect of
perinatal exposure, another strategy was adopted for prenatal exposure (during pregnancy only). In
this case, we isolated TH cells from mice activated them in-vitro in order to investigate if BzBP had an
effect on their activation and differentiation processes. Additionally, we performed the experiments on
both na¨ıve and total TH cell populations. The lack of influence of any past immunological event and
the opportunity to have a single type of cells for RNA-sequencing constituted two major advantages
77
5. Discussion and conclusions
of working with na¨ıve TH cells only. However, it appeared that prenatal exposure to BzBP did not
have any measurable effect on those cells. A high number of genes were nonetheless regulated in these
cells throughout their activation (by comparing the different time-points) and we could thus exclude
that these results were due to RNA-sequencing experiments-related issues (see Section 3.3). On the
contrary, prenatal exposure to BzBP affected total populations of TH cells, which included effector
and memory cells in addition to na¨ıve cells (see Section 3.4). But we also observed that this effect was
varying along the activation time-line. We indeed found around 300 DE genes just after isolation (“0
hours” time-point), almost none after 48 hours of in vitro activation, and more than 800 DE genes after
6 days of in vitro activation and cultivation. Functional analyses revealed that the DE genes found at
the “0 hours” and “6 days” time-points were associated with RNA metabolism and cell cycle processes,
respectively (see Sections 3.4.1 and 3.4.2).
Differences between the effects of prenatal exposure to BzBP were therefore observed between na¨ıve
and total TH cells populations. Although the cell culture medium was supplemented with IL-2 in both
cases, one can assume that the lack of effect on na¨ıve TH cells alone was related to the absence of
cytokines that are normally produced by the surrounding other TH cell sub-populations, and on which
depends their activation and differentiation (see Section 1.1). On the other hand, considering the results
obtained for total TH cell populations, one might consider that BzBP preferentially influences effector
and memory TH cells.
Additionally to these observations, we saw that almost no genes were regulated after 48 hours of in
vitro activation. These results are consistent with the fact that we did not observe significant differences
in the number of activated TH cells if the mice were prenatally exposed to BzBP (see Section 3.2).
However, an effect was observed at the “0 hours” and “6 days” time-points that correspond to cells
that were not activated in vitro and cells that were first activated and then not stimulated anymore,
respectively. Prenatal exposure to BzBP could therefore have an influence rather on “resting” cells than
on activated cells. Nevertheless, only a few genes were found to be regulated at both these time-points
what suggests that BzBP affects TH cells and leads to an enhanced asthma phenotype by influencing
different processes upstream and downstream the activated state.
To our knowledge, we were the first ones reporting an effect of BzBP on the transcriptome of TH
cells [? ]. However, a few studies have been focusing on the effect of maternal exposure to BzBP on gene
expression in other cell types. ? ] observed a regulation of the gene expression in male rats testes after
in utero exposure to different phthalates, including BzBP. These regulated genes were mainly associated
with lipid, sterol and cholesterol homeostasis and transport. On the other hand, ? ] highlighted an
influence of in utero exposure to BzBP on the gene expression profile of the mammary glands in rats,
and the regulated genes were associated with different GO terms including immune system process and
cell cycle. While the type of exposure in these studies was similar to ours (ingestion exposure), the
results we obtained partially differ. Nevertheless, this could be attributed to the differences in model
organisms (rat vs. mouse) and in investigated cell types. The present study therefore reveals a whole
new aspect of the effect of maternal exposure to BzBP.
Despite changes in their transcriptome, we could not observe any significant changes in the amount of
secreted asthma-associated cytokines (IL-5, IL-13, IL-4, IFNγ) by TH cells following prenatal exposure
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to BzBP (see Section 3.2). While no results concerning the influence on the activation of TH cells have
been published yet, the effect of BzBP on the secretion of immunological markers such as cytokines has
been investigated in a couple of studies, with nonetheless contradictory results. For instance, ? ] found
out that topical exposure to BzBP did not lead to variation in the expression and in the secretion of IL-4
and IL-13 in B6C3F1 mice. However, maternal exposure to BzBP has been described as resulting in the
up-regulation of IL-5, IL-13 and IL-4 in splenocytes (comprise TH cells) from BALB/cByJ mice [? ].
The two studies differed in the type of exposure, in the mouse strain but also in the antigen challenging
with ovalbumin (OVA). Indeed, it appears that a regulation of immunological markers by BzBP might
be visible only if the animals had been challenged with an antigen such as OVA, as previously discussed
by ? ]. The mice used for our study of the effect of prenatal exposure to BzBP were not challenged
with OVA and the lack of significant results concerning the amount of secreted cytokines might thus
be related.
5.2 Prenatal exposure to BzBP regulates putative key drivers
of allergic reactions in TH cells
During the process of identifying putative key drivers in allergic reactions resulting from maternal
exposure to BzBP, we focused on the results from the experiment concerning prenatal exposure. The
reason behind this was that we wanted to be able to clearly determine which exposure phase was re-
sponsible for the regulation of these genes. In addition, we had a special interest in identifying lncRNAs
as key players but functional data are still missing for most of the annotated ones. To reach our goal,
our strategy thus consisted in performing correlation network analysis and in inferring functions to
non-coding transcripts from close genes in the network. The correlation network analysis led to the
identification of groups of genes (or “modules”) that were associated with TH cell- or immune-related
functions, and that contained genes sensitive to prenatal exposure to BzBP. The latter comprised lncR-
NAs and newly assembled genes. We filtered these for structurally coherent genes (see Section 3.5.2)
and for genes whose “close” genes (with corr > 0.85 in the network) were involved in TH cell-related
pathways. Following this procedure, we ended up with a list of four genes (Gm15441, XLOC 070362,
XLOC 089487, XLOC 449244 ) that we kept investigating (see Section 3.5).
The differential expression of those four genes could be confirmed by RT-qPCR for only one of
them due to high variation between the samples (see Figure 3.13). Nevertheless, although the results
were not statistically significant, the regulation trend by prenatal exposure to BzBP appeared to be
the same for the RT-qPCR results as in the RNA-sequencing data. This lack of statistical significance
could be attributed to the normalization of RT-qPCR results. While the RNA-sequencing results
were normalized taking into account all the genes, the RT-qPCR results were normalized to the level of
expression of a single reference gene, Gapdh. This reference gene may have been a poor choice to evaluate
the expression of transcripts in TH cells as it may be unstable in this cell type [? ]. Additionally, the
normalization of RT-qPCR results to several references genes instead of a single one has been associated
with more accurate results for small expression differences [? ]. This last point should probably have
been considered in a dynamic system such as activated TH cells and for transcripts with | log2 Fold
Change | < 1 according to RNA-sequencing results. Furthermore, to get a biological confirmation
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that these transcripts are regulated by prenatal exposure to BzBP, RT-qPCR should be performed on
additional newly prepared samples (isolated from other individuals) [? ]. There is therefore a need
for investing more effort in the confirmation of the regulation of these genes expression in the future.
Nevertheless, the results of the PCR and RT-qPCR confirmed that these genes that were until now
only bioinformatically predicted are actually expressed in TH cells (see Chapter 3).
5.2.1 The lncRNA Gm15441 might cooperate with TH cell activation fac-
tors
The predicted lncRNA Gm15441 was part of the selected genes. Although it was already annotated,
no functional characterization has been published for this gene yet. We found that it was regulated (1)
throughout the TH cell activation time-line (down-regulated in the activated cells at the “48 hours”
time-point) and (2) by prenatal exposure to BzBP (down-regulated in non-activated cells at the “0
hours” time-point). Correlation network analysis revealed that Gm15441 belonged to a module related
to immune-functions, with a Module Membership kME = 0.90. Additionally, pathway analysis showed
that some of the genes from the same module and highly correlated to Gm15441 (corr > 0.85) were
involved in TH cell-related pathways such as “TCR signaling” or “CD28 signaling”. These genes were
also key drivers of the module, with Module Membership kME > 0.87 (see Section 3.6).
The genes highly correlated to Gm15441 are involved in overlapping pathways that are related
to TH cell activation after contact with an antigen at the surface of an APC (see Section 1.2.4). In
addition, these genes (e.g. Cd3g, Cd247, Fyn, Ikbke, Ikbkg...) have also been described individually
as involved in the regulation of TH cell activation. For instance, Cd3g and Cd247 encode for the
chains γ and ζ from the CD3 complex, respectively. The latter is associated with the TCR and is
critical for the intracellular signaling cascades following the contact with an antigen (see Section 1.2.4).
Additionally, the γ chains have been associated with a negative feedback regulation of the TCR after
TH cell activation [? ]. As for Fyn, it encodes for a kinase that is activated after contact with an
antigen and that is involved in the first steps of the signal transduction by phosphorylating the ITAM
from the CD3 chains [? ]. On the other hand, Ikbke and Ikbkg encode for IκB kinases (IKK) that are
involved in the regulation of the activity of the transcription factors NFAT and NFκB [? ? ], which are
critical for the activation of T cells (see Section 1.2.4). To summarize, Gm15441 was thus found to be
highly correlated (corr > 0.85) with genes involved in TH cell activation-related pathways, suggesting
that the lncRNA could be involved as well in such processes.
As explained in Section 3.5.2, we used the Module Membership kME as an estimation of the Intra-
modular Connectivity kIM and we defined “hub-like genes” those with a Module Membership kME >
0.80. The lncRNA Gm15441 was therefore found to be a “hub-like gene”. Most of the correlated genes
with Gm15441 mentioned above were also defined as such but with Module Memberships higher than
the one of our lncRNA of interest (Supplementary Table S8 in Appendix B). Although Gm15441 is
likely involved in the same processes as them, this observation suggests that Gm15441 is rather not a
regulator of the expression of the other genes.
The genes Cd3g and Cd247 were comprised in the list of genes with the highest correlation scores
with Gm15441 (called top 35 in Chapter 3). Using network inference, one could thus assume that
Gm15441 is involved in pathways associated with TH cells activation in a CD3 complex-related manner.
80
5.2. Prenatal exposure to BzBP regulates putative key drivers of allergic reactions in TH cells
Nevertheless, the way of action of Gm15441 is still to be determined and the consequences of its
regulation by prenatal exposure to BzBP remain therefore unclear for now.
5.2.2 A newly assembled gene may be part of the CAMK4/CABIN1/MEF2D
regulatory system
The gene XLOC 070362 was predicted along this study. It was located on chromosome 11 between
the genes Pgam2 and Polm that encode for a sub-unit of an enzyme involved in the glycolytic pathway
and the polymerase mu, respectively. We could not assess any coding potential to this newly assembled
gene with our strategy. However, its expression and regulation by prenatal exposure to BzBP at the
“6 days” time-point were both confirmed by PCR and RT-qPCR (see Section 3.7). The construction
of a correlation network revealed that this gene was comprised in a group of genes (black module)
associated with autophagy. We classified XLOC 070362 as a “hub-like” gene within this group due to
its Module Membership kME = 0.93. Thanks to pathway analysis, we found out that XLOC 070362
was more specifically correlated (corr > 0.85) with members of the “Nur77 signaling pathway” (Cabin1,
Camk4, Map2k5, Mef2d and Bcl-2 ). Among these genes, Camk4 and Cabin1 were part of the genes
with very high correlation scores with XLOC 070362 (top 35 - see Section 3.7) with corr = 0.96 and
0.93, respectively. Moreover, Camk4, which codes for a calmodulin-dependent kinase, was also found
to be a “hub-like” gene in the black module (kME = 0.96) and was up-regulated by prenatal exposure
to BzBP after 6 days of in vitro activation and cultivation (see Section 3.7).
Autophagy consists first of all in an intracellular degradation system by which a cell destroys
cytoplasmic elements in its lysosome to maintain a healthy state, but it can also lead to cell death
[? ]. It has been associated with various physiological processes including some related to T cells,
such as their development, activation and differentiation [? ? ? ]. Additionally, autophagy has been
recently associated with asthma phenotype and severity by, for instance, regulating the eosinophilic
inflammation [? ]. Besides, the autophagy gene Atg16l1 has been linked to the regulation of Treg and
TH2 populations to avoid intestinal inflammation [? ]. Our first goal during our analysis was to identify
transcripts that may be involved in the development of allergic reactions following prenatal exposure to
BzBP, and to do so, we prioritized the investigation of groups of genes that were clearly associated with
TH cell functions. However, due to these pieces of information concerning the autophagy process, and
despite the fact that the clear role of autophagy in the development of TH cell-related allergic reactions
was not determined yet, we decided to keep investigating the group of genes that was associated with
this process in our study as well, hence the investigation of this newly assembled gene XLOC 070362.
As mentioned before, XLOC 070362 was found to be highly correlated (corr > 0.85) in the network
with genes involved in the “Nur77 signaling pathway”. The protein NUR77 (or NR4A1) has been
described as a mediator of both non-apototic (by autophagy) and apoptotic cell death [? ]. However,
the genes correlated with XLOC 070362 that were enriched in this pathway actually appeared to be
related rather to the NUR77-mediated apoptosis than to the autophagy process (Supplementary Figure
S10 in Appendix A). In more detail, MEF2D has been described as the main transcription factor that
activates the expression of Nur77 and as being repressed by CABIN1 with which it interacts [? ? ].
When the TH cells are activated, the calmodulin-dependent kinase CAMK4 phosphorylates CABIN1
what results in the nuclear export of the latter, in the release of MEF2D and in the enhancement of
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Nur77 expression [? ? ]. The consequent NUR77 protein interacts then with BCL-2. This interaction
causes a change in the conformation of BCL-2 what results in its conversion into a pro-apoptotic factor
and therefore leads to apoptosis [? ]. Considering the toxicological aspect of our study, we observed
that prenatal exposure to BzBP led to the up-regulation of the gene Camk4 and to the down-regulation
of the gene Nur77, but did not result in significant changes in the number of dead cells (see Section 3.2).
However, according to the description of the pathway given above, one would assume that if Camk4 is
up-regulated then the expression of Nur77 and the number of dead cells should increase. As mentioned
before, NUR77 is involved in several pathways and can therefore be regulated in different ways. This
means that its regulation following prenatal exposure to BzBP could be due to another pathway that
we did not identify here. Moreover, considering that the gene Nur77 was not associated with the same
group of genes in our network analysis (turquoise module while the others were in the black one - see
Section 3.7), one should also consider the genes that are highly correlated with XLOC 070362 in a
“Nur77 signaling pathway”-independent manner.
While CABIN1 and MEF2D were primarily associated with the regulation of NUR77 activity, it
appears that these proteins are also involved in the regulation of cytokines expression. ? ] used a mouse
model expressing a truncated version of CABIN1 that could not interact with MEF2D and, contrary to
all expectations, they did not observed an increase in the number of apoptotic cells but did notice an in-
crease in the expression of IFNγ, IL-2 and of the TH2 cytokines IL-4, IL-9, IL-13 after TH cells in vitro
activation. Additionally, they observed higher levels of serum IgG1, IgG2b, and IgE. This means that
some of the genes that are highly correlated with XLOC 070362 can also be involved in a phenotype
that is likely linked to allergic reactions development (see Section 1.4). We observed an up-regulation of
Camk4 expression in our RNA-sequencing data when comparing the two treatment groups, what should
result in theory in a decrease of the CABIN1-mediated MEF2D inhibition and therefore in an increase
of cytokines expression. However, although the genes of some of the mentioned cytokines tended to
be regulated in our RNA-sequencing data when comparing the two treatment groups (at the “6 days”
time-point), none reached the FDR threshold of 0.05. These unexpected results could be attributed to
different factors. First, we did not have the same experimental set-ups as in the mentioned study [? ]:
we activated the cells for 72 hours with 4µg/mL of anti-CD3 and anti-CD28 antibodies and then let
them in culture for 72 additional hours without stimulation before performing RNA-sequencing, while
they activated their cells for 48 hours with 10µg/mL of anti-CD3 antibodies and measured directly the
amount of cytokine transcripts by RNase protection. In addition of the “softer” activation we used,
the 3 days without stimulation probably had an impact on the cytokine production as well. This idea
is supported by our ELISA results since the cytokine concentrations at the “6 days” time-point were
below the detection range. Additionally, the ELISA results also showed that the amounts of secreted
cytokines were highly variable between our individuals at earlier time-points (see Section 3.2) what
could also explain the lack of significant results during differential expression analysis. Finally, one
could also argue that the increase of the Camk4 gene expression does not necessarily result in a higher
activity of the CAMK4 protein and therefore in a stronger inhibition of CABIN1 activity and in an
increase of cytokine genes expression.
To summarize, we observed that XLOC 070362 was highly correlated (corr > 0.85) in the con-
structed network with the gene Camk4 and with Cabin1, which codes for the primary target of the
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protein encoded by Camk4. Additionally, the newly assembled gene was also correlated with Mef2d,
which codes for the protein MEF2D that is itself regulated by CABIN1. Using network inference,
we suggest that XLOC 070362 is also involved in this CAMK4/CABIN1/MEF2D regulation system.
Furthermore, already published studies suggest that the activation of CAMK4/CABIN1/MEF2D leads
to either apoptosis via the “Nur77 signaling pathway” or to changes in cytokine profiles. Suggesting
that XLOC 070362 is working with CAMK4/CABIN1/MEF2D presupposes that XLOC 070362 may
also be involved in such processes.
Prenatal exposure to BzBP led to the up-regulation of XLOC 070362 and Camk4 at the “6 days”
time-point. One could then assume that XLOC 070362 either regulate Camk4 expression, or acts
together with the encoded kinase and therefore is involved in the regulation of CABIN1. Nevertheless,
the mechanisms by which XLOC 070362 is involved in this system remain to be clarified, especially as
we could not determine yet if this gene encodes for a novel protein or a lncRNA. Moreover, prenatal
exposure to BzBP did not lead to significant changes in the number of dead cells or in the expression
of cytokines. Thus, the consequences of the up-regulation of XLOC 070362 by this exposure must still
be enlightened.
5.2.3 The TH1/TH2 balance may be influenced by two newly assembled
lncRNAs
We classified both newly assembled genes XLOC 089487 and XLOC 449244 as potentially non-
protein coding genes. XLOC 089487 is located on the chromosome 11, upstream of the Ccr7 gene
that encodes for a chemokine receptor. It was found to be up-regulated during TH cell activation and
to remain at this higher expression level when kept further in culture (until the “6 days” time-point).
Prenatal exposure to BzBP led to the up-regulation of this gene at the “6 days” time-point. On the
other hand, XLOC 449244 is located on the chromosome 7, in a region lacking in annotation. This
gene was strongly up-regulated throughout the activation time-line of TH cells and prenatal exposure
to BzBP led to a 2-fold decrease of its expression level at the “6 days” time-point (see Section 3.8)).
During the network analysis, both newly assembled genes were found to be correlated and to be key
drivers of a module of genes (Module Memberships kME = 0.89 and 0.91, respectively) that functional
analysis associated with T cell activation and differentiation. Finally, pathway analysis showed that
some of the genes correlated with these lncRNAs (e.g. Jun, Nfkbia, Tnfaip3, Map3k8...) were involved
in pathways related to the inflammation control, including the “TLR Receptor signaling”, “TNFR1
and TNFR2 signaling”, “NFκB signaling”, or yet “CD27 signaling” pathways (see Section 3.8).
The TLR (“Toll-like Receptors”) were first associated only with the activation of the innate immune
system (see Section 1.1). However, over the years, it appeared that they also play a role in the activation
and the regulation of TH cells. Indeed, it was found that TLR are expressed at the surface of TH cells
as well and that they are involved in the TH1-/TH2- responses balance [? ? ]. The CD27 and NFκB
signaling pathways were both previously described as involved in the regulation of the activation,
maintenance and survival of TH cells [? ? ? ? ], but also in the regulation of the inflammatory T cell
responses [? ? ]. As for the “TNFR1 and TNFR2 signaling” pathways, they have been described as
involved in inflammatory and anti-inflammatory activities, respectively, as reviewed by ? ]. While TH1
cells produce pro-inflammatory cytokines, the TH2-driven immune response is generally considered as
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“anti-inflammatory” but has been associated with allergies and asthma (see Section 1.4). Due to the
critical roles of the described pathways in the TH cell differentiation process and in the maintenance of
the sub-populations balance, one could then assume that they are involved in such pathologies. This
has been actually shown in several studies and most of these pathways have indeed been described as
involved in the regulation of allergic airway inflammation [? ? ? ? ], except for the “CD27 signaling
pathway” for which the role in such process has been discussed [? ]. Interestingly, the genes Nfkbia,
Tnfaip3 and Jun, with which both newly assembled lncRNAs are highly correlated (corr > 0.85), were
described as involved in the regulation of airway inflammation and asthma development too if considered
independently [? ? ? ]. Using network inference, we therefore suggest that the two newly assembled
lncRNAs XLOC 089487 and XLOC 449244 act together in the regulation of the inflammatory response
and therefore in the regulation of asthma development.
More precisely, XLOC 089487 was found to be highly correlated with Nfkbia and Tnfaip3 (included
in the top 35 - see Section 3.8) that both encode for proteins which inhibit NFκB activity [? ? ].
NFκB has been described as involved in the differentiation into most of the TH cell sub-populations [?
], including for TH2 cells by regulating IL-4 expression [? ]. Nevertheless, it appears that NFκB leads
anyway mainly to TH1 differentiation [? ? ? ? ]. Given its high correlation with NFκB-inhibitors,
XLOC 089487 might be involved as well in the regulation of NFκB activity and therefore in the down-
regulation of the expression of inflammatory cytokines and of the TH1 phenotype. We can exclude that
the lncRNA is involved in the regulation of gene expression of Nfkbia and Tnfaip3 since their level of
expression was not influenced by prenatal exposure to BzBP. Nevertheless, XLOC 089487 could either
cooperate with the encoded proteins NFKBIA and TNFAIP3, or act independently on the regulation
of NFκB. This suggestion that XLOC 089487 may be involved in the inhibition of NFκB and therefore
in the down-regulation of TH1 differentiation is supported by the fact that prenatal exposure to BzBP
leads to the up-regulation of this gene at the “6 days” time-point, when we supposedly have more TH2
cells in the making since prenatal exposure to BzBP leads to a TH2-driven asthma phenotype [? ].
On the other hand, we found that the expression profile of XLOC 449244 was highly correlated
with the ones of Nfkbia, Map3k8, Bmpr1a and Jun (see Section 3.8). These genes are all involved in the
“TLR signaling” and “NFκB signaling” pathways that both lead preferentially to the differentiation of
na¨ıve cells into TH1 cells [? ? ? ? ]. Considering these “close” genes individually, Bmpr1a encodes
a cell surface receptor of the same name that is up-regulated after TCR stimulation and that can lead
to the activation of gene expression via either the SMAD pathway (canonical) or the NFκB pathway
(non-canonical) [? ]. The activation of the receptor BMPR1A has been associated with an increase
of Treg and TH17 differentiation [? ? ] and a decrease of TH1 differentiation in a SMAD-dependent
manner [? ]. However, its role in the NFκB pathway in TH differentiation remains to be determined.
Additionally, the gene Bmpr1a has been described as a target of STAT4, a TH1-promoting transcription
factor [? ] what suggests that this gene might after all still be associated with the TH1-differentiation
process. As for Map3k8, it encodes for a kinase that promotes TH1-differentiation [? ] including by
the activation of NFκB and c-Jun [? ? ]. The latter is encoded by the gene Jun and is activated by
c-Jun N-terminal kinases (JNK) that are necessary for the differentiation into TH1 cells [? ? ]. Given
that our newly assembled gene is highly correlated with all these genes, XLOC 449244 could also have
similar functions and therefore be involved in the TH1 differentiation process. Due to the fact that
Jun is the gene with the highest correlation score with XLOC 449244 in the network (corr = 0.96)
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but that it is not regulated by prenatal exposure to BzBP, we first propose that the lncRNA could be
involved in such process in a c-Jun-related manner. However, we also found that XLOC 449244 was
highly correlated with Nfkbia (corr = 0.89), which encodes an inhibitor of NFκB and that is therefore
rather associated with a down-regulation of the TH1 phenotype. Nevertheless, the encoded protein
NFKBIA was already described as being down-regulated by a lncRNA. Indeed, ? ] showed that the
lncRNA HOTAIR regulates NFKBIA in case of DNA damage response in ovarian cancer. We therefore
suggest that NFKBIA may be regulated by another lncRNA, encoded by the newly assembled gene
XLOC 449244. Nevertheless, ? ] noticed a diminution of NFKBIA in HOTAIR-overexpression cells by
performing Western-Blot, what does not allow to conclude if the regulation of NFKBIA by HOTAIR
is made at the translation or at the post-translation level. Considering that we did not observe any
regulation of Nfkbia in our RNA-sequencing data when comparing our two treatment groups, we also
propose that NFKBIA might be regulated by the lncRNA XLOC 449244 at the post-transcriptional
level. In either proposed mechanisms, the lncRNA encoded by XLOC 449244 would therefore be
involved in promoting the TH1 differentiation process. We observed that this gene is severely down-
regulated by prenatal exposure to BzBP at the “6 days“ time-point (log2 Fold Change < −1), what
could lead to the TH2-driven asthma phenotype as well.
To summarize, both lncRNAs may be involved in the regulation of the na¨ıve TH cells differentiation
into TH1 cells. However, our results suggest that they have adverse functions since XLOC 089487
may inhibit a TH1 differentiation-related pathway while XLOC 449244 may promote another one.
The TH1/TH2 balance is a fine-tuned system with regulators involved in the promotion of both sub-
populations and the antagonist functions of these genes are thus plausible. Besides, we know that
asthma induced by prenatal exposure to BzBP is associated with an increased TH2 activity [? ]. We
suggest that this effect of BzBP may be related to the regulation of these two lncRNAs that could then
result in a TH1/TH2 imbalance.
5.2.4 Conclusions on the effect of prenatal exposure to BzBP on the TH
cells non-coding transcriptome
Prenatal exposure to BzBP had been associated with an enhanced asthma phenotype however,
the underlying mechanisms remained unclear. Due to the fact that lncRNAs can be influenced by
environmental factors (see Section 1.6), we wanted to investigate if this exposure to BzBP led to
the differential expression of non-coding transcripts in TH cells (one of the main actors in such a
pathology) and if some of the regulated transcripts may be involved in the development of asthma.
During our study, we actually found that prenatal exposure to BzBP led to the differential expression
of a consequent portion of non-coding transcripts. For further characterization of the latter, we kept
focus on transcripts that were regulated by prenatal exposure to BzBP and that were also correlated
with groups of genes associated with TH cells functions. Indeed, because of how our network was
constructed (see Section 3.5.1), we considered that the lncRNAs that were “close” to such group of
genes were likely to have similar functions. Nevertheless, we cannot exclude that the way we performed
our analysis and we selected our “genes of interest” may have not been optimal. The unexpected results
during the investigation of the newly assembled gene XLOC 070362 accentuate this remark. Indeed,
we selected the group of genes to which XLOC 070362 belonged because of their link to autophagy
that is indirectly related to TH cell regulation. But it appears that the newly assembled gene may after
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all be involved in a transcriptional regulation system, which targets among other TH2-cytokines genes.
This suggests that a broader analysis of our data, without focusing only on groups of genes directly
associated with TH cell-related functions, could be beneficial to identify more putative key drivers of
the BzBP-induced asthma phenotype. This study is therefore the first step in understanding the effects
of prenatal exposure to BzBP on the non-coding transcriptome of TH cells but further investigations
should be carried in order to get a more complete picture.
Nevertheless, during our analysis, we could highlight new putative roles for four lncRNAs and
newly assembled genes in TH cell-related functions. Additionally, these genes were also found to be
regulated by prenatal exposure to BzBP and could thus be associated with the subsequent development
of asthma. Despite the fact that the underlying mechanisms could not be clarified for all yet, we propose
a preliminary model on how these genes may be involved in TH cell functions and therefore be key drivers
in asthma development (summarized in Figure 5.1). Additional experiments and characterization will
be necessary to confirm the roles of these investigated transcripts in TH cells and to complete the
proposed model.
Figure 5.1. Transcripts regulated by prenatal exposure to BzBP in TH cells are putative key drivers
in the subsequent asthma phenotype. - Figure on next page - The analysis of our RNA-sequencing data
highlighted four transcripts regulated by prenatal exposure to BzBP that may be involved in asthma development.
For each of the transcripts, several proposed modes of action are illustrated in the present figure. Red annotations
indicate the effects of prenatal exposure to BzBP, such as the regulation of gene expression or the consequences
on phenotypes. Questions marks indicate that no conclusion could be made about the latter yet.
In more details, the antisense Gm15441 might act in cooperation with the γ and ζ chains of the CD3 complex
in the regulation of TH cell activation and of the TCR expression. Although it was down-regulated by prenatal
exposure to BzBP, the outcome of such a regulation is not known yet. On the other hand, we proposed that the
newly assembled gene XLOC 070362 codes for an element that can regulate either the expression of the Camk4
gene or the activity of the related protein. The up-regulation of this gene could therefore lead to an up-regulation
of TH2 cytokines. Finally, the two lncRNAs XLOC 089487 and XLOC 449244 may regulate the differentiation
of TH cells into TH1 cells. By affecting the expression of these genes, prenatal exposure to BzBP on these genes
could impair the TH1/TH2 balance and therefore be involved in the development of the associated TH2-driven
asthma phenotype previously described [? ].
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5.3 BzBP influences lncRNAs associated with germinal center
B cell functions
To our knowledge, no studies were published yet concerning the effect of BzBP on B cells. However,
our results show that prenatal exposure to BzBP leads to differential expression of several hundreds
of genes in those cells as well, including of lncRNAs and newly assembled genes. Functional analysis
first revealed that the DE protein-coding genes were associated with cell organization, metabolism and
gene expression (see Section 4.1). Additionally, in the second phase of our analysis, we wanted to
identify putative roles of the DE lncRNAs and newly assembled transcripts, which were not considered
during the functional analysis. We integrated B cell developmental data published by ? ] in order to
perform a network correlation analysis (see Section 4.2). Some groups of genes (or “modules”) of the
constructed network that were associated with B cell-related functions comprised lncRNAs and newly
assembled genes. Some of the latter were defined as “hub-like” genes (estimation of the Intramodular
Connectivity with Module Memberships kME > 0.80) and were found regulated by prenatal exposure
to BzBP in our own data. Filtering for those who were highly correlated (corr > 0.85) with coherent
groups of genes in B cell developmental data, we identified two lncRNAs (Gm38865 and Gm37033 )
that, in addition of being sensitive to BzBP-exposure, were up-regulated in germinal center B cells and
were correlated with protein-coding genes involved in B cell-related functions in B cell developmental
data (Table 4.3).
It is worth noticing that the two lncRNAs Gm38865 and Gm37033 were annotated as sense intronic
lncRNAs of two genes described as involved in B functions themselves: Foxp1 and Itpkb, respectively [?
? ? ]. Although no correlation could be found between these genes and the two lncRNAs either in the
network correlation analysis based on the B cell development data nor in our data on BzBP exposure,
these localizations already suggest that these two lncRNAs may be involved in immune functions since
the gene order is “not random”, as previously discussed by ? ].
Germinal center B cells are by definition located in germinal centers in secondary lympho¨ıd organs.
These cells are undergoing different phenomenons following the activation by an antigen: intense clonal
expansion, somatic hypermutation (fine tuning of the variable part of the produced immunoglobulins)
and isotope class switching [? ? ? ] (see Section 1.3.3). It is thus at this stage that B cells can turn
to be IgE-producing, making those cells critical for the development of allergic reactions [? ]. Given
that the two lncRNAs Gm38865 and Gm37033 were strongly up-regulated in this type of cells, one
can assume that they play a role in germinal center-related functions.
Additionally, network correlation analysis on B cell developmental data revealed that these two
lncRNAs associate with several protein-coding genes themselves involved in B cell functions. The gene
Gcsam (or also called M17 ) was part of these genes. It is also specifically expressed in germinal center
B cells [? ] but its role in these cells remains unclear. Indeed, ? ] did not observe changes in germinal
center functions (e.g. somatic hypermutation or class isotope switch) in their M17−/− mouse model.
However, its human homolog HGAL has been associated with the negative regulation of cell migration
[? ] and in the maintenance of germinal centers [? ]. Due to the high similarities between the two
genes, it is tempting to conclude that Gcsam/M17 is involved in such functions as well. Gm38865 and
Gm37033 were also highly correlated to the gene Nuggc or SLIP-GC (“Speckled-like pattern in the
germinal center”) that is a GTPase specific to germinal center B cells identified by ? ]. The same group
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proposed more recently that Nuggc/SLIP-GC is involved in the regulation of the activation-induced
cytidine deaminase (AID) activity [? ]. The latter generates DNA breaks in germinal center B cells and
is a trigger of the somatic hypermutation process. ? ] advanced that Nuggc/SLIP-GC protect DNA
sequence from AID and that it is therefore involved in the regulation of the somatic hypermutation
process. However, AID was also found to be involved in the regulation of germinal center size by
inducing DNA breaks what led to B cell apoptosis [? ]. One can therefore wonder if Nuggc/SLIP-GC
may be involved in the regulation of AID in this context as well and thus in the regulation of germinal
center size.
The last gene with which both lncRNAs were highly correlated was the Havcr1 (or Tim-1 ) gene.
The latter belongs to the TIM (“transmembrane - or T cell - immunoglobulin and mucin domain”)
family, which is involved in the immune response regulation [? ], and has been associated with asthma
development in both human and mouse [? ? ? ]. Additionally, Havcr1/Tim-1 has been proposed as a
marker for both germinal center B cells and Breg [? ? ]. Nevertheless, although the role of Havcr1/Tim-
1 in Breg has been recently described [? ], we are more interested here in its role in germinal center B
cells since this is the B cell sub-population that was represented in the B cell developmental data that
we integrated for network correlation analysis (see Section 4.2). Indeed, even tough Breg and germinal
center B cells can co-localize [? ], ? ] sorted the sub-population of germinal center B cells using their
specific marker GL7 [? ] and the protein Fas, which is highly expressed on germinal center B cells [? ]
but not on Breg [? ]. We can thus exclude that the observations made here concern Breg. But, while
Havcr1/Tim-1 is expressed in germinal center B cells, its function within those cells remain unclear.
Havcr1/Tim-1 was found to not be necessary for the germinal center response [? ] and no significant
difference in Ig secretion were observed in a Tim1−/− mouse model by ? ]. However, this last point is
contested by the results of ? ] who found out that Havcr1/Tim-1 is involved in the antibody production
(including for IgE, a key actor in allergic reactions - see Section 1.4) after sensitization with OVA and
stimulation with anti-TIM-1 antibodies. They additionally suggested that Havcr1/Tim-1 lead to these
changes by influencing the differentiation of germinal center B cell into plasma cells, which are the
antibody-secreting cells (see Section 1.3.3).
In short, Gm38865 and Gm37033 are both highly correlated with a group of genes that are specific
for germinal center B cell and that are involved in related functions. This reinforces our previous
suggestion that these lncRNAs may play roles in such cells. Nevertheless, each of the two lncRNAs
was also correlated with a few more genes. For instance, Gm37033 was found highly correlated in
the network based on B cell developmental data with Rgs13 that codes for a “regulator of G protein
signaling” (RGS). This gene is mainly expressed in germinal center B cells where it has been associated
with the responsiveness to chemokines and thus with the regulation of the cell migration [? ]. More
recently, RGS13 has been described as a nuclear repressor of CREB, a transcription factor involved
in the proliferation of germinal center B cells [? ] and ? ] proposed that RGS13 is involved in the
regulation of germinal center sizes. On the other hand, Gm38865 was correlated with Ffar3 (or Gpr41 ),
a receptor for short chain fatty acids, that is expressed by a wide variety of cells including immune
cells [? ]. Although it has been associated with anti-inflammatory activities with the activation of
innate immune cells [? ], a higher amount of Treg in the thymus [? ] and a TH2-orientated immune
response in lungs [? ], its function in B cells is still unknown. Finally, Gm38865 was also found to be
correlated with Fas that is highly expressed in germinal B cells but is not necessary for the response
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to an antigen [? ]. However, Fas appears to be required for the selection of germinal center B cells and
the maintenance of T and B cells homeostasis [? ]. Additionally, ? ] showed that its inactivation leads
to the generation of unconventional germinal center B cells and to IgE and auto-antibodies production
[? ].
Considering the results of the studies summarized here, we used network inference to propose that
Gm38865 and Gm37033 are involved in the control of Ig production and in the maintenance of germinal
centers, especially by the control of their size. Additionally, coming back to the toxicological aspect of
our study, we observed that Gm37033 was anti-correlated with Havcr1/Tim-1 (see Section 4.4.2) when
prenatally exposed to BzBP (see Section 4.4.2). At a false discovery rate of less than 0.05, Havcr1/Tim-
1 was not considered as differentially expressed in the “prenatally exposed to BzBP” group but it is
worth noting the tendency to up-regulation (log2 Fold change = 0.67, p− adjusted = 7.9× 10−02). We
then additionally propose that Gm37033 is involved in germinal center maintenance in a Havcr1/Tim-
1 -related manner. Although the underlying mechanisms remain to be clarified, the results of our study
therefore suggest that the down-regulation of these lncRNAs by prenatal exposure to BzBP could lead
to dysfunction of germinal centers, and thus be involved in the associated asthma phenotype, which is
characterized by an increased antibody production [? ].
Figure 5.2. LncRNAs regulated by prenatal exposure to BzBP in germinal center B cells may be
involved in the development of the associated asthma phenotype. The integration of B cell developmental
data to our own RNA-sequencing data allowed for the identification of two lncRNAs that are regulated by prenatal
exposure to BzBP and that may be involved in B cell-functions. Due to the central role of the latter in asthma
development, we propose that these lncRNAs are involved in the development of asthma that may occur after
prenatal exposure to BzBP. For each of these transcripts, several modes of action are proposed in the hereby
figure with green arrows. Dotted green arrows mean that we could not find any evidence yet of the regulation of
the concerned gene/protein by one of the lncRNAs of interest. Black arrows and text summarize the results of
published studies. Grey texts and plain lines correspond to suggestions made in published studies but that were
not proven yet, or to the results of studies concerning one protein but where the link with the upstream regulator
was not made (e.g. AID can be controlled by SLIP-GC and AID controls germinal center size but it was not
shown yet that SLIP-GC regulates AID activity in that context). Additionally, dotted grey lines correspond to
results of homologous proteins (e.g. role of M17) or to suggestions based on literature reading. Finally, red
annotations indicate the effects of prenatal exposure to BzBP, such as the regulation of gene expression or the
consequences on following phenotypes. Questions marks indicate that no conclusion could be made yet about the
latter.
In short, we propose that Gm37033 and Gm38865 are involved in the regulation of germinal center size and/or
in the regulation of IgE production, a characteristic element of allergic reactions. Due to their correlation in
our BzBP-exposure data, we additionally propose that Gm37033 does so by regulating the expression of the gene
Tim-1.
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Prenatal exposure to BzBP does not only affect the transcriptome of TH cells but also of B cells.
Once again, we wanted to identify lncRNAs or newly assembled transcripts that are regulated by
this substance and that may be key drivers in the subsequent development of asthma. We performed
network correlation analysis integrating genes newly assembled in our data with published data and
we followed the same strategy as for the analysis of the RNA-sequencing from TH cells by selecting
modules of genes that were directly associated with immune- or B cell-related functions by functional
analysis. There is therefore the possibility that we excluded promising lncRNAs and newly assembled
genes of further analysis, as we already addressed in Section 5.2. However, the integration of these
published data about B cell development and activation [? ] enabled the identification of putative
functions for two lncRNAs that had been annotated but not described yet, the sense intronic lncRNAs
Gm38865 and Gm37033. We suggest that they are both involved in the regulation of germinal centers
and we propose a preliminary model summarized in Figure 2. Additional experiments (e.g. loss of
functions experiments, measure of the germinal center size,...) are required to confirm our hypotheses
and to fully understand the consequences of the down-regulation of these genes by prenatal exposure
to BzBP.
5.4 The effects of maternal exposure to BzBP are variable
In the present study, mice were exposed to BzBP via drinking water, at a concentration of 3µg/mL.
The same mouse model was used in both prenatal and perinatal exposure experiments but with different
exposure periods (from 7 days before conception until birth and weaning, respectively). The level of
exposure was already defined as relevant and comparable to the human exposure in ? ]. We discussed
above the influence of such exposures on gene expression in immune cells and the putative roles of some
BzBP-regulated transcripts that may be involved in the development of the related asthma phenotype.
However, the analysis of our RNA-sequencing data also revealed that the effect of the exposure to BzBP
can be influenced by different factors.
Despite normalization during sample preparation and analysis, variations between the samples of a
same group were observed in the RNA-sequencing data of maternally exposed mice (Figures 3.1, 3.5
and 4.1). This could be explained by differences between each animal on the genetic but also on the
environmental levels (e.g. different litters, different cages, possible different volumes of BzBP-containing
water drunk by their pregnant mother) and a clearer picture may have been obtained with a larger
number of biological replicates. Nevertheless, the two groups (non-exposed vs. exposed) contained
both males and females and the variations observed may therefore also result from the sex-associated
differences in the immune system [? ? ]. This idea is supported by (1) the PCA results where a gender
effect was observed for all the cell types (see Chapters 3 and 4) and (2) the results we obtained for
ELISA experiments where we noticed different concentration baselines of secreted cytokines for control
males and females (see Section 3.2). Moreover, phthalates and BzBP have been previously described
as having different effects on both genders [? ? ] and this study could be the illustration of this fact
in mouse immune cells.
As mentioned previously, RNA-sequencing was performed on total populations of TH cells from
mice that were perinatally or prenatally exposure to BzBP. While differential expression could be
observed in both cases, the proportion of DE genes differs between both (with a factor of about 10)
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and no significant overlap between the results was found (see Section 3.4.1). According to the previous
paragraph, one could assume that this is linked to the differences of male/female proportions in both
experiments (more males than females in the case of perinatal exposure and vice versa for the prenatal
exposure). But the variations between the two experiments may also be due to age differences between
the two groups of mice (3 and 10-13 weeks old, respectively). While this choice was initially made in
order to have a more “mature” immune system in the experiments with prenatal exposure to BzBP,
variations of the immune system and of its cells throughout lifespan have been reported, including for
T cells functions [? ? ]. Additionally, ? ] recently reported differences in the transcriptome of TH
cells from mice according to their age. Although this study compared young (2-3 months) vs. old (28
months) mice, one can wonder if variations in the gene expression exist as well between younger ages.
Considering this point, we performed differential expression analysis on our different RNA-sequencing
datasets in order to see if the age had on influence on the gene expression or not (performed on
control samples only). We indeed found that more than 10000 genes are regulated when comparing the
transcriptomes of 3 and 10-13 weeks old mice. Moreover, these age-regulated genes comprised large
fractions of the genes we also found to be regulated by perinatal or prenatal exposure (around 70% and
68%, respectively - Supplementary Figure S19 in Appendix A). This means that the transcriptome of
TH cells varies in early life as well what could be a serious explanation of the lack of overlap between
our two experiments.
One other point to be addressed concerning the lack of overlap between the two sets of experiments
in TH cells is the length of time between the end of the exposure and the sample preparation. Indeed,
it was observed that the differential expression of some genes caused by perinatal exposure to BzBP
varies over time (comparison of 3 and 8-12 weeks old perinatally exposed mice) [? ] and a similar
phenomenon could be considered in the case of prenatal exposure. Having this in mind, it is worth
noticing that the perinatally exposed mice used for RNA-sequencing sample preparation were sacrificed
directly after weaning, what means directly after the end of the exposure period, while the prenatally
exposed mice were sacrificed about 10 weeks after birth. Since the prenatally exposed mice were not in
contact with BzBP after birth, the time-lapse between the last exposure and the sample preparation
was much longer than for perinatally exposed mice (10-13 weeks vs. 1-3 days, respectively). The
prenatal exposure effect may have diminished over that time, what could explain the reduced number
of regulated genes observed in this experiment in comparison to the first one.
Taken together, our observations suggest that the effect of maternal exposure to BzBP can vary
according to the gender but also over the lifetime because of (1) changes in the immune system due
to aging and (2) time of recovery after last exposure. Considering these remarks, the lack of overlap
between the results concerning the effects perinatal and prenatal exposure to BzBP in TH cells is
therefore not a real concern but rather the illustration of a dynamic system that requires more targeted
investigations in order to potentially identify gender- and age-specific effects.
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5.5 How can BzBP trigger global changes at the transcrip-
tomic level?
The present study highlighted that maternal exposure to BzBP leads to the regulation of several
hundreds of genes in both TH cells and B cells (see Chapters 3 and 4) but did not permit until now
to identify the cellular mechanisms that can lead to changes in the expression profiles of such a broad
variety of genes.
Epigenetics modifications have been described as influenced by environmental factors and are im-
portant regulators in gene expression (see Section 1.5.3). One could therefore assume that maternal
exposure to BzBP leads to the regulation of gene expression by influencing such regulation layers. For
instance, perinatal exposure to BzBP was associated with changes in DNA methylation patterns in
the promoter regions of DE genes in TH cells [? ]. However, none of the DMR found then could be
found upstream the TSS of the four transcripts of interest regulated by prenatal exposure to BzBP
identified in TH cells and described in the present study (see Section 3.5.3). This could be, on one
hand, due to the variations between the two experimental set-ups discussed in Section 5.4, since DNA
methylation patterns vary with age for example [? ]. But, on the other hand, this could also be ex-
plained if changes in DNA patterns were rather leading to the regulation of upstream regulators (e.g.
transcription factors) than of the genes themselves. In addition, we could also not integrate the results
obtained for perinatal exposure to BzBP in TH cells to the analysis of our B cells data due to the high
variability of the methylome of immune cells [? ]. The effect of prenatal exposure to BzBP on the
DNA methylation of immune cells remains therefore to be determined but could be a first explanation
of how this substance leads to gene expression regulation.
On the other hand, ? ] showed that exposure to BzBP is associated with changes in another type
of epigenetic modifications: they observed BzBP-induced changes in histone modifications in dendritic
cells, what resulted into the differential expression of genes and into a TH2-polarized immune response.
Chromatin modifications in immune cells could therefore be another way for BzBP to regulate the
transcriptome.
Interestingly, we found out that three out of the four investigated BzBP-regulated transcripts in TH
cells were also expressed in B cells. However, they were not regulated by prenatal exposure to BzBP
in those cells. Similarly, the two lncRNAs regulated by BzBP in B cells were found expressed in TH
cells but not regulated by maternal exposure. These observations suggest that the regulation of gene
expression by maternal exposure to BzBP is cell-type specific. They therefore also support the idea
that changes in epigenetic modifications may be a key mechanism in the effect of prenatal exposure to
BzBP, due to their critical role in tissue- or cell-type-specific gene expression (see Section 1.5.3).
Even though it appears that maternal exposure to BzBP may lead to global changes in gene expres-
sion by influencing epigenetics modifications, a question remains unanswered: are these BzBP-induced
changes in epigenetic modifications transmitted from the exposed mother to the offspring or are they
due to direct exposure? We showed in ? ] that perinatal exposure to BzBP led to an enhanced asthma
phenotype in the offspring (F1) supported by changes in DNA methylation patterns and differential
expression of genes. It was also shown that this exposure to BzBP led to DNA methylation changes in
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the mother (F0). Additionally, given that the F2 generation also presented enhanced airway inflamma-
tion, a trans-generational effect caused by altered epigenetic modifications was suspected. Nevertheless,
it has been shown that phthalates and BzBP can diffuse in breast milk [? ? ] and go through the
placental barrier [? ]. Therefore, maternal exposure may not lead only to epigenetic modifications
that are transmitted from one generation to another but also to “direct” regulations. Supporting this
remark, we found published studies highlighting both differential expression of genes induced by in
utero exposure in fetal testis and in mammary gland [? ? ], and changes in epigenetic modifications in
immune cells (dendritic cells) following direct exposure to BzBP [? ]. Taken together, these observa-
tions suggest that the influence of maternal exposure to BzBP on the transcriptome might result from
a combination of regulation layers of epigenetic modifications.
The regulation of transcription factors activity by BzBP could be another way to explain the
regulation of the transcriptome by this substance. For instance, ? ] showed that BzBP-exposure can
enhance the expression of genes marker of the activity of PPARα, a nuclear receptor. In addition, in
silico studies predicted that BzBP can directly interact with PPAR but also androgen and progesterone
receptors [? ? ], and ? ] showed that BzBP interact with eIF4F, an important translation initiator
(see Section 1.5.2). None of the genes coding for these proteins were found to be regulated by prenatal
exposure to BzBP in our RNA-sequencing data. Nevertheless, their activity can have been altered by
the substance. The presence of their binding sites upstream the TSS of the genes described in this
study should therefore be verified and, more generally, one should investigate if their binding sites are
enriched in promoter regions of the genes found to be sensitive to maternal exposure to BzBP.
5.6 Adaptive immune cells and BzBP: conclusions and per-
spectives
The present study highlighted for the first time the effect of maternal exposure to BzBP on the
non-coding transcriptome of adaptive immune cells. Indeed, we found that this exposure can lead to
differential expression of several hundreds of genes in both TH and B cells. These genes comprised
lncRNAs and genes newly assembled during this study, including some that were identified as putative
key players in these cells. For instance, we identified BzBP-regulated lncRNAs and newly assembled
genes in TH cells that we suspect to be involved in major processes such as cell activation, regulation
of cytokines production, or yet regulation of the inflammatory response. In addition, we identified two
more lncRNAs that are regulated by prenatal exposure to BzBP in B cells and for which we propose
functions in germinal center B cells. Since the TH cell-related processes and the B cell sub-population
mentioned above have all been associated with the development of allergic reactions such as asthma,
we assume that the genes described in this study could thus be key drivers in such phenomenons after
prenatal exposure to BzBP.
To our knowledge, hypotheses on the functional roles of these genes were proposed for the first time
in this study. The latter thereby opens the door to more investigations to determine their modes of
action with, for example, functional characterization by loss of function experiments. Such experiments
would be necessary in order to better understand the consequences of the regulation of these specific
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genes, and therefore to better understand the complete picture of the effect of prenatal exposure to
BzBP on TH and B cells. Furthermore, we suggest that the regulation of the transcriptome by BzBP-
exposure may be associated with changes in epigenetic modifications. Further investigations of changes
in DNA methylation or histone modifications could thus provide information concerning the underlying
mechanisms. Additionally, the genes described in this study have been for the most part classified as
non-protein coding. Due to the fact that lncRNAs have been described as involved in the set-up and
maintenance of epigenetic modifications, and considering the models we proposed for the different genes
of interest, one could consider investigating the putative function of these transcripts in the regulation
of epigenetic modifications as well.
Finally, despite the fact that differences between the mouse and human immune systems have been
described before [? ], this study still gives a first glimpse to underlying mechanisms that might occur
similarly in young children. Moreover, even if the primary sequences of some of the described genes do
not appear to be conserved in Human, the functions of lncRNAs are generally held by their secondary
structures (see Section 1.6) and, while we might not have been able to find homologs for these genes,
there might still be lncRNAs that act analogously at the same loci. Some more efforts to transpose
these results from one organism to another remain therefore necessary, especially if these genes turn
out to be biomarkers of allergic reactions related to prenatal exposure to BzBP.
BzBP is a common environmental factor to which each of us is exposed on a daily basis and that
is highly difficult to avoid. The public awareness concerning its impact on health increased over the
last years and processes to find alternatives to its use have been initiated [? ? ]. In the meantime,
the understanding of how this chemical can lead to the development of pathologies remains therefore
important in order to eventually be able to counter its effects one day.
This study is one of the first steps of such a process since it gives a whole new layer of information
concerning the toxicological effects of maternal exposure to BzBP. Our results indeed highlight how
prenatal exposure to BzBP may be associated with allergy and asthma development by providing
information about putative key drivers in such phenomenons and by giving an insight of underlying
cellular mechanisms. Moreover, by showing that BzBP influences non-coding transcripts that may be
involved in such pathologies, our study also contributes to filling the gaps in the knowledge concerning
the roles of lncRNAs in environmental health.
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Figure S2. Immunoglobulins gene rearrangement. Adapted from “Kuby Immunology” [? ].
Figure S3. Prenatal exposure to BzBP and the secretion of asthma related cytokines by TH cells. -
Figure on the next page - The concentrations were measured by ELISA. The results are shown for the time-points
for which detection was possible. Left panel: all the samples were considered together. Right panel: The gender
was taken into account. (A) IL-4. (B) IL-13. (C) IL-5. (D) IFNγ.
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Figure S3. Principal component analysis for “na¨ıve TH cells” after prenatal exposure to BzBP. PCA
was performed on normalized counts (“regularized log” transformation from DESeq2 R package) from the “na¨ıve
TH cells” samples. The figures A, B and C correspond respectively to the “0 hour”, “48 hours” and “6 days”
time-points.
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Figure S4. Network correlation analysis based on TH cells data: clustering of the samples. The
samples were clustered based on their expression profiles. Each letter (from A to G) corresponds to a mouse
from which TH cells were isolated. Further information concerning each sample are displayed below the cluster
tree with grey standing for “yes” and white for “no”.
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Figure S5. Network correlation analysis based on TH cells data: analysis of the network topology.
(A) Scale independance. The linear regression model fitting index R2 is plotted for soft-powers β between 1
and 40. (B) Mean Connectivity. The mean number of connections is plotted for soft-powers β between 1 and
40.
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Figure S6. Network correlation analysis based on TH cells data: identification of genes modules.
Genes were clustered according to their dissimilarity (based on topological overlap). Each module to which genes
were associated with is represented by a color in the lower part.
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Figure S7. Modules of genes obtained by WGCNA for TH cells data - Detailed results. The correlation
between each module and each trait was calculated (Pearson method). The resulting correlation coefficients and
p-values (between brackets) are indicated on the heatmap.
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A. Supplementary figures
Figure S8. The “T cell receptor signaling” pathway includes genes highly correlated with Gm15441.
The figure was adapted from the output of the IPA software. The genes or groups of genes highlighted in yellow
or in green are highly correlated with Gm15441 in the network produced with WGCNA (corr > 0.85). The genes
in green are part of the genes the most correlated with Gm15441 (top 35).
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Figure S9. The “CD28 Signaling in TH cells” pathway includes genes highly correlated with
Gm15441. The figure was adapted from the output of the IPA software. The genes or groups of genes highlighted
in yellow or in green are highly correlated with Gm15441 in the network produced with WGCNA (corr > 0.85).
The genes in green are part of the genes the most correlated with Gm15441 (top 35).
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A. Supplementary figures
Figure S10. Genes correlated with XLOC 070362 are involved in the “Nur77 signaling in T lym-
phocyte” pathway. The figure was adapted from the output of the IPA software. The genes or groups of genes
highlighted in yellow or in green are highly correlated with XLOC 070362 in the network produced with WGCNA
(corr > 0.85). The genes in green are part of the genes the most correlated with XLOC 070362 (top 35).
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Figure S11. XLOC 089487 is correlated with genes involved in TNFR1 and TNFR2 signaling path-
ways. The figure was adapted from the output of the IPA software. The genes or groups of genes highlighted in
yellow or in green are highly correlated with XLOC 089487 in the network produced with WGCNA (corr > 0.85).
The genes in green are part of the genes the most correlated with XLOC 089487 (top 35). (A) TNFR2 signaling
pathway. (B) TNFR1 signaling pathway.
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A. Supplementary figures
Figure S12. XLOC 089487 is correlated with genes involved in the TLR signaling pathway. The
figure was adapted from the output of the Ingenuity Pathway Analysis software. The genes or groups of genes
highlighted in yellow or in green are highly correlated with XLOC 089487 in the network produced with WGCNA
(corr > 0.85). The genes in green are part of the genes the most correlated with XLOC 089487 (top 35).
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Figure S13. XLOC 449244 is correlated with genes involved in the CD27 signaling pathway The figure
was adapted from the output of the IPA software. The genes or groups of genes highlighted in yellow or in green
are highly correlated with XLOC 449244 in the network produced with WGCNA (corr > 0.85). The genes in green
are part of the genes the most correlated with XLOC 449244 (top 35).
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A. Supplementary figures
Figure S14. XLOC 449244 is correlated with genes involved in the NF-κB signaling pathway The
figure was adapted from the output of the IPA software. The genes or groups of genes highlighted in yellow or
in green are highly correlated with XLOC 449244 in the network produced with WGCNA (corr > 0.85). The genes
in green are part of the genes the most correlated with XLOC 449244 (top 35).
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Figure S15. Network correlation analysis based on B cell development data: analysis of the network
topology. (A) Scale independance. The linear regression model fitting index R2 is plotted for soft-powers β
between 1 and 40. The horizontal line represents the threshold (R2 > 0.80) for power determination. (B) Mean
Connectivity. The mean number of connections is plotted for soft-powers β between 1 and 40.
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Figure S16. Network correlation analysis based on B cell developmental data: identification of genes
modules. Genes were clustered according to their dissimilarity (based on topological overlap). (A) Each module
to which genes were associated with is represented by a color in the lower part. (B) Highly correlated modules
were merged (with |cor(E(N), E(M))| > 0.75, where E(N) and E(M) correspond to the Eigengenes of two distinct
modules). This reduced the number of modules from 38 to 19.
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Figure S17. Modules of genes obtained by WGCNA for B cell developmental data published by ? ] -
Detailed results. The correlation between each module and each trait was calculated (Pearson method). The
resulting correlation coefficients and p-values (between brackets) are indicated on the heatmap.
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LOC108168256
Rcbtb1
Rab11fip3
Gm38244
Xpo7
XLOC_051934
A530083I20Rik
Clec2g
Plec
Gm15987
Gm28720
Gm11532
Cd274
Foxj2
Rapgef4os3
Gimap5
Fam105a
Slc16a6
Gm32904
Gm43413
Gm9208
XLOC_038191
Uba6
Rapgef4os2
Gm33799
4833403J16Rik
XLOC_231822
Chrnb1
Gm16170
Scd1
Mast4
Bank1
Iglv3
Gstz1
RP24-83E15.3
XLOC_262860
Wipf1
Fcamr
Ankrd11
Tdo2
Gm16094
Macf1
XLOC_499486
Gimap8
Cmya5
Nxpe1-ps
Golgb1
XLOC_138236
XLOC_498458
LOC108168201
Gm43388
Gm40496
Gm40475
Nxpe4
XLOC_386966
Gm26669
Shisa5
Dmtf1
XLOC_063403
XLOC_067797
Usf3
XLOC_067802Atg16l2
Fcer2a
XLOC_178510
Stk17b
Spon1
XLOC_465850
Bmyc
XLOC_054211
Icosl
Slc4a3
Armc9
XLOC_067798
XLOC_049659XLOC_255526
Figure S18. Subnetworks centered on remaining selected genes after network analysis on B cell
developmental data. The different shapes of the nodes correspond to their biotype: rectangles are protein-
coding genes, ellipses are lncRNAs, octagones are miscRNAs, round squares are antisense RNAs, and triangles
are newly assembled genes.
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A. Supplementary figures
7814
196
96
2011
26
7
853
Regulated by age
(3 weeks old vs. 
10-13 weeks old)
Regulated by prenatal 
exposure to BzBP
(10-13 weeks old mice)
Regulated by perinatal 
exposure to BzBP
(3 weeks old mice)
Figure S19. Aging influences the transcriptome of TH cells and the effect of maternal exposure
to BzBP. Differential expression analysis was performed in order to identify the number of genes that were
regulated in TH cells during the growth of the mice (performed only on the control samples). We looked for
the overlap of these results with the output from differential expression analyses that were performed to identify
the effects of perinatal and prenatal exposure to BzBP. All the number of DE genes presented on this picture
correspond to a FDR 0.05.
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Supplementary tables
Cell type Target Primer efficency
TH cells Gm15441 2.800
TH cells XLOC 089487 1.834
TH cells XLOC 070362 1.990
TH cells XLOC 449244 2.785
B cells Gm38865 1.860
B cells Gm37033 1.941
Reference Gapdh 1.832
Table S1. Primer efficiency determination was performed ahead of qPCR validation.
# Gene Sizes
1 Gm15441 309
2 Gm15441 626
3 Gm15441 1023
4 Gm15441 1103
5 XLOC 070362 249 or 876
6 XLOC 089487 395 or 410
7 XLOC 089487 594 or 945 or 1093 or 1119
A. Standard PCR.
Gene Sizes
Gm15441 135
XLOC 070362 136 or 163
XLOC 089487 173
XLOC 449244 175
Gm37033 173
Gm38865 150
B. qPCR.
Table S2. Expected sizes for the PCR products. The sizes are indicated in base pairs (bp). Several sizes
are indicated when different splicing are possible. (a) Standard PCR products. The first column indicates which
primer pair in concerned, referring to the Table in Section 2.5.3. (b) RT-qPCR products.
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GO ID p-value Count Size Term
GO:0016071 1.57× 10−4 12 492 mRNA metabolic process
GO:0006397 3.23× 10−4 10 381 mRNA processing
GO:0008380 3.96× 10−4 9 320 RNA splicing
GO:0006396 4.04× 10−4 14 712 RNA processing
Table S3. Genes regulated in TH cells by prenatal exposure to BzBP (without in vitro activation)
were associated with GO terms related to RNA metabolism. 4 GO terms were significantly enriched
(p < 0.001) for the “biological process” ontology. The columns “Size” and “Count” correspond to the number
of genes annotated and to the number of genes from our data set in a given GO term, respectively.
Gene identifier Gene Symbol
ENSMUSG00000021928 Ebpl
ENSMUSG00000026814 Eng
ENSMUSG00000029622 Arpc1b
ENSMUSG00000034868 Myl12b
ENSMUSG00000039109 F13a1
ENSMUSG00000041375 Ccdc9
ENSMUSG00000045128 Rpl18a
ENSMUSG00000046027 Stard5
ENSMUSG00000060739 Nsa2
ENSMUSG00000062284 Gm6030
ENSMUSG00000064999 Gm26035
ENSMUSG00000065251 Gm23971
ENSMUSG00000065725 Gm26165
ENSMUSG00000069911 Fam196b
ENSMUSG00000070997 1700055D18Rik
ENSMUSG00000074398 Gm15441
ENSMUSG00000076465 Trbv5
Gene identifier Gene Symbol
ENSMUSG00000076480 Trbv29
ENSMUSG00000076665 Ighv7-1
ENSMUSG00000077611 Gm23946
ENSMUSG00000077714 Snord17
ENSMUSG00000079139 Gm4204
ENSMUSG00000089542 Gm25835
ENSMUSG00000094797 Igkv6-15
ENSMUSG00000096205 Gm22068
ENSMUSG00000097346 Gm26619
ENSMUSG00000098120 Gm5914
ENSMUSG00000099937 Gm28872
ENSMUSG00000104699 Rps4x-ps
ENSMUSG00000109539 Gm44667
ENSMUSG00000109875 RP23-284K1.5
ENSMUSG00000110275 RP23-179K7.3
102631979 LOC102631979
Table S4. Comparison of the results obtained with TH cells after perinatal and prenatal exposure
to BzBP. The list of genes found to be DE in both experiments is presented in this table. Nevertheless, this
overlap was tested empirically and appeared to be random.
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Gene Identifier log2FC p-adjusted
Dhx36 ENSMUSG00000027770 -0.61 1.05× 10−7
Hdgfrp3 ENSMUSG00000025104 0.53 4.98× 10−2
Table S5. Prenatal exposure to BzBP has a limited effect on gene expression in TH cells after 48
hours of in vitro activation. 2 genes were found DE (FDR 0.05) after 48 hours of in vitro activation.
Gene Identifier Biotype
Sod1 ENSMUSG00000022982 protein coding
Arhgap19 ENSMUSG00000025154 protein coding
Txn1 ENSMUSG00000028367 protein coding
Tomm7 ENSMUSG00000028998 protein coding
Psmd7 ENSMUSG00000039067 protein coding
Atp5k ENSMUSG00000050856 protein coding
Tceb2 ENSMUSG00000055839 protein coding
Npm3 ENSMUSG00000056209 protein coding
Tma7-ps ENSMUSG00000059058 lncRNA
Gm24455 ENSMUSG00000065282 small ncRNA
Rpl37rt ENSMUSG00000072692 pseudogene
Gm4204 ENSMUSG00000079139 pseudogene
Rpl38-ps2 ENSMUSG00000080921 pseudogene
Gm14277 ENSMUSG00000084113 pseudogene
Gm23144 ENSMUSG00000093831 small ncRNA
Gm3788 ENSMUSG00000094392 pseudogene
Gm23355 ENSMUSG00000094726 small ncRNA
Gm4617 ENSMUSG00000096544 pseudogene
Gm16754 ENSMUSG00000097439 lncRNA
Gm26825 ENSMUSG00000097554 lncRNA
Gm28872 ENSMUSG00000099937 lncRNA
Hist1h3h ENSMUSG00000101355 protein coding
Gm42826 ENSMUSG00000106001 lncRNA
XLOC 422034 newly assembled
Table S6. Genes were found DE in TH cells at different time-points of the activation time-line. 24
genes were found differentially expressed after “0 hour” and “6 days” of in vitro activation and cultivation.
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Gene Identifier Biotype Time log2FC p-adjusted kME
Map6 ENSMUSG00000055407 protein coding 6 days -1.16 1.16× 10−2 0.92
Fsd1l ENSMUSG00000054752 protein coding 6 days -1.12 3.35× 10−3 0.91
Ndrg1 ENSMUSG00000005125 protein coding 6 days -1.48 1.24× 10−4 0.82
Ecm1 ENSMUSG00000028108 protein coding 6 days -0.98 1.52× 10−2 0.82
Enah ENSMUSG00000022995 protein coding 6 days -1.56 8.93× 10−3 0.81
A. purple module
Gene Identifier Biotype Time log2FC p-adjusted kME
- XLOC 483227 newly assembled 6 days 0.55 3.18× 10−2 0.97
Trim16 ENSMUSG00000047821 protein coding 6 days -1.01 4.70× 10−2 0.91
- XLOC 449244 newly assembled 6 days -1.06 1.93× 10−2 0.91
- XLOC 089487 newly assembled 6 days 0.72 3.52× 10−2 0.89
Cox7c ENSMUSG00000017778 protein coding 0 hour -0.46 4.49× 10−2 0.85
Socs1 ENSMUSG00000038037 protein coding 6 days -1.04 3.97× 10−2 0.83
B. salmon module
Gene Identifier Biotype Time log2FC p-adjusted kME
Plod2 ENSMUSG00000032374 protein coding 6 days -1.29 5.94× 10−3 0.96
- XLOC 183106 newly assembled 6 days -1.17 1.13× 10−2 0.96
- XLOC 274473 newly assembled 6 days -1.46 5.14× 10−3 0.96
Vegfa ENSMUSG00000023951 protein coding 6 days -1.38 1.78× 10−4 0.95
Scd2 ENSMUSG00000025203 protein coding 6 days -1.26 3.72× 10−4 0.95
Unc13a ENSMUSG00000034799 protein coding 6 days -1.44 1.79× 10−3 0.95
Eno2 ENSMUSG00000004267 protein coding 6 days -0.83 1.94× 10−2 0.94
Trip10 ENSMUSG00000019487 protein coding 6 days -0.77 2.25× 10−2 0.94
Cwc15 ENSMUSG00000004096 protein coding 0 hour -0.43 4.39× 10−3 0.93
- XLOC 194540 newly assembled 6 days -1.17 6.50× 10−3 0.93
Hemk1 ENSMUSG00000032579 protein coding 6 days -0.95 2.38× 10−2 0.92
Hk2 ENSMUSG00000000628 protein coding 6 days -1.55 2.69× 10−4 0.91
Elovl6 ENSMUSG00000041220 protein coding 6 days -0.95 2.66× 10−2 0.91
Lrp11 ENSMUSG00000019796 protein coding 6 days -0.97 1.22× 10−2 0.89
Nsa2 ENSMUSG00000060739 protein coding 0 hour -0.41 8.02× 10−3 0.87
Gzmc ENSMUSG00000079186 protein coding 6 days -1.15 3.83× 10−2 0.83
C. pink module
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Table S7. Genes that were regulated by prenatal exposure to BzBP in TH cells are key drivers in
modules associated with immune functions. The genes that were (1) regulated by prenatal exposure to BzBP
and (2) with a Module Membership kME > 0.80 in one of the selected module (from the network correlation
analysis) were filtered. The lncRNAs and newly assembled genes are highlighted since they were the targets of
further investigations. The columns ”Time”, ”log2FC” and ”p-adjusted correspond to the time-point at which
a gene was found regulated by prenatal exposure to BzBP, the log2 Fold Change and the adjusted p − value
(Benjamini and Hochberg method), respectively. (A) purple, (B) salmon, (C) pink, (D) black, (E) blue modules.
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Gene Identifier Adjacency Correlation kME
Gpr34 ENSMUSG00000040229 0.57 0.95 0.94
Sept1 ENSMUSG00000000486 0.57 0.95 0.96
Crbn ENSMUSG00000005362 0.55 0.94 0.96
Gimap4 ENSMUSG00000054435 0.55 0.94 0.98
Polr3gl ENSMUSG00000028104 0.53 0.94 0.97
Numb ENSMUSG00000021224 0.52 0.94 0.98
Grk4 ENSMUSG00000052783 0.52 0.94 0.95
Sept6 ENSMUSG00000050379 0.52 0.94 0.95
Gm44053 ENSMUSG00000108137 0.51 0.94 0.91
Stk4 ENSMUSG00000018209 0.51 0.94 0.97
Trbc1 ENSMUSG00000076490 0.51 0.94 0.90
Hp1bp3 ENSMUSG00000028759 0.51 0.94 0.97
Sntb1 ENSMUSG00000060429 0.51 0.94 0.97
Gm6611 ENSMUSG00000091997 0.50 0.94 0.97
Gm25848 ENSMUSG00000080440 0.50 0.93 0.81
Arglu1 ENSMUSG00000040459 0.50 0.93 0.86
Gm43071 ENSMUSG00000105272 0.49 0.93 0.92
Arid4a ENSMUSG00000048118 0.49 0.93 0.95
Ubn1 ENSMUSG00000039473 0.49 0.93 0.97
Sepp1 ENSMUSG00000064373 0.49 0.93 0.99
Trbv14 ENSMUSG00000076471 0.48 0.93 0.97
Gm5511 ENSMUSG00000100615 0.48 0.93 0.97
Phf21a ENSMUSG00000058318 0.47 0.93 0.98
Fyb ENSMUSG00000022148 0.47 0.93 0.98
Rb1cc1 ENSMUSG00000025907 0.47 0.93 0.97
Cd3g ENSMUSG00000002033 0.47 0.93 0.92
Msn ENSMUSG00000031207 0.47 0.93 0.97
Mbnl1 ENSMUSG00000027763 0.47 0.93 0.96
Dcaf6 ENSMUSG00000026571 0.47 0.93 0.98
Epc2 ENSMUSG00000069495 0.47 0.93 0.93
Gimap6 ENSMUSG00000047867 0.47 0.93 0.99
Cdk19 ENSMUSG00000038481 0.45 0.93 0.98
Cd247 ENSMUSG00000005763 0.45 0.93 0.94
Filip1l ENSMUSG00000043336 0.45 0.93 0.96
Ipcef1 ENSMUSG00000064065 0.45 0.92 0.98
A. Gm15441
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Gene Identifier Adjacency Correlation kME
Inadl ENSMUSG00000061859 0.69 0.97 0.98
Camk4 ENSMUSG00000038128 0.65 0.96 0.96
Ttc33 ENSMUSG00000022151 0.63 0.96 0.96
Gm12846 ENSMUSG00000081046 0.63 0.96 0.89
Myo1h ENSMUSG00000066952 0.56 0.95 0.96
XLOC 063497 XLOC 063497 0.55 0.94 0.96
Gm19325 ENSMUSG00000101365 0.55 0.94 0.96
Map3k5 ENSMUSG00000071369 0.51 0.94 0.97
Zfp746 ENSMUSG00000057691 0.51 0.94 0.96
Samhd1 ENSMUSG00000027639 0.51 0.94 0.99
Pskh1 ENSMUSG00000048310 0.50 0.94 0.96
Evl ENSMUSG00000021262 0.50 0.93 0.98
Smap2 ENSMUSG00000032870 0.49 0.93 0.97
Ranbp9 ENSMUSG00000038546 0.49 0.93 0.96
Dpy19l3 ENSMUSG00000043671 0.49 0.93 0.94
Akap7 ENSMUSG00000039166 0.49 0.93 0.96
Gatsl2 ENSMUSG00000015944 0.49 0.93 0.95
Gm26799 ENSMUSG00000097579 0.49 0.93 0.97
Fam169b ENSMUSG00000074071 0.48 0.93 0.98
Ccdc28a ENSMUSG00000059554 0.48 0.93 0.94
Lgals4 ENSMUSG00000053964 0.47 0.93 0.94
Arhgap18 ENSMUSG00000039031 0.47 0.93 0.99
Dcaf5 ENSMUSG00000049106 0.46 0.93 0.98
Zrsr1 ENSMUSG00000044068 0.46 0.93 0.96
Gpr132 ENSMUSG00000021298 0.46 0.93 0.97
Cabin1 ENSMUSG00000020196 0.46 0.93 0.88
Spata6 ENSMUSG00000034401 0.45 0.93 0.99
Zc3hav1 ENSMUSG00000029826 0.45 0.93 1.00
XLOC 410958 XLOC 410958 0.45 0.93 0.92
Capn3 ENSMUSG00000079110 0.45 0.93 0.97
RP24-306C18.10 ENSMUSG00000110251 0.45 0.93 0.97
Gm8369 ENSMUSG00000058470 0.45 0.92 0.96
Gm36931 ENSMUSG00000103779 0.45 0.92 0.90
Tmem231 ENSMUSG00000031951 0.44 0.92 0.91
Cisd3b 100504524 0.44 0.92 0.96
B. XLOC 070362
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Gene Identifier Adjacency Correlation kME
XLOC 500167 XLOC 500167 0.55 0.94 0.92
XLOC 483227 XLOC 483227 0.53 0.94 0.97
XLOC 004203 XLOC 004203 0.51 0.94 0.94
XLOC 043359 XLOC 043359 0.50 0.93 0.91
XLOC 081057 XLOC 081057 0.46 0.93 0.94
Tnfaip3 ENSMUSG00000019850 0.45 0.93 0.98
XLOC 280275 XLOC 280275 0.45 0.93 0.96
XLOC 473483 XLOC 473483 0.45 0.93 0.91
XLOC 289520 XLOC 289520 0.42 0.92 0.94
XLOC 342224 XLOC 342224 0.42 0.92 0.95
XLOC 227223 XLOC 227223 0.38 0.91 0.94
XLOC 302607 XLOC 302607 0.38 0.91 0.94
Tgif1 ENSMUSG00000047407 0.37 0.91 0.95
XLOC 430418 XLOC 430418 0.35 0.90 0.96
Gm45053 ENSMUSG00000108368 0.35 0.90 0.96
Dusp1 ENSMUSG00000024190 0.35 0.90 0.97
XLOC 245725 XLOC 245725 0.35 0.90 0.96
Platr23 ENSMUSG00000097229 0.34 0.90 0.95
XLOC 132130 XLOC 132130 0.34 0.90 0.84
XLOC 314709 XLOC 314709 0.33 0.90 0.92
Kdm4d ENSMUSG00000053914 0.32 0.90 0.93
XLOC 525342 XLOC 525342 0.32 0.90 0.89
Nfkbia ENSMUSG00000021025 0.32 0.89 0.98
XLOC 008599 XLOC 008599 0.32 0.89 0.92
XLOC 209859 XLOC 209859 0.31 0.89 0.87
Stat4 ENSMUSG00000062939 0.31 0.89 0.90
Per1 ENSMUSG00000020893 0.31 0.89 0.94
XLOC 449284 XLOC 449284 0.30 0.89 0.94
Cacnb3 ENSMUSG00000003352 0.30 0.89 0.96
Serhl ENSMUSG00000058586 0.29 0.89 0.95
XLOC 252568 XLOC 252568 0.27 0.88 0.95
Tlk2 ENSMUSG00000020694 0.27 0.88 0.86
XLOC 122838 XLOC 122838 0.26 0.88 0.94
Cblb ENSMUSG00000022637 0.25 0.87 0.91
Tph1 ENSMUSG00000040046 0.25 0.87 0.93
C. XLOC 089487
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Gene Identifier Adjacency Correlation kME
Jun ENSMUSG00000052684 0.62 0.96 0.98
Fbxo44 ENSMUSG00000029001 0.51 0.94 0.94
XLOC 274505 XLOC 274505 0.49 0.93 0.97
XLOC 304766 XLOC 304766 0.46 0.93 0.96
Irf5 ENSMUSG00000029771 0.42 0.92 0.94
Pim2 ENSMUSG00000031155 0.42 0.92 0.98
Trib3 ENSMUSG00000032715 0.42 0.92 0.90
Cuedc1 ENSMUSG00000018378 0.41 0.92 0.96
Yes1 ENSMUSG00000014932 0.41 0.92 0.97
D630039A03Rik ENSMUSG00000052117 0.39 0.91 0.97
XLOC 290964 XLOC 290964 0.39 0.91 0.96
Hist1h1c ENSMUSG00000036181 0.39 0.91 0.94
Tnfsf8 ENSMUSG00000028362 0.39 0.91 0.96
Trim16 ENSMUSG00000047821 0.36 0.91 0.91
Stc2 ENSMUSG00000020303 0.36 0.90 0.97
Map3k8 ENSMUSG00000024235 0.36 0.90 0.96
Gm6169 ENSMUSG00000057762 0.35 0.90 0.91
XLOC 252568 XLOC 252568 0.34 0.90 0.95
XLOC 289520 XLOC 289520 0.34 0.90 0.94
Cish ENSMUSG00000032578 0.34 0.90 0.96
AA467197 ENSMUSG00000033213 0.33 0.90 0.94
Scpep1 ENSMUSG00000000278 0.33 0.90 0.93
XLOC 202617 XLOC 202617 0.32 0.89 0.90
Dusp1 ENSMUSG00000024190 0.32 0.89 0.97
Bmpr1a ENSMUSG00000021796 0.32 0.89 0.95
Adam9 ENSMUSG00000031555 0.32 0.89 0.95
Cd69 ENSMUSG00000030156 0.32 0.89 0.96
XLOC 430418 XLOC 430418 0.32 0.89 0.96
Ing2 ENSMUSG00000063049 0.31 0.89 0.95
Nfkbia ENSMUSG00000021025 0.31 0.89 0.98
Gm17767 ENSMUSG00000099413 0.30 0.89 0.94
Lgalsl ENSMUSG00000042363 0.30 0.89 0.97
XLOC 229996 XLOC 229996 0.30 0.89 0.94
Dlg2 ENSMUSG00000052572 0.30 0.89 0.90
Gm5424 ENSMUSG00000046687 0.29 0.89 0.95
D. XLOC 449244
Table S8. Genes with the highest adjacency (top 35) in the correlation network for each selected genes
in the TH cell data. For each of the selected genes, the 35 genes with the highest adjacency (adjabs(X,Y ) =
((corr(X,Y ) + 1)/2)β) were selected. The corresponding correlation coefficients are also indicated. The Module
Membership kME for the module to which the genes were associated with is indicated. (A) Gm15441, (B)
XLOC 070362, (C) XLOC 089487, (D) XLOC 449244.
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GO ID p-value Count Size Term
GO:0048869 1.00× 10−5 120 1326 cellular developmental process
GO:0098602 5.21× 10−5 38 307 single organism cell adhesion
GO:0002757 9.02× 10−5 20 123 immune response-activating signal transduc-
tion
GO:0002429 9.30× 10−5 14 69 immune response-activating cell surface re-
ceptor signaling pathway
GO:0030154 9.35× 10−5 107 1206 cell differentiation
GO:0030036 1.11× 10−4 31 239 actin cytoskeleton organization
GO:0040011 1.23× 10−4 49 450 locomotion
GO:0002764 1.42× 10−4 20 127 immune response-regulating signaling path-
way
GO:0030029 1.50× 10−4 32 254 actin filament-based process
GO:0002768 1.51× 10−4 14 72 immune response-regulating cell surface re-
ceptor signaling pathway
GO:0050851 1.63× 10−4 13 64 antigen receptor-mediated signaling pathway
GO:0016337 2.20× 10−4 34 282 single organismal cell-cell adhesion
GO:0048856 2.24× 10−4 139 1689 anatomical structure development
GO:0098609 3.15× 10−4 43 394 cell-cell adhesion
GO:0044767 3.41× 10−4 147 1821 single-organism developmental process
GO:0031346 4.10× 10−4 19 127 positive regulation of cell projection organization
GO:0032502 4.16× 10−4 148 1843 developmental process
GO:0002253 4.90× 10−4 20 139 activation of immune response
GO:0007155 5.30× 10−4 52 516 cell adhesion
GO:0051130 5.68× 10−4 48 467 positive regulation of cellular component organiza-
tion
GO:0006955 6.09× 10−4 45 431 immune response
GO:0051128 6.11× 10−4 81 902 regulation of cellular component organization
GO:0050852 6.26× 10−4 9 39 T cell receptor signaling pathway
GO:0022610 6.98× 10−4 52 522 biological adhesion
GO:0048870 7.38× 10−4 43 410 cell motility
GO:0051674 7.38× 10−4 43 410 localization of cell
GO:0002250 7.40× 10−4 21 154 adaptive immune response
GO:0040012 7.84× 10−4 30 255 regulation of locomotion
GO:0016477 8.47× 10−4 41 388 cell migration
GO:2000251 9.45× 10−4 4 8 positive regulation of actin cytoskeleton reorganiza-
tion
GO:0008360 9.65× 10−4 12 67 regulation of cell shape
GO:0032486 9.95× 10−4 3 4 Rap protein signal transduction
GO:0034242 9.95× 10−4 3 4 negative regulation of syncytium formation by
plasma membrane fusion
Table S9. The genes belonging to the cyan module (identified by correlation network analysis on B
cells data) were associated with GO terms related to immune functions. 33 GO terms were significantly
enriched (p < 0.001) for the “biological process” ontology. The columns “Size” and “Count” correspond to the
number of genes annotated and to the number of genes from our data set in a given GO term, respectively.
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GO ID p-value Count Size Term
GO:0007165 3.98× 10−5 167 1439 signal transduction
GO:0044700 7.45× 10−5 174 1527 single organism signaling
GO:0023052 8.06× 10−5 174 1529 signaling
GO:0050896 9.51× 10−5 247 2312 response to stimulus
GO:0002923 1.01× 10−4 5 7 regulation of humoral immune response me-
diated by circulating immunoglobulin
GO:0006955 1.42× 10−4 61 431 immune response
GO:0007154 1.42× 10−4 174 1544 cell communication
GO:0002250 1.91× 10−4 28 154 adaptive immune response
GO:0009605 1.93× 10−4 76 574 response to external stimulus
GO:0071359 2.65× 10−4 9 26 cellular response to dsRNA
GO:0060326 2.87× 10−4 16 69 cell chemotaxis
GO:0006952 3.74× 10−4 60 437 defense response
GO:0002683 4.11× 10−4 28 161 negative regulation of immune system process
GO:0016441 7.02× 10−4 10 35 posttranscriptional gene silencing
GO:0035194 7.02× 10−4 10 35 posttranscriptional gene silencing by RNA
GO:0035195 7.02× 10−4 10 35 gene silencing by miRNA
GO:1902953 7.11× 10−4 3 3 positive regulation of ER to Golgi vesicle-mediated
transport
GO:0002228 7.82× 10−4 8 24 natural killer cell mediated immunity
GO:0042267 7.82× 10−4 8 24 natural killer cell mediated cytotoxicity
GO:0061013 8.50× 10−4 7 19 regulation of mRNA catabolic process
GO:0002682 8.73× 10−4 62 470 regulation of immune system process
GO:0050789 9.25× 10−4 330 3317 regulation of biological process
Table S10. The genes belonging to the lightgreen module (identified by correlation network analysis
on B cells data) were associated with GO terms related to immune functions. 22 GO terms were
significantly enriched (p < 0.001) for the “biological process” ontology. The columns “Size” and “Count”
correspond to the number of genes annotated and to the number of genes from our data set in a given GO term,
respectively.
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GO ID p-value Count Size Term
GO:1902108 1.41× 10−4 4 9 regulation of mitochondrial membrane permeability
involved in apoptotic process
GO:0002227 1.49× 10−4 3 4 innate immune response in mucosa
GO:0045669 4.34× 10−4 5 20 positive regulation of osteoblast differentiation
GO:0005976 6.07× 10−4 6 32 polysaccharide metabolic process
GO:0002523 7.10× 10−4 3 6 leukocyte migration involved in inflammatory
response
GO:0035794 7.10× 10−4 3 6 positive regulation of mitochondrial membrane per-
meability
GO:0097345 7.10× 10−4 3 6 mitochondrial outer membrane permeabilization
GO:1902110 7.10× 10−4 3 6 positive regulation of mitochondrial membrane per-
meability involved in apoptotic process
GO:1902686 7.10× 10−4 3 6 mitochondrial outer membrane permeabilization in-
volved in programmed cell death
GO:0097530 7.21× 10−4 6 33 granulocyte migration
Table S11. The genes belonging to the skyblue module (identified by correlation network analysis on B
cells data) were associated with GO terms related to immune functions. 10 GO terms were significantly
enriched (p < 0.001) for the “biological process” ontology. The columns “Size” and “Count” correspond to the
number of genes annotated and to the number of genes from our data set in a given GO term, respectively.
GO ID p-value Count Size Term
GO:0032637 5.91× 10−6 9 23 interleukin-8 production
GO:0032677 2.51× 10−5 8 21 regulation of interleukin-8 production
GO:0051239 2.84× 10−4 78 843 regulation of multicellular organismal process
GO:0032755 5.50× 10−4 7 24 positive regulation of interleukin-6 produc-
tion
GO:0006955 5.74× 10−4 45 431 immune response
GO:0032879 8.29× 10−4 74 818 regulation of localization
GO:0051241 8.42× 10−4 37 340 negative regulation of multicellular organismal pro-
cess
GO:0001816 9.19× 10−4 28 235 cytokine production
GO:0045349 9.87× 10−4 3 4 interferon-alpha biosynthetic process
GO:0045354 9.87× 10−4 3 4 regulation of interferon-alpha biosynthetic
process
Table S12. The genes belonging to the brown module (identified by correlation network analysis on B
cells data) were associated with GO terms related to immune functions. 10 GO terms were significantly
enriched (p < 0.001) for the “biological process” ontology. The columns “Size” and “Count” correspond to the
number of genes annotated and to the number of genes from our data set in a given GO term, respectively.
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GO ID p-value Count Size Term
GO:0002376 1.29× 10−6 145 853 immune system process
GO:0019886 1.42× 10−6 8 10 antigen processing and presentation of exoge-
nous peptide antigen via MHC class II
GO:0002495 2.13× 10−6 9 13 antigen processing and presentation of pep-
tide antigen via MHC class II
GO:0002504 2.13× 10−6 9 13 antigen processing and presentation of pep-
tide or polysaccharide antigen via MHC class
II
GO:0035556 6.01× 10−5 136 846 intracellular signal transduction
GO:0045321 2.38× 10−4 62 337 leukocyte activation
GO:0007154 2.60× 10−4 223 1544 cell communication
GO:0023052 2.69× 10−4 221 1529 signaling
GO:0001775 2.98× 10−4 67 374 cell activation
GO:0007165 3.26× 10−4 209 1439 signal transduction
GO:0044700 3.44× 10−4 220 1527 single organism signaling
GO:0002478 3.56× 10−4 8 17 antigen processing and presentation of exoge-
nous peptide antigen
GO:0050865 4.00× 10−4 41 203 regulation of cell activation
GO:0006955 5.44× 10−4 74 431 immune response
GO:0016192 5.63× 10−4 79 467 vesicle-mediated transport
GO:0007264 6.41× 10−4 40 201 small GTPase mediated signal transduction
GO:0045730 7.66× 10−4 6 11 respiratory burst
GO:0048002 7.76× 10−4 11 32 antigen processing and presentation of pep-
tide antigen
GO:0050896 8.93× 10−4 314 2312 response to stimulus
GO:0048710 9.77× 10−4 5 8 regulation of astrocyte differentiation
GO:0006810 9.99× 10−4 206 1443 transport
Table S13. The genes belonging to the black module (identified by correlation network analysis on B
cells data) were associated with GO terms related to immune functions. 21 GO terms were significantly
enriched (p < 0.001) for the “biological process” ontology. The columns “Size” and “Count” correspond to the
number of genes annotated and to the number of genes from our data set in a given GO term, respectively.
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Table S14. Genes that were regulated by prenatal exposure to BzBP in B cells are key drivers
in modules associated with immune functions. The genes that were (1) regulated by prenatal exposure
to BzBP and (2) with a Module Membership kME > 0.80 in one of the selected module (from the network
correlation analysis on B cells developmental data) were filtered. The lncRNAs and newly assembled genes are
highlighted in the tables since they were the targets of further investigations.
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Online supplementary
tables
Large supplementary tables were stored on the Helmholtz Center for Environmental Research - UFZ
archiving system. They are publicly available and can be downloaded following the links indicated in
this table.
# Title url
SO-1 Perinatal exposure to BzBP led to differential ex-
pression in TH cells
http://www.ufz.de/record/dmp/
archive/5994/
SO-2 Genes regulated in TH cells by perinatal exposure
to BzBP were associated Gene Ontology terms
related to immune functions
http://www.ufz.de/record/dmp/
archive/5995/
SO-3 Prenatal exposure to BzBP has a limited effect
on gene expression in na¨ıve TH cells
https://www.ufz.de/record/dmp/
archive/5996/
SO-4 Prenatal exposure to BzBP leads to differential
expression in TH cells (without in vitro activa-
tion)
https://www.ufz.de/record/dmp/
archive/5997/
SO-5 Prenatal exposure to BzBP leads to differential
expression in TH cells after 6 days of in vitro ac-
tivation and cultivation
https://www.ufz.de/record/dmp/
archive/5998/
SO-6 Genes regulated in TH cells by prenatal exposure
to BzBP after 6 days of in vitro activation and
cultivation were associated with GO terms related
to DNA processes and cell cycle
https://www.ufz.de/record/dmp/
archive/5999/
SO-7 Network correlation analysis based on TH cells
data: genes belonging to the some modules were
associated with GO terms related to immune re-
lated functions
https://www.ufz.de/record/dmp/
archive/6000/
SO-8 Prenatal exposure to BzBP led to differential ex-
pression in B cells
http://www.ufz.de/record/dmp/
archive/6001/
SO-9 Genes regulated in B cells by prenatal exposure
to BzBP were associated with GO terms related
to cell organization and metabolism
http://www.ufz.de/record/dmp/
archive/6002/
131
132
List of abbreviations
AHR Airway hyperreactivity
AID Activation-induced cytidine deaminase
APC Antigen-presenting cell
BCR B cell receptor
bp Base pairs
Breg Regulatory B cell
BzBP Benzyl-butyl-phthalate
C Constant (for “constant domain” or “constant genes”)
CD Cluster of differentiation
CDR Complementary-determining region
COPD Chronic obstructive pulmonary disease
D Diversity (for “diversity gene”)
DE Differentially expressed
DEHP di-2-ethylhexyl phthlate
DEP diethyl phthlate
DMR Differentially methylated regions
DN Double-negative
DNA Deoxyribonucleic acid
DP Double-positive
EDC Endocrine disrupting compounds
ELISA Enzyme-linked immunosorbent assay
ER Endoplasmic reticulum
GO Gene ontology
H Heavy (for “heavy chain”)
I
Ig Immunoglobulin
IFNγ Interferon gamma
IL Interleukin
IKK IκB kinases
IPA Ingenuity Pathway Analysis
J Junction (for “junction gene”)
JNK c-Jun N-terminal kinases
L Light (for “light chain”)
LPS Lipo-polysaccharide
MHC Major histocompatibility complex
NLR NOD-like receptor
nt Nucleotides
OVA Ovalbumin
PPAR Peroxisome proliferator-activated receptor
PBS Phosphate-buffered saline
PCA Principal component analysis
PCR Polymerase chain reaction
PPR Pattern recognition receptors
pre-B cell B cell precursor
pro-B cell B cell progenitor
PVC Polyvinyl chloride plastics
qPCR Real-time polymerase chain reaction
RGS Regulator of G protein signaling
RNA Ribonucleic acid
RT Reverse transcription
TAP Transporter associated with antigen-processing
TIM Transmembrane - or T cell - immunoglobulin and mucin domain
TC T cytotoxic cell
TCR T cell receptor
TD Thymus-dependent antigen
TH T helper cell
TI Thymus-independent antigen
II
TLR Toll-like receptor
Treg Regulatory T cell
TSS Transcription starting sites
uap Universal Analysis Pipeline
V Variable (for “variable domain” or “variable genes”)
WAO World Allergy Organization
WGBS Whole-genome bisulfite sequencing
III
IV
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Allergies and asthma result from immune responses to common environmental antigens. Direct
exposure to environmental pollutants has already been associated with the development of such diseases
and evidences pile up that early life exposure to these substances is critical. The group of chemicals
called “phthalates” are part of the incriminated substances. Cellular elements that can be influenced
by such exposure comprise long non-coding RNAs (lncRNAs). They are involved in both normal and
pathological cell functions and have been associated with some immune-related diseases such as allergic
reactions. Nevertheless, the role they play in environmental health still requires to be clarified.
Maternal exposure to benzyl butyl phthalate (BzBP), a chemical from the phthalate family, has been
associated with allergy and asthma development in cohort studies. The underlying cellular mechanisms
remain nonetheless mostly unknown. Because the immune cells T helper (TH) and B cells are key actors
in such pathologies, we hypothesized that maternal exposure to BzBP may have an impact on asthma
and allergy development by affecting these cells. We therefore focused on the effect of this exposure on
TH and B cells, with a particular interest in BzBP-induced changes in lncRNAs expression, motivated
by their cellular functions and their putative responsiveness to chemicals.
Using a mouse model and RNA-sequencing, we observed that maternal exposure to BzBP led to
differential expression of lncRNAs in TH cells. The results of a weighted correlation network analy-
sis suggest that some of the non-coding transcripts regulated by prenatal exposure to BzBP may be
involved in TH cell-related functions such as cell activation, TH2-cytokines expression and regulation
of the inflammatory response. BzBP-induced regulation of lncRNAs was also observed in B cells. Re-
cently published RNA-sequencing data for B cell development and activation (Brazao et al., 2016) were
integrated with our own data for correlation network analysis. Based on its results, we hypothesized
that two BzBP-regulated lncRNAs may play a role in germinal center B cell functions.
We thus identified non-coding transcripts regulated by prenatal exposure to BzBP that may be
involved in TH cell-related processes and in germinal center B cell functions. Because these processes
and this B cell sub-population are associated with the development of allergic reactions, we suspect
these genes to also be actors in such phenomenons. We propose models of how these genes are involved
in immune-related functions and how their regulation by BzBP may be critical. Taken together, these
data thus provide a whole new layer of information of the toxicological effect of prenatal exposure to
BzBP and of how this exposure might be associated with allergies and asthma development by provid-
ing an insight of underlying cellular mechanisms. Moreover, our study also contributes to filling the
gaps in the knowledge concerning the roles of lncRNAs in environmental health by showing that BzBP
influences non-coding transcripts that may be involved in pathologies.
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Long non-coding RNAs and environmental health: a role in linking early
life phthalate exposure to allergies and asthma
by Virginie Dubourg
- Summary -
Allergies and asthma result from immune responses to common environmental antigens and concern
hundreds of millions of individuals worldwide according to the World Allergy Organization. Despite
the fact that both diseases have been described as having a strong genetic background, influences
by environmental factors are not negligible. In fact, direct exposure to environmental pollutants (e.g
tobacco smoke or chemicals) has already been associated with the development of such diseases and
evidences pile up that early life exposure to these substances is critical. The group of chemicals called
“phthalates” are classified among the incriminated substances.
Long non-coding RNAs (lncRNAs) are part of the cellular elements that can be influenced by
the exposure to environmental pollutants. They are non-protein coding RNAs, usually longer than
200 nucleotides, with a broad variety of functions (e.g. transcription and translation regulations, epi-
genetic modifications set-up...) and acting through various mechanisms such as protein-, DNA- or
RNA-binding. LncRNAs have been extensively studied over the last decades, highlighting potential
roles in both normal and pathological cell functions, and have actually been associated with various
diseases including some immune-related ones such as allergic reactions. Nevertheless, the role they play
in environmental health still requires to be clarified.
Maternal exposure to benzyl butyl phthalate (BzBP), a chemical from the phthalate family present
in daily-life products (e.g. vinyl flooring, adhesives), has been associated with allergies and asthma de-
velopment in cohort studies. The underlying cellular mechanisms remain nonetheless mostly unknown.
From a mechanistic point of view, allergies and asthma are considered as complex pathologies but sev-
eral cellular key actors have been identified, including the immune cells named T helper (TH) cells and
B cells. Both are involved in these diseases through various mechanisms that are generally linked to
their development and activation (process that consists in “turning-on” the immune cells after contact
with an antigen). For instance, allergic reactions have been associated with a TH2-driven immunity
and IgE secretion by B cells. Considering these facts, we hypothesized that maternal exposure
to BzBP may have an impact on asthma and allergy development by affecting TH and B
cells. The present study therefore focused on the effect of maternal exposure to BzBP on
these cells, with a particular interest in BzBP-induced changes in lncRNAs expression,
motivated by their cellular functions and their putative responsiveness to chemicals.
Maternal exposure to BzBP leads to the regulation of lncRNAs in TH cells
Mice were exposed to BzBP through drinking water (concentration: 3µg/mL - comparable to human
exposure [1]) from one week before mating until delivery or weaning of their offspring. By performing
RNA-sequencing on cells isolated from the offspring of the exposed mice, we observed in a first experi-
mental phase that perinatal exposure (during pregnancy and breastfeeding) to BzBP led to differential
expression of several thousand genes in TH cells, as now published in Jahreis et al. (2017) [1]. These
XIII
BzBP-regulated genes comprised hundreds of lncRNAs.
With the aim of getting a better understanding of the underlying mechanisms, the same mouse
model and RNA-sequencing were used again to investigate the impact of prenatal exposure (during
pregnancy only) to BzBP on the transcriptome of TH cells throughout their activation. This second
experimental phase included the in vitro activation and cultivation of TH cells (for 0, 48 hours or 6
days). The results showed that prenatal exposure to BzBP led to gene expression regulation in TH
cells as well, including of lncRNAs and genes newly assembled during this study. Moreover, we noticed
that this exposure had a distinct impact on the transcriptome of the cells at different time-points.
Several hundreds of genes were regulated in the non-in vitro-activated cells (“0 hours” time-point) and
in the “resting” cells of the “6 days” time-point (3 days of in vitro activation plus 3 additional days of
cultivation in fresh medium), but close to none were regulated after 48 hours of in vitro stimulation.
These results suggest a dynamic effect of the prenatal exposure to BzBP and that processes upstream
and downstream of the activation of TH cells itself might be influenced.
LncRNAs potentially involved in TH cells functions are regulated by BzBP
Functional analysis (by Gene Ontology Enrichment) revealed that the genes regulated by prenatal
exposure to BzBP in TH cells may be involved in RNA metabolism and in cell cycle regulation.
However, this type of analysis did not include any information concerning lncRNAs and newly assembled
genes. To counter this problem, weighted correlation network analysis was performed in order to
investigate the role of the BzBP-regulated lncRNAs and newly assembled genes. Shortly, groups (or
modules) of highly correlated genes (based on expression profiles through the samples) were identified
and those that were associated with immunological functions by functional analysis were selected.
Some of the BzBP-regulated non-coding transcripts were (1) identified as putative key drivers in these
selected modules (based on high intramodular connectivity), and (2) found to be highly correlated
(corr > 0.85) with protein-coding genes associated with specific TH cell functions. Based on network
inference, we hypothesized that these transcripts are involved in similar functions as the protein-coding
with which they are correlated. For instance, we propose that the lncRNA Gm15441 is involved in
the regulation of TH cell activation, that one newly assembled gene (name: XLOC 070362, location:
chr11:5804953-5809907 - plus strand) could be involved in TH2-cytokines expression, and that two more
newly assembled genes (XLOC 089487, chr11:99181664-99200362 - minus strand and XLOC 449244
chr7:125190356-125192918 - plus strand) may take part in the regulation of the inflammatory response,
including by regulating the TH1-TH2 balance. All these processes have been associated with allergies
and asthma. We thus propose a model of how these transcripts may be involved in TH cell functions
and how their regulation by BzBP may be critical for allergic phenotypes (Figure 1) .
Prenatal exposure to BzBP also influences lncRNAs associated with germinal
center B cell functions
Differential expression due to prenatal exposure to BzBP was also observed in mouse B cells, includ-
ing for lncRNAs. The same strategy as for the TH cell data was employed and a weighted correlation
network analysis was performed in order to elaborate hypotheses concerning the roles of regulated
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non-coding transcripts. To do so, recently published RNA-sequencing data for B cell development and
activation [2] were integrated with our own data. The result showed that some of the lncRNAs regu-
lated by prenatal exposure to BzBP were highly correlated with genes involved in B cell functions. We
used network inference to hypothesize that two of those lncRNAs (the predicted lncRNAs Gm38865
and Gm37033 ) may play a germinal center B cell-specific role. Germinal center B cells are by defini-
tion located in germinal centers in secondary lympho¨ıd organs, where they undergo several maturation
steps. For instance, B cells can turn to be IgE-producing at this developmental stage, making this type
of cells critical for the development of allergic reactions. A model of how these two transcripts may be
involved in B cell functions is summarized in Figure 2.
BzBP-regulated lncRNAs as potential regulators of allergic reactions devel-
opment
To summarize, we could identify several lncRNAs and newly assembled genes that are regulated by
prenatal exposure to BzBP and that may be involved in TH cell-related processes and in germinal cen-
ter B cell functions. Due to the association of the concerned processes and of this B cell sub-population
with the development of allergies and asthma, we suspect these genes to also be actors in such phe-
nomenons after prenatal exposure to BzBP. To our knowledge, the putative roles of these genes were
described for the first time in this study. This latter thereby opens the door to more investigations to
determine their modes of actions and the consequences of their regulation by BzBP.
BzBP is a common environmental contaminant to which each of us is exposed on a daily basis
and that is highly difficult to avoid. The public awareness concerning its impact on health increased
over the last years and processes to find alternatives to its use have been initiated. In the meantime,
the understanding of how this chemical can lead to the development of pathologies remains therefore
important in order to eventually be able to counter its effects one day. This study is one of the first
steps of such a process since it gives a whole new layer of information concerning the toxicological effects
of BzBP, and more specifically how prenatal exposure to BzBP may be associated with allergies and
asthma development, by providing an insight of underlying cellular mechanisms. Moreover, by showing
that BzBP influences non-coding transcripts that may be involved in some pathologies, our study also
contributes to filling the gaps in the knowledge concerning the roles of lncRNAs in environmental
health.
References
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Figure 1. Transcripts regulated by prenatal exposure to BzBP in TH cells may be involved in the
subsequent asthma phenotype. The analysis of our RNA-sequencing data combined with weighted correla-
tion network analysis highlighted four transcripts regulated by prenatal exposure to BzBP that may be involved
in asthma development. For each of the transcripts, several proposed modes of action are illustrated in the
present figure. Red annotations indicate the effects of prenatal exposure to BzBP, such as the regulation of gene
expression or the consequences on phenotypes. Questions marks indicate that no conclusion could be made about
the latter yet.
In more details, the antisense Gm15441 might act in cooperation with the γ and ζ chains of the CD3 complex
in the regulation of TH cell activation and of the TCR expression. Although it was down-regulated by prenatal
exposure to BzBP, the outcome of such a regulation is not known yet. On the other hand, we proposed that the
newly assembled gene XLOC 070362 codes for an element that can regulate either the expression of the Camk4
gene or the activity of the related protein. The up-regulation of this gene could therefore lead to an up-regulation
of TH2 cytokines. Finally, the two lncRNAs XLOC 089487 and XLOC 449244 may regulate the differentiation
of TH cells into TH1 cells. By affecting the expression of these genes, prenatal exposure to BzBP on these genes
could impair the TH1/TH2 balance and therefore be involved in the development of the associated TH2-driven
asthma phenotype previously described [1].
Figure 2. LncRNAs regulated by prenatal exposure to BzBP in germinal center B cells may be
involved in the development of the associated asthma phenotype. The integration of B cell developmental
data with our own RNA-sequencing data for weighted correlation analysis allowed for the identification of two
lncRNAs that are regulated by prenatal exposure to BzBP and that may be involved in B cell functions. For
each of these transcripts, several modes of action are proposed in this figure (represented by with green arrows).
Dotted green arrows mean that we could not find any evidence yet of the regulation of the concerned gene/protein
by one of the lncRNAs of interest. Black arrows and text summarize the results of published studies. Grey texts
and plain lines correspond to suggestions made in published studies but that were not proven yet, or to the results
of studies concerning one protein but where the link with the upstream regulator was not made (e.g. AID can be
controlled by SLIP-GC and AID controls germinal center size but it was not shown yet that SLIP-GC regulates
AID activity in that context). Additionally, dotted grey lines correspond to results of homologous proteins (e.g.
role of M17) or to suggestions based on literature reading. Finally, red annotations indicate the effects of prenatal
exposure to BzBP, such as the regulation of gene expression or the consequences on phenotypes. Questions marks
indicate that no conclusion could be made about the latter yet.
In short, we propose that Gm37033 and Gm38865 are involved in the regulation of germinal center size and/or
in the regulation of IgE production, a characteristic element of allergic reactions. Due to their correlation in
our BzBP-exposure data, we additionally propose that Gm37033 does so by regulating the expression of the gene
Tim-1.
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Long non-coding RNAs and environmental health: a role in linking early
life phthalate exposure to allergies and asthma
by Virginie Dubourg
- Zusammenfassung -
(U¨bersetzung von Fra¨nze Vorreiter)
Laut der Welt Allergie Organisation sind mehrere hundert Millionen Menschen weltweit von Al-
lergien und Asthma betroffen, welche durch fehlregulierte Immunantworten gegen harmlose, in unserer
Umwelt enthaltene Antigene hervorgerufen werden. Bei beiden Krankheitsbilder wird von einem starken
genetischen Hintergrund betroffener Individuen ausgegangen, aber auch der Einfluss von Umweltfak-
toren wird als nicht unerheblich eingestuft. So wurde die direkte Exposition mit Umweltschadstoffen,
wie beispielsweise Zigarettenrauch oder anderen Chemikalien, mit der Entwicklung von Allergien und
Asthma in Verbindung gebracht, wobei eine Exposition in fru¨hen Lebensphasen als besonders kritisch
gilt. Unter den hierbei als besonders belastend eingestuften Chemikalien findet sich auch die Gruppe
der “Phtalate”.
Auf zellula¨rer Ebene geho¨ren die langen nicht-codierende RNAs (lncRNAs) zu jenen Elementen,
die sich durch Umweltschadstoffe beeinflussen lassen. LncRNAs sind als RNAs, die nicht fu¨r Proteine
codieren und la¨nger als 200 Nukleotide sind, definiert. Sie besitzen in der Zelle eine breite Palette
an unterschiedlichsten Funktionen (z.B. Regulation von Transkriptions- und Translationsprozessen,
Etablierung epigenetischer Modifikationen etc.), die durch eine Vielzahl an Mechanismen basierend
auf Protein-, DNA- und/oder RNA-Bindungskapazita¨ten vermittelt werden. Innerhalb des vergan-
genen Jahrzehnts wurden lncRNAs intensiv studiert und katalogisiert. Dabei wurde besonders ihr
Beitragspotential zu gesunden und krankheitsassoziierten Zellfunktionen hervorgehoben und erkannt.
So wurden lncRNAs mit unterschiedlichsten Krankheitsbildern, darunter auch Immunsystem-assoziierte
Krankheiten, wie beispielsweise allergischen Reaktionen, in Verbindung gebracht. Dennoch bleibt es of-
fen, die Rolle von lncRNAs innerhalb des von der Umwelt beeinflussten Gesundheitszustands einzelner
Individuen weiter zu beleuchten.
Die Exposition von Mu¨ttern mit Benzyl-Butyl-Phtalat (BzBP), einer Chemikalie aus der Fami-
lie der Phtalate, die sich in vielen Produkten des ta¨glichen Lebens befindet (z.B. Vinylbodenbela¨gen
und Klebstoffen), wurde innerhalb von verschiedenen Kohortenstudien mit dem Entwicklungspotential
von Allergien und Asthma ihrer Kinder in Verbindung gebracht. Die dabei zugrundenliegenden zel-
lula¨ren Mechanismen sind bisher zum Großteil nicht bekannt. Allergien und Asthma besitzen komplexe
Pathologien, wobei T-Helfer-(TH)-Zellen und B-Zellen als zellula¨re Schlu¨sselfiguren im Krankheitsmech-
anismus identifiziert wurden. Beide Zellarten tragen durch unterschiedliche Mechanismen innerhalb
ihres Entwicklungs- und Aktivierungsprozesses (welcher die Immunzelle nach Kontakt mit einem Anti-
gen “anschaltet”) zum jeweiligen Krankheitsverlauf bei. So wurden beispielsweise allergische Reak-
tionen mit der sogenannten TH2-gesteuerten Immunantwort und der IgE-Sekretion durch B-Zellen in
Verbindung gebracht. Resultierend aus all diesen Fakten gehen wir in dieser Arbeit davon
aus, dass die Exposition von Mu¨ttern mit BzBP einen Einfluss auf die TH-Zell- und B-
Zellaktivita¨t und damit die Asthma- und Allergieentwicklung ihrer Kinder hat. Aufgrund
der zellula¨ren Funktion und der Sensitivita¨t gegenu¨ber Chemikalien von TH-und B-Zellen
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ist es das Ziel dieser Arbeit, den Effekt der mu¨tterlichen Exposition mit BzBP auf die
kindlichen TH- und B-Zellen mit einem besonderen Augenmerk auf die induzierten Un-
terschiede innerhalb der lncRNA-Expression aufzukla¨ren.
Exposition von Mu¨ttern mit BzBP fu¨hrt zur Regulation von lncRNAs in
TH-Zellen der Nachkommen
Weibliche Ma¨use wurden im Zeitraum von einer Woche vor ihrer Verpaarung bis zur Geburt bzw.
Entwo¨hnung ihrer Nachkommen u¨ber ihr Trinkwasser mit BzBP exponiert (vergleichbar zu menschlicher
Exposition, Konzentration 3 µg/mL). Innerhalb einer ersten experimentellen Versuchsreihe konnten
wir durch Sequenzierung der RNA aus Zellen der Jungtiere von exponierten Mu¨ttern nachweisen,
dass die perinatale Exposition (wa¨hrend der Tragezeit und des Sa¨ugens) mit BzBP in TH -Zellen zur
differentiellen Expression von mehreren Tausend Genen fu¨hrt (publiziert in Jahreis et al., 2017 [1]).
Mit dem Ziel, den dabei zugrundeliegenden Mechanismus genauer aufzukla¨ren und den Effekt einer
pra¨natalen BzBP-Exposition (nur wa¨hrend der Tragezeit) na¨her zu beschreiben wurde das gleiche
Mausmodell und der gleiche Sequenzierungsansatz in einer zweiten Versuchsreihe zur Untersuchung
der Transkiptome von TH -Zellen innerhalb ihrer Aktivierung verwendet. Dabei wurden die TH -Zellen
in vitro aktiviert und nachfolgend fu¨r 0h, 48h und 6 Tage kultiviert. Die Ergebnisse dieser zweiten
Versuchsreihe zeigten, dass auch die lediglich pra¨natale Exposition mit BzBP zu einer Regulation
der Genexpression, darunter lncRNAs und im Rahmen dieser Arbeit neu-assemblierte Gene, in TH -
Zellen fu¨hrte. Zusa¨tzlich hatte die pra¨natale Exposition mit BzBP einen Effekt auf die Transkriptome
von Zellen unterschiedlicher Aktivierungsstadien. So lagen beispielsweise mehrere hundert Gene in
den nicht aktivierten Zellen (0h-Zeitpunkt) und den “nach Aktivierung ruhenden” Zellen (6 Tage-
Zeitpunkt, 3 Tage in vitro Aktivierung und nachfolgende Kultivierung u¨ber 3 Tage nach erfolgtem
Mediumwechsel) reguliert vor. Dagegen zeigte sich innerhalb der 48h in vitro aktivierten Zellen nahezu
keine Genregulation. Diese Ergebnisse deuten darauf hin, dass die pra¨natale Exposition mit BzBP
einen dynamischen, nicht dauerhaft stabilen Effekt in TH -Zellen hervorruft und vor allem Prozesse vor
und nach der Aktivierung von TH -Zellen direkt durch die Exposition beeinflusst sein ko¨nnten.
BzBP reguliert lncRNAs mit einer mo¨glichen Relevanz innerhalb der Funk-
tion von TH-Zellen
Unter Verwendung einer “Gene Ontology Enrichment”-Analyse wurde versucht die durch die pra¨natale
Exposition mit BzBP in TH -Zellen regulierten Gene funktionell na¨her zu charakterisieren und zu
beschreiben. Diese funktionelle Analyse ergab, dass die in TH -Zellen durch pra¨natale BzBP-Exposition
reguliert vorliegenden Gene eine Rolle innerhalb des RNA-Metabolismus’ und der Zellzyklus-Regulation
spielen, wobei sich keinerlei Informationsgehalt u¨ber die reguliert vorliegenden lncRNAs und neu as-
semblierten Gene ergab. Um auch fu¨r die durch BzBP reguliert vorliegenden lncRNAs und neu assem-
blierten Gene funktionelle Ru¨ckschlu¨sse zu ermo¨glichen, wurde eine “Weighted Correlation Network
Analysis” (gewichtete Korrelationsnetzwerkanalyse) durchgefu¨hrt. Basierend auf den entsprechenden
Expressionsprofilen innerhalb der verschiedenen Proben wurden dabei zuna¨chst Module (Gruppen)
an hochkorrelierenden Genen identifiziert. Zur weiteren Charakterisierung wurden danach nur jene
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Module ausgewa¨hlt, fu¨r die sich eine immunologische Funktion innerhalb der funktionellen Analyse
ergab. Einige der durch BzBP reguliert vorliegenden nicht-codierenden Transkripte lagen dabei er-
stens als mutmaßliche Schlu¨sselmoleku¨le innerhalb ihrer Module (angezeigt durch ihre hohe intramod-
ulare Konnektivita¨t) und zweitens hochkorrelierend (Korrelation > 0, 85) mit fu¨r TH -Zellen relevanten
protein-codierenden Genen vor. Aufgrund der Schlussfolgerungen, die aus der Netzwerkanalyse gezogen
werden ko¨nnen, gehen wir davon aus, dass diese nicht-codierenden Transkripte eine a¨hnliche Funktion
aufweisen wie die protein-codierenden Gene, mit denen sie in Korrelation vorliegen. So nehmen wir
beispielsweise an, dass erstens die lncRNA Gm15441 bei der Regulierung der Aktivierung von TH -
Zellen eine Rolle spielt, dass zweitens ein neu assembliertes Gen (Name: XLOC 070362, codiert auf
dem Plusstrang von Chr 11: 5804953-5809907) bei der Expression von TH2-Cytokinen beteiligt sein
ko¨nnte und drittens zwei weitere neu assemblierte Gene (XLOC 089487 codiert auf dem Minusstrang
von Chr11: 99181664-99200362 und XLOC 449244 codiert auf dem Plusstrang von Chr7: 125190356-
125192918) bei der Regulierung der Entzu¨ndungsantwort, dabei unter anderem auch bei der Kontrolle
des TH1-TH2-Gleichgewichtes, beteiligt sein ko¨nnten. All diese Prozesse spielen vor allem bei Allergien
und Asthma eine zentrale Rolle, sodass wir ein Modell, welches die Implizierung dieser Transkripte in-
nerhalb verschiedener TH -Zellfunktionen beschreibt und wie ihre Regulierung durch BzBP kritisch fu¨r
die Entwicklung eines allergischen Pha¨notyps sein ko¨nnte, vorschlagen (Abbildung 1).
Eine pra¨natale BzBP-Exposition beeinflusst auch lncRNAs mit assoziierten
germinal-center B-Zellfunktionen
Eine durch pra¨natale BzBP-Exposition hervorgerufene differentielle Genexpression, auch von lncRNA-
Genen, wurde nicht nur in TH -Zellen, sondern auch in Maus-B-Zellen beobachtet. Fu¨r den B-Zelldatensatz
wurde die gleiche Auswertungsstrategie, eine “Weighted Gene Correlation Analysis”, die Ru¨ckschlu¨sse
u¨ber die Funktionen einiger nicht-codierender Transkripte erlaubt, angewandt, die im Rahmen des TH -
Zelldatensatzes bereits Verwendung fand. Um eine “Weighted Gene Correlation Analysis” durchfu¨hren
zu ko¨nnen, wurden ku¨rzlich publizierte RNA-Sequenzierungsdaten, die innerhalb von B-Zellaktivierungs-
und Entwicklungsprozessen aufgenommen wurden [2], in unsere eigenen Daten integriert. Die Ergeb-
nisse unserer Analyse zeigten, dass einige der durch die pra¨natale BzBP Exposition regulierten lncR-
NAs hochkorreliert mit Genen vorlagen, die fu¨r die Funktion von B-Zellen relevant sind. Aufgrund der
Schlussfolgerungen, die aus der angewandten Netzwerkanalyse gezogen werden ko¨nnen, gehen wir davon
aus, dass zwei der in B-Zellen durch BzBP-Exposition reguliert vorliegenden lncRNAs (Gm38865 und
Gm37033 ) eine germinal-center-B-Zell-spezifische Funktion aufweisen. Germinal-center B-Zellen liegen
per Definition in den germinalen Zentren von sekunda¨ren lymphoiden Organen vor, wo sie mehrere Rei-
fungsschritte durchlaufen. So ko¨nnen B-Zellen beispielsweise innerhalb eines dieser Reifungsschritte in
IgE-produzierende B-Zellen umgewandelt werden, was diesen Schritt kritisch werden la¨sst in Bezug auf
die Entwicklung von allergischen Reaktionen. Die Abbildung 2 zeigt ein Model, welches die Rollen
der beiden Transkripte (Gm38865 und Gm37033 ) innerhalb der Funktionsausu¨bung von B-Zellen
beschreibt.
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Durch BzBP regulierte lncRNAs sind potentielle Regulatoren der Entwick-
lung allergischer Reaktionen
Zusammenfassend konnten wir mehrere lncRNAs und neu assemblierte Transkripte identifizieren,
die durch eine pra¨natale Exposition mit BzBP reguliert werden und an TH -Zell-relevanten Prozessen
und der Funktionen von germinal-center B-Zellen beteiligt sein ko¨nnten. Aufgrund ihrer Assoziation
mit kritischen Immunprozessen und germinal-center B-Zellen, welche bei der Entwicklung von Allergien
und Asthma eine Rolle spielen, gehen wir davon aus, dass auch die von uns identifizierten Transkripte
eine Rolle innerhalb dieser Pathologien nach erfolgter pra¨nataler Exposition mit BzBP spielen. Laut
unserem Kenntnisstand wurden die potentiellen Funktionen der von uns in dieser Studie beschriebenen
Transkripte zum ersten Mal hinterfragt und katalogisiert, wobei die hier erzielten Ergebnisse den Raum
fu¨r weitere Untersuchungen in Bezug auf die den Transkripten innewohnenden Funktionsmechanismen
und die genauen Konsequenzen aus ihrer Regulation durch BzBP o¨ffnen. BzBP ist ein weit verbreiteter
Umweltschadstoff, welchem wir alle auf ta¨glicher Basis ausgesetzt sind und welchem nur sehr schwer
auszuweichen ist. Die o¨ffentliche Wahrnehmung in Bezug auf die gesundheitlichen Auswirkungen der
ta¨glichen BzBP-Exposition hat innerhalb der letzten Jahre stark zugenommen, sodass sich erste Ini-
tiativen zeigen, Alternativen zur Verwendung von BzBP zu finden. In der Zwischenzeit ist es dennoch
von enormer Wichtigkeit ein Versta¨ndnis daru¨ber zu schaffen, wie diese Chemikalie zur Entwicklung
verschiedenster Pathologien beitra¨gt, um eines Tages eventuell daraus resultierende Gegenstrategien
zu entwickeln und umzusetzen. Die in dieser Arbeit beschriebene wissenschaftliche Studie stellt dabei
einen ersten Schritt dar, da sie eine komplett neue Informationsebene, was den toxikologischen Effekt
von BzBP und daru¨ber hinaus den pra¨natalen Expositionseffekt von BzBP auf zellula¨re Mechanismen
und die Entwicklung von Allergien und Asthma betrifft, beschreibt. Zudem zeigt unsere Studie, dass
auch nicht-codierende Transkripte bei Entstehung solcher Pathologien von Bedeutung sein ko¨nnten.
Sie schließt somit eine Wissenslu¨cke bezu¨glich der Rolle von lncRNAs innerhalb des von der Umwelt
beeinflussten Gesundheitszustands einzelner Individuen.
Quellen
[1] Susanne Jahreis, Saskia Trump, Mario Bauer, Tobias Bauer, Loreen Thu¨rmann, Ralph Feltens,
QiWang, Lei Gu, Konrad Gru¨tzmann, Stefan Ro¨der, et al. Maternal phthalate exposure promotes
allergic airway inflammation over 2 generations through epigenetic modifications. Journal of Allergy
and Clinical Immunology, 2017.
[2] Tiago F Braza˜o, Jethro S Johnson, Jennifer Mu¨ller, Andreas Heger, Chris P Ponting, and Victor LJ
Tybulewicz. Long noncoding rnas in b-cell development and activation. Blood, 2016.
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Abbildung 1. Durch pra¨natale BzBP-Exposition regulierte, in TH-Zellen vorliegende Transkripte
ko¨nnten bei der Entwicklung eines aus der Exposition resultierenden Asthmapha¨notyps eine Rolle
spielen. Die Analyse unserer RNA-Sequenzierungsdaten in Kombination mit einer “Weighted Correlation
Network Analysis” fu¨hrte zur besonderen zur Kenntnisnahme von vier Transkripten, die bei der Entstehung
von Asthma von Bedeutung sein ko¨nnten. Fu¨r jedes dieser Transkripte sind in dieser Abbildung mehrere
vorgeschlagene Aktionsmodi dargestellt. Rote Markierungen deuten stets auf den Endeffekt einer pra¨natalen
BzBP-Exposition, beispielsweise auf eine resultierende Regulation der Genexpression oder auf eine Konsequenz
bezu¨glich des zellula¨ren Pha¨notyps, hin. Fragezeichen (?) hingegen zeigen an, dass keine Schlussfolgerungen
u¨ber den Endeffekt der Exposition mo¨glich waren.
Das Antisense-Transkript Gm15441 ko¨nnte in Zusammenarbeit mit den γ- und ζ-Ketten des CD3-Komplexes an
der Regulation der TH-Zellaktivierung und der TCR-Expression beteiligt sein. Gm15441 wurde als Konsequenz
der pra¨natalen BzBP-Exposition herunterreguliert. Der schlussendliche Effekt einer solchen Herunterregulierung
bleibt aber offen. Ein zweites Transkript, das neu assemblierte XLOC 070362, codiert hingegen fu¨r ein zellula¨res
Element, welches entweder die Expression des CAMK4-Gens reguliert oder die Aktivita¨t des daraus resultieren-
den Proteins steuert. Die aus der Exposition resultierende Hochregulierung des XLOC 070362-Gens ko¨nnte
somit zu einer Hochregulierung von TH2-Cytokinen fu¨hren. Die zwei neu assemblierten Gene XLOC 089487
und XLOC 449244 ko¨nnten im Gegenzug dazu die Differenzierung von TH-Zellen in TH1-Zellen regulieren.
Somit ko¨nnte die pra¨natale Exposition mit BzBP u¨ber die Beeinflussung der XLOC 089487- und XLOC 449244-
Expression einen Effekt auf das TH1-TH2-Gleichgewicht und somit auf die Entwicklung eines TH2-beeinflussten
Asthmapha¨notyps haben (beschrieben in [1]).
Abbildung 2. Durch pra¨natale BzBP-Exposition regulierte, in germinal-center-B-Zellen vorliegende
lncRNAs ko¨nnten bei der Entwicklung eines aus der Exposition resultierenden Asthmapha¨notyps
eine Rolle spielen. Die Integrierung eines B-Zellentwicklungsdatensatzes in unsere eigenen RNA-
Sequenzierungsdaten in Kombination mit einer “Weighted Correlation Network Analysis” fu¨hrte zur Identi-
fizierung zweier durch die pra¨natale BzBP-Exposition regulierten lncRNAs, welche fu¨r die Funktion von B-Zellen
von Bedeutung sein ko¨nnten. Fu¨r beide lncRNAs sind in dieser Abbildung mehrere vorgeschlagene Aktionsmodi
dargestellt (bebildert durch gru¨ne Pfeile). Gepunktete gru¨ne Pfeile deuten darauf hin, dass wir bisher keinen An-
haltspunkt in Bezug auf die Regulation des Genproduktes/Proteins durch die entsprechende lncRNA gefunden
haben. Schwarze Pfeile hingegen fassen zusammenspielend mit dem entsprechenden Text die Ergebnisse und
Fakten aus bereits publizierten Studien zusammen. Grauer Text und gerade Linien verdeutlichen Vorschla¨ge
und Theorien, die in publizierten Studien gea¨ußert, aber nicht bewiesen wurden. Zudem deuten grauer Text
und gerade Linien auch an, dass Schlussfolgerungen zu einem Protein gezogen wurden, aber die Verbindung
zu einem dazugeho¨rigen “Upstream”-Regulator nicht gezogen wurde (z.B. kann AID von SLIP-GC kontrol-
liert werden, AID selbst kontrolliert die Gro¨ße von germinal-Centers, es bleibt aber bisher offen, ob SLIP-GC
AID auch im Kontext der germinal-Center-Gro¨ße reguliert). Gepunktete graue Linien verdeutlichen Ergeb-
nisse mit homologen Proteine (z.B. die Rolle von M17) oder durch uns formulierte Ideen basierend auf der zur
Verfu¨gung stehenden Literatur. Rote Markierungen hingegen deuten stets auf den Endeffekt einer pra¨natalen
BzBP-Exposition, beispielsweise auf eine resultierende Regulation der Genexpression oder auf eine Konsequenz
bezu¨glich des zellula¨ren Pha¨notyps, hin. Fragezeichen (?) zeigen an, dass keine Schlussfolgerungen u¨ber den
Endeffekt der Exposition mo¨glich waren.
Wir gehen davon aus, dass Gm37033 und Gm38865 bei der Regulation der Gro¨ße von germinal-Centers und/oder
der Regulation der IgE-Produktion, einem charakteristischen Element von allergischen Reaktionen, beteiligt sind.
Aufgrund der Korrelation in unseren BzBP-Expositionsdatensatz denken wir zudem, dass die Beteiligung von
Gm37033 auf der Regulation des TIM-1-Genes beruht.
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